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Abstract 
 
This thesis is concerned with designing and synthesising novel chemosensors for use as multi-
functional imaging agents for both MRI and optical imaging towards Zn
2+
 sensing. 
The divalent zinc ion (Zn
2+
) is an essential biological element for living organisms and partakes in a 
number of biological mechanisms.  As a result, any Zn
2+
 change in its homeostasis can lead to 
implications to a broad range of pathologies, both physical and neurological.  This has made imaging 
Zn
2+ 
ions
 
crucial towards the elucidation of its distribution and function in cells and tissues.  For this 
project, we have been designing novel multi - modal molecular imaging agents that will target Zn
2+
 in 
cells, and hopefully in the presence of possible competing cations. 
It is the synergistic combination of MRI and optical imaging that has led to the design and synthesis 
of a first generation of compounds.  The aims have been to synthesise chemical probes based on MRI 
agents with the ability to sense Zn
2+ 
levels via optical - MRI methods.  In order to synthesise these 
probes, both a Gd
3+
 based MRI contrast agent and chromophore have been used for MRI and 
fluorescence visualization respectively.  A Zn
2+
 sensor has also been attached, which upon binding 
should cause a molecular or electronic change which would be detected primarily via the 
chromophore. 
Three probes were designed and their synthesis towards them explained throughout the thesis.   
The first section of the thesis describes the preparation of a quinoline-based DO3A derivative for 
eventual complexation to a Gd
3+ 
centre.  The synthesis and purification methods are discussed, 
followed by some preliminary studies of the probe‟s behaviour towards Zn2+ ions. 
The second part of the thesis explains the various building blocks required to subsequently synthesise 
the final two probes, by discussing various synthetic approaches, in particular efforts to derivatise new 
fluorophores and Zn
2+
 sensing groups. 
The final part of the thesis discusses approaches towards a 1,7 - bi-substituted DOTA - based Gd
3+
 
complex and a DOTA - based tetraamide Gd
3+
 complex.  The successful probes that were developed 
were fully characterised and have undergone preliminary MRI and biological tests.  They have been 
found to be MRI active with the ability to enter and be non - toxic towards cells with an ability to 
sense Zn
2+
 ions selectively.  Fluorescence tests have also exhibited a change in fluorescence by the 
probe when perturbed by Zn
2+
 ions.     
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1. Introduction 
1.1. Molecular Imaging 
Over the past twenty years molecular imaging has taken a central stage in the scientific community.  
Molecular imaging is the revolutionary technology that has emerged through the convergence of 
various disciplines, including chemistry, biology, physics, medicine, bioinformatics and engineering 
to name but a few.  Molecular imaging focuses on an in-depth understanding of biological processes, 
early detection and characterisation of diseases, and treatment evaluation based on visualising 
molecules and molecular events which occur at the cellular and sub - cellular level in living organisms 
in a non-invasive manner.
1-4
 The field differs from „classical‟ diagnostic imaging by probing for 
molecular abnormalities to allow for early detection, diagnosis and potential treatment of disease 
rather than image the end effects of these molecular alterations.  Molecular imaging makes use of 
chemistry and traditional imaging systems based on nuclear magnetic resonance, radionuclides, 
ultrasound, or the visible-IR region of the optical spectrum to provide powerful new imaging tools 
such as magnetic resonance imaging (MRI), positron emission tomography (PET), single - photon 
emission computed tomography (SPECT), ultrasound, confocal and two-photon microscopy.  Table 
1.1 highlights the various sensitivities and resolutions of some of the molecular imaging techniques 
used.  The variations observed with each modality gives them unique strengths and weaknesses due to 
varying spatial and temporal resolution limits.  Despite weaknesses that exist in each modality, these 
modalities are constantly being modified and improved to make scans quicker, gain better images and 
thus make the overall prognosis a faster process.  From a clinical view, the main advantage is that the 
work should be a straightforward translation from animal work to the clinic. 
 
Modality Spatial 
Resolution 
Time 
Resolution 
Sensitivity 
Magnetic Resonance 
MR imaging 
1
H spectroscopy 
 
Sub - mm 
> mm 
 
1 - 2 s 
> 5 min 
 
mM Gd, nM Fe (≈ 10 cells/voxel) 
> 10 μM 
Nuclear medicine 
PET 
SPECT 
 
mm 
Sub - mm 
 
s - mins 
min 
 
pM tracer 
Sub - nM tracer 
Optical 
Bioluminescence 
Fluorescence 
 
mm 
μm 
 
min 
ms 
 
≈ 100 cells/voxel 
pM 
Ultrasound 
Micro bubbles 
 
μm 
 
Ms 
 
1 bubble 
Table 1.1: Resolution and sensitivities for molecular imaging modalities, modified from Gillies.
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These modalities have also provided the potential for real - time detection in living systems with high 
spatial resolution, specificity and bioavailability information that is difficult or sometimes impossible 
to obtain using conventional techniques such as atomic absorption spectroscopy, radioisotope 
labelling, histochemical techniques and inductively coupled plasma mass spectrometry.  They have 
also provided scientists and clinicians with the ability to obtain in vivo images of anatomy and 
physiology in whole animals and humans.
1-3,6
 
The tools of molecular imaging are the imaging modalities and their corresponding contrast agents, 
which induce an interaction between themselves and a biological target at a molecular level and even 
cellular level, in a number of ways.  These modalities have been developed from traditional imaging 
systems, which span the electromagnetic spectrum from ultrasonic to gamma - ray and X-ray 
frequencies.  Within the spectrum, magnetic resonance imaging (MRI), optical imaging and nuclear 
imaging emerged as key molecular imaging techniques.
2
 Other techniques that have also been 
developed are X-ray and CT imaging and ultrasound. 
The most prominent method, whereby better and clearer images have been obtained has been through 
the use of contrast agents.  Typically imaging techniques use endogenous tissue as contrast to form 
images of specifically targeted tissue.  However, there has been the development of exogenous 
compounds that have the ability to give better spatial resolutions which in turn enhances and/or 
produces a better contrast.
1-3,7
 One main drawback to contrast agents is that each respective contrast 
agent needs to be tailored with specific physical properties to work effectively in its chosen modality.  
Table 1.2 highlights examples of contrast agents that are currently used for the different modalities.   
 
Modality Active agent – Contrast medium Other information 
PET 
11
C (20.4 min); 
19 
F (110 min) – half 
- lives in brackets  
19
F is used in > 80 % of all PET scans. 
SPECT 
111
In (2.8 d); 
123
I (13.2 h); 
99m
Tc 
(6 h) - half - lives in brackets 
99m
Tc used clinically. 
MRI Gadolinium (Gd) based; Iron (Fe) 
based 
Gd is T1 agent (10 - 100 μM); Fe is T2 
agent (1 - 10 μM). 
Ultrasound Microbubbles Stabilized liposomes.  Can be made 
specific with surface ligands. 
Bioluminescence Genetically encoded luciferase Methods are not fully understood or 
developed for in vivo imaging. 
In vivo 
Fluorescence 
Genetically encoded fluorescent 
proteins 
Proteins will aggregate in vivo. 
Table 1.2: Selected examples of common contrast agents used for different modalities, modified from 
Gillies.
5
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The development of contrast agents has become extremely important and continues despite the 
various limitations, which are being circumvented through the improvement of equipment, 
development of better contrast agents and more accurate programs for visualization of data.  From a 
chemistry point of view, one solution has been through the development of multi - modal imaging.  
The limitations of the modalities mean that only specific molecular targets can be assessed and not all 
information on all aspects of biological structure and function can be provided.  Multi-modal imaging 
has the ability to generate more than one signature from a single biological matrix by combining 
modalities, compared to a single signature from use of a single modality.  This can provide conclusive 
validation for future molecular imaging experiments.  Such multi - modal imaging agents have gained 
popularity as a result of this efficient and versatile approach to target validation via multiple imaging 
techniques.
8,9
  
The most popular combination of modalities in molecular imaging has been MRI and optical imaging, 
more commonly fluorescence imaging.
8-10
 Other modalities that have been used together have been 
PET/SPECT and optical imaging, MRI and PET, X-ray tomography and MRI.  For the purpose of the 
project, the combination of MRI and fluorescence imaging will be concentrated on. 
 
1.2.  Multi - Modal Imaging 
Multi - modal imaging is not simply combining two sets of contrast agents from respective modalities.  
In order to have a successful multi - modal imaging agent, both sets of contrast agents must have 
identical pharmacokinetic properties that complement each other.  MRI and fluorescence imaging are 
a good example of this. 
 
1.2.1. Magnetic Resonance Imaging 
MRI has become the slight front runner when compared to other modalities due to its superb 
anatomical resolution.  It has also become an important diagnostic method in both medicinal practice 
and in biological and preclinical research.  It is a non - invasive procedure based on the magnetic 
fields of protons within the body, which eventually forms a two - dimensional view of internal organs 
or tissues.
11
 MRI relies on the enhancement of local water proton relaxation in tissues.  It is the 
change in the intensity of the proton signal of water between voxels which increases the contrast of 
MRI.  The intensity of the signal in each voxel is dependent on several intrinsic parameters, such as 
proton density, longitudinal (R1) and transverse (R2) NMR relaxation rates, and extrinsic parameters, 
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such as magnetic field strength, pulse sequence, and the presence of contrast agents.
1,2
 Currently, 
some 35 % of all clinical MRI examinations are performed with contrast agents.
12
 
MRI contrast agents can be divided into two main groups based on whether they alter the longitudinal 
relaxation time, T1 (the time taken for the protons to realign with the external magnetic field) or the 
transverse relaxation time, T2 (the time taken for the protons to exchange energy with other nuclei).  
Those that alter the T1 relaxation rate are generally based on Gd
3+
 complexes, and known as „positive 
agents‟.  These make up the majority of those that are clinically approved for intravenous 
administration.  Those that alter the T2 relaxation rate are contrast agents based on superparamagnetic 
iron oxide nanoparticles, and known as „negative agents‟.13,14  The main focus in this project will be 
on the Gd
3+ 
- based complexes. 
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Figure 1.1: DOTA ligand (left), Dotarem – DOTA bound to Gd3+ (right). 
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Figure 1.2: DTPA ligand (left), Magnevist – DTPA bound to Gd3+ (right). 
 
 
Gd
3+
 complexes that have been clinically approved are based on polyaminocarboxylate ligands 
forming highly stable complexes (Figure 1.1 and 1.2).  Currently the two types of organic ligands that 
have been used as the main backbone of the contrast agent are either the twelve-membered 
tetraazamacrocyclic cyclen derivatives (cyclen = 1, 4, 7, 10 – tetraazacyclododecane) or acyclic 
triamines (diethylene-triamine derivatives), where each has been synthesized to afford an octadentate 
coordination via several chelating groups.
15
  To date, Dotarem (Figure 1.1) and Magnevist (Figure 
1.2), are the two main contrast agents, that have been clinically approved for intravenous 
administration, with many still being designed and synthesised.
14
  
In order to increase the sensitivity of MRI contrast agents, either the T1 or T2 relaxation times need to 
be altered.  As Gd
3+
-based contrast agents alter the T1 relaxation rate, there are three main approaches 
to affect the T1 value
8
:  
a) Increasing the number of water molecules directly coordinated to the Gd
3+
 ion (q);  
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b) Altering the residence lifetime of inner-sphere water molecules (τm);  
c) Attaching MRI contrast agents to polymers, macromolecular carriers and proteins to 
increase tumbling rate (τR). 
Despite the superb anatomical resolution displayed by MRI, it is let down by its intrinsic insensitivity, 
and the need for relatively high concentrations of molecular agents (0.01 - 0.1 mM) to produce a 
sufficient alteration in the water signal intensity.
1
 This is problematic as most desirable molecules for 
visualisation in molecular imaging can be present in much lower concentrations, falling between the 
nano-molar range and sometimes even the pico-molar range.
5
  The local concentration of the contrast 
agents is also unknown.  This differs with optical imaging, which is capable of submicron resolution 
and has more sensitive contrast agents.  Unfortunately, fluorescence imaging suffers greatly from 
optical aberration and light scattering when given samples thicker than 200 μM.5  
 
1.3.  Fluorescence Imaging 
Fluorescence imaging was one of the earliest imaging modalities developed, with particular effects in 
biological sciences, whereby microscopes have been an important fundamental tool.
16
 Historically 
most microscopic studies have taken place with fixed cells, whereby only a snapshot of what is 
happening can be deciphered, or a hypothesis postulated when working out biological interactions and 
cellular events,
17
 but recent technical advances of light detection, advances in molecular biology, 
chemistry, optics, nanotechnology, the commercial availability of fast, inexpensive computer software 
and an increasing number of novel, improved exogenous probes, has enabled optical imaging for 
studying dynamic processes in living cells.
17-21
  This has opened the door to endless possibilities to 
researchers for imaging and the characterisation of single living cells as well as their dynamic 
processes.  A common technique for studying dynamic cellular events is fluorescence microscopy.  
Fluorescence microscopy itself has revolutionised cell and molecular biology and relies on the 
principle of fluorescence.  
 
1.3.1. Fluorescence Microscopy 
Fluorescence microscopy allows the selective and specific detection of molecules at low 
concentrations with a high signal - to - noise ratio.  It is essential that the targeted molecule fluoresces 
if it is to be of use in fluorescence microscopy
22
.  Contrast agents used to enhance fluorescent 
microscopy images are known as fluorophores.  The first contrast agents that were used for 
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fluorescence imaging were either endogenous tissues, endogenous cellular molecules or exogenous 
fluorescent molecules.  From a synthetic chemistry point of view, small organic fluorophores that 
have been used include organic dyes, such as rhodamine, fluorescein or photo - proteins such as the 
green fluorescent protein
23,24,25
.     
 The huge stumbling block for fluorescence imaging is that living matter is not suited to its study due 
to the scattering properties in visible wavelengths and the light protective mechanism that exist in 
most species to prevent photodamage of internal tissues by the sun.
6
   
 
 
Figure 1.3: Photon absorbance and scatter by various body tissues. From Gillies.
7
 
 
In the UV region, photons are absorbed strongly by macromolecules such as proteins and above 
1000 nm water absorbs photons via rotational and vibrational energy transitions.
7
 Light in the near 
infrared range can transverse tissue very efficiently as the absorption by water and haemoglobin is 
relatively low in this region, known as the diagnostic window (seen in Figure 1.3).  Ideally, in order to 
gain maximum success from the fluorescent probe the wavelength used needs to lie in this diagnostic 
window.  
Fluorescence of these molecules begins when a molecule in a singlet electronic ground state (S0) 
absorbs a photon of suitable energy, and an excited electron is then promoted to an orbital of higher 
energy, which relaxes quickly to an S1 singlet excited state or an S2 singlet state (S2 containing more 
energy than S1).  These singlet states decay via two main methods.  The first occurs with photon 
emission (i.e. fluorescence), or the second, in a nonradiative (NR) manner.  It is the outermost 
electron orbitals of the fluorophore molecule that affect the wavelengths of absorption and emission 
which in turn determines the efficiency of the fluorophore.  Many successful fluorophores possess as 
much conjugation as possible, such as using aromatic molecules where the outer electrons are 
delocalised across the π - bonds.  Aromatic compounds also have a low energy difference that exists 
between the ground and excited state molecules, which means that low - energy photons, usually 
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present in the visible - part  of the electromagnetic spectrum, can be used for exciting electrons, and 
thus, limiting the damage to cells. 
Fluorescence imaging has the ability to achieve submicron resolution.  Its contrast agents are more 
sensitive and less toxic than MRI contrast agents, but it suffers from low depth penetration and light 
scattering of tissues.  This complementary behaviour offers a synergistic effect between MRI and 
optical imaging yielding successful multi-modal imaging agents.
8-10, 99-101
 
 
1.4.  Multi - Modal Imaging Contrast Agents 
These multi-modal imaging contrast agents can combine the high spatial and temporal resolution and 
deep tissue penetration of MRI with the sensitivity of the fluorescence imaging probes.  Fluorescence 
imaging is capable of submicron resolution and optical imaging contrast agents are far more sensitive 
than MRI contrast agents, unfortunately optical imaging suffers greatly by optical aberration and light 
scattering to the other 100 – 300 μM of a specimen.  This makes MRI and optical imaging a 
complementary pairing with their new probes incorporating the advantages of both techniques giving 
a synergistic effect.  Several methods have been used to develop multi-modal contrast agents for MRI 
and fluorescence imaging and can be divided into three classes:  
a) T1 agents covalently bound to a fluorescent molecule;  
b) T1 agents and fluorophore non-covalently associated;  
c) T2 agents covalently bound to a fluorescent probe.   
The majority of multimodal agents are MRI contrast agents coupled to organic dyes, but more 
recently, reports of luminescent lanthanides, characterized by large Stokes shifts and long-lived 
luminescence, or quantum dots have appeared in the literature.
26-29
 The majority of these agents have 
also been found invaluable in the imaging of experimental animals.
26-29
 These contrast agents are 
generally of inherently low sensitivity and lack a real target site, which leaves room for improvement. 
A further application for molecular imaging has been towards the interrogation of metal ion chemistry 
from the subcellular to the organism level with metal responsive small molecular probes coupled to 
various fluorophores and MRI chelating ligands for use in fluorescence imaging and MRI 
respectively.  One metal that has attracted particular interest is the divalent zinc cation.   
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1.5.  Zinc 
1.5.1. Significance of Zn2+ 
The divalent Zn ion is an essential biological element for living organisms, and has attracted 
significant attention due to its role in many vital biological processes.  It is recognised as a vital 
component in catalytic centres and structural cofactors of many Zn
2+
- containing enzymes and DNA-
binding proteins.  It has been found essential in many biological processes such as brain functions and 
pathology, gene transcription, immune function and mammalian reproduction.
30,31,32,33
 As a result, any 
disruption of the Zn
2+
 homeostasis, like Zn
2+
 deficiency or imbalance in Zn
2+
 distribution within the 
body, organ or cell has implications for a broad range of pathologies both physical
34
 and 
neurological.
35
  Those neurological diseases that have most been associated with a disorder in Zn
2+
 
metabolism are Alzheimer‟s disease, amyotrophic lateral sclerosis, epilepsy and ischemic stroke.35  In 
addition to these problems, a number of other bodily functions can be affected, including immune, 
gastro-enterological and endocrine systems.
36,37
  Unfortunately these effects, more often than not 
become involved with other diseases ranging from AIDS
38
 to diabetes
42
, making the consequential 
pathologies worse.   
Although total Zn
2+ 
concentrations are high, the majority of the ion is tightly bound to enzymes and 
proteins.  „Free‟ Zn2+ ions exist in tissues such as the brain, intestine, pancreas and retina, where their 
concentration varies from the subfemtomolar to millimolar range.
30,39,40
 Zn
2+
-secreting cells exist in 
the salivary gland, the pancreatic β-cells and pancreatic exocrine cells, the prostate epithelial cells, 
Paneth cells in the intestine, mast cells, granulocytes, pituitary cells and CNS neurons.
41
 The 
pancreatic β-cells release free chelatable Zn2+ simultaneously with release of insulin such that the local 
concentration of Zn
2+ surrounding activated β-cells may be as high as 0.48 mM.42 Thus, monitoring 
release of Zn
2+
 from β-cells in and ex vivo is an important goal in understanding the mechanism and 
treatment of diabetes in particular.
43
 
As a consequence, imaging Zn
2+ 
has become crucial to the elucidation of Zn
2+ 
concentration, 
distribution, kinetics and functions in cells and tissues.  There is also the added problem that Zn
2+
 
exists in the body as labile and tightly bound zinc pools which have been difficult to separate and 
image.   
 
1.5.2. Zinc Detection Methods 
Despite the large role Zn
2+
 plays, its behaviour is still not completely understood, as a result of its 
„non properties‟44 resulting from its d10 electronic configuration making it spectroscopically and 
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magnetically inert, leaving typical analytical techniques such as UV/Vis spectroscopy and nuclear 
magnetic resonance (NMR) spectroscopy redundant.  Ideally a sensitive non-invasive technique to 
trace and visualise free Zn
2+
 ions is desired.  However early Zn
2+
 sensing methods were invasive and 
could not provide a real-time dynamic image and were limited to post-mortem samples.  Initially, the 
techniques used were atomic absorption spectroscopy (AA), the γ-emitting radioactive isotope 65Zn, 
and colorimetry and staining methods. 
 
1.5.3. Traditional Zinc Sensing Methods 
Atomic absorption (AA) provided a sensitive and selective method for Zn
2+
 detection and has been 
used to track the release of Zn
2+
 into extracellular fluid after neuronal stimulation.  However, AA has 
limited spatial resolution and is destructive to the sample.
45
 An alternative method made use of the γ-
emitting radioactive isotope 
65
Zn.  Radioactive tracing experiments were used to show release and 
uptake of Zn
2+
 upon neuronal stimulation
46
 and to identify brain tumours,
47
 but this procedure exposed 
samples to ionizing and potentially toxic γ-radiation and were ineffective for applications that require 
subcellular resolution.  It was also found that both AA and radioactive tracing techniques were 
incapable of distinguishing between labile and tightly bound Zn
2+
 pools, which meant traditional 
invasive histochemical procedures, such as the use of dithizone pioneered by Maske,
48
 were relied on 
to provide further information about Zn
2+
. 
Dithizone is a colorimetric indicator for labile Zn
2+
 which was able to provide the first evidence for 
exchangeable Zn
2+
 pools in the brain.
48-50
 Dithizone is a Zn
2+
-selective stain but is sensitive to 
environmental factors such as light, solvent and heat.  Timm‟s staining provided a method with 
greater sensitivity to Zn
2+
 in biological samples.  Timm‟s staining is a silver amplification method, 
whereby metals are precipitated using sulfide and subsequently visualised using a silver development 
process.  The original method was developed and modified to furnish Zn
2+ 
specificity.
51-55
 The main 
advantage of Timm‟s staining is that the optical properties of the silver development make the method 
compatible with both light and electron microscopy.  
These methods have been able to provide some information about Zn
2+
 biology, but as mentioned 
earlier, are invasive and unable to provide a real-time dynamic image.  This is where molecular 
imaging differs and has helped towards a greater understanding of Zn
2+
.  Due to high sensitivity, 
fluorescence sensors have been widely used to not only detect Zn
2+ 
ions, but other ions of biological 
and environmental interests.
11,56
 Fluorescent Zn
2+ 
sensors have also been reviewed extensively 
focusing on their various aspects.
12,31,56
 Amongst the most successful alternatives to fluorescence 
imaging has been magnetic resonance imaging (MRI), which allows non-invasive, high resolution 
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imaging of opaque bodies and monitoring of dynamic processes.  The increasing number of MRI 
agents targeted to various metal cations exhibits the active research field.  There has been more 
interest in the development of MRI contrast agents that are able to respond to biological events.
57
 
Furthermore, developments have also seen multi-modal imaging being employed.  A few bimodal 
MRI and fluorescence imaging agents with the ability to respond to not only Zn
2+
 but other analytes 
are being reported in the literature.
58
 
Herein we discuss molecular probes that are fluorescent based and MR-based and to a certain extent 
directed towards biological applications.  Those that are of use when designing a novel probe will be 
included.  This is by no means an extensive list, but rather a synopsis of the probes that could be 
relevant to this project. 
 
1.5.4. Fluorescent Chemosensors for Zinc Detection 
Progress in the area of fluorophore-based chemosensors has contributed significantly to the 
development of a variety of fluorescent probes for the detection of Zn
2+
 ions.  A fluorescent molecular 
probe is made up of a fluorophore attached to a chelating agent or an ionophore with or without a 
spacer group.
31
 A change in the fluorescence intensity or wavelength occurs as a result of analyte 
binding, which leads to a signal output.  This signal transduction follows a mechanism that is either 
caused by charge transfer, electron transfer, excimer formation, or conformation change.  There are 
two main mechanisms that are followed: Photo - induced electron transfer (PET) sensors and photo-
induced charge transfer (PCT) probes, represented in Figure 1.4. 
 
 
Figure 1.4: Schematic representation of the PET and PCT mechanisms. (From Jiang, P.
31
) 
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A number of sub - groups have appeared in the literature.
31,43,56
 Firstly, intensity-based fluorescent 
Zn
2+
 sensors have been used for tracking labile pools of Zn
2+
 in biological systems, with the signal 
derived from a fluorescence microscopy image of a cell stained with a Zn
2+ 
- specific chemosensor 
aiding the determination of the presence of Zn
2+.  Relative λem increases can reasonably be correlated 
with increases of [Zn
2+
], especially when the intensity has been shown to be modulated by externally 
induced changes of Zn
2+
 availability.  However, the fluorescence quantum yield of the sensor is in 
most cases solvent dependent, this in turn is the main cause of limitation of intensity-based 
fluorescent sensors.  Another limitation with intensity-based fluorescent zinc sensors is that it is 
difficult to control the excitation input and collected emission out intensities, especially in biological 
samples, which makes it difficult for these probes to quantify changes in dynamic Zn
2+
 concentrations 
in complex environments.  Ratiometric sensors have been one of the solutions to rectify this problem 
as they have the ability to simultaneously monitor both the free and bound states of the probe.  A 
fluorescent ratiometric sensor responds to an analyte, which causes a shift in its emission maximum 
(λmax-em), which can or cannot occur simultaneously with a variation in intensity.  The shift in the 
emission wavelength, when distinctive enough, allows for the emission maximum of the co - existing 
free and bound Zn
2+
 species to be individually identified, thus allowing the calculation of the ratio of 
emission maxima of the two species.  Together with the known binding constant of the sensor, the 
unknown Zn
2+
 concentration can be determined.  The ratiometric signal is internally calibrated and 
neither the light source nor photobleaching affects the ratio of the signal of the bound sensor to that of 
the unbound. 
 
1.5.5. Quinoline - based probes 
Quinolines and their derivatives were the first fluorogenic agents used for Zn
2+
 imaging in a 
quantitative manner.  Initial studies with 8 - aminoquinoline (8 - AQ)
59,60
 and 8 - hydroxyquinoline (8 
- HQ) found that a fluorescence change was induced due to the interruption of the hydrogen bonding 
amongst these compounds.
31,59,60
  Both 8 - AQ and 8 - HQ were found too reactive and unsuitable for 
biological applications, which led to the introduction of a quinoline sulfonamide moiety by 
Fredrickson to act as fluorescent chemosensors for Zn
2+
 and Cd
2+
 ions, and became the first probe to 
be applied for in vitro imaging of Zn
2+
.
61
   
TSQ (Figure 1.5), 1, was found to be a pH independent, selective and non-toxic probe.  It became 
widely used to localise Zn
2+
 pools in the central nervous system
62,63
 and to stain pancreatic islet cells 
selectively for their flow cytometric isolation.
64,65
  Unfortunately 1 suffered from poor water 
solubility.  In an attempt to minimise and in some cases eradicate this issue, many derivatives such as 
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the Zinquin homologues (examples being 2 and 3, Figure 1.6) were prepared by introducing 
carboxylate groups and ester groups.
66,67
 
 
1 
Figure 1.5: TSQ probe.
62,63
 
 
The quinoline dye has allowed for a greater understanding towards Zn
2+
 biology but limitations are 
their optical brightness, unstable partition coefficients and ability to form mixed fluorophore to Zn
2+
 
complexes.   
 
Zinquin A 
2 
 
Zinquin E 
3 
Figure 1.6: Zinquin family of probes. 
Despite these limitations with the quinoline fluorophore, fluorescent sensors based on the quinoline 
fluorophore are still being synthesised and tested.  A carboxamidoquinoline with an alkoxyethylamino 
chain was synthesised
68
 (4, Figure 1.7) and shown to exhibit ratiometric behaviour.  Compound 4 has 
shown good water solubility and high selectivity for sensing Zn
2+
 ions amongst other competing 
cations.  Preliminary cellular studies found that 4 could enter yeast cells and signal the presence of 
Zn
2+
.  Following studies in an aqueous buffer solution, an increasing addition of Zn
2+
 saw the value of 
the fluorescence quantum yield increased by 8 and a 75 nm red - shift from 440 nm to 515 nm of 
fluorescence emission observed.  The highest sensing ability for Zn
2+ 
was also found to occur under 
the physiological pH window.   
 
4 
Figure 1.7: AQZ probe. 
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The commonly used Zn
2+
 sensor dipicolylamine (DPA) has also been appended onto the quinoline 
moiety to give 7 - MOQ, 5, (Figure 1.8) as opposed to using the quinoline directly as the Zn
2+
 
sensor.
69
 This sensor displays a high selectivity and sensitivity for Zn
2+
 in biological conditions.  
Sensor 5 also exhibited a 14-fold fluorescence enhancement in response to Zn
2+
.  Further 
derivatization at the methyl at the R - position to a dodecyloxy group (6) saw enhanced cell 
permeability and positive imaging Zn
2+ 
in living cells using a two-photon microscopy. 
 
 
R   
Me = 5 .Zn 
DDC = 6 .Zn 
Figure 1.8: 7 - MOQ probe. 
 
1.5.6. Xanthene based fluorophores 
The xanthene family of compounds contains fluorophores such as fluorescein, rhodamine and eosin 
dyes.  In an attempt to shift the excitation wavelength up from the UV region, a library of compounds 
based on a fluorescein platform has been developed by Lippard and Tsien (Figure 1.9 and Figure 
1.10). 
70,71
  
 
 
 
 X   
 Cl = ZP1 - 7  
 H = ZP2 - 8  
 F = ZP3 - 9  
Figure 1.9: ZP family of probes. 
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The Zinpyr (Zp) probes (5-14) make use of the DPA chelating agents.  The first member of the Zp 
series, Zinpyr - 1 (7) combines a dichlorofluorescein core with two appended DPA moieties at the 4 
and 5 position of the top of the xanthenon ring core.  7 also exhibited selectivity for Zn
2+
 over hard 
metal ions, such as Ca
2+ 
and Mg
2+ 
that are abundant in cellular systems.  These compounds offer 
optical brightness values that are up to 50 fold greater than their quinoline counterparts. 
 
 
X Y Z   
H H Cl = ZP4 -  10 
F H Cl = ZP5 - 11 
Cl H Cl = ZP6 - 12 
OMe H Cl = ZP7 - 13 
H F F = ZP8 - 14 
Figure 1.10: 2
nd
 generation ZP probes. 
 
The fluorescein platform allows for functionalization at different positions which has led to a 
complementary class of fluorescein - based Zn
2+
 probes to the Zp family.  The ZnAF family (15-18) 
also utilise a fluorescein reporter 
72-74
 and DPA receptor for Zn
2+
 detection (Figure 1.11).  The DPA 
receptor is appended to the carboxyphyenyl ring at position 4‟ (15 and 17) or position 5‟(16 and 18).72  
These ZnAF sensors displayed lower background fluorescence values and a larger turn-on response 
compared with their ZP counterparts, however their Zn
2+
 bound forms were not as bright as the 
unbound ZP counterparts.
73
  
The initial success with the ZP family of compound led to further work by Lippard et al.
75
 in an 
attempt to further derivatise the fluorescein core.  The introduction of a naphthalene moiety shifted 
the probe from an intensity based probe to a single wavelength ratiometric based sensor.  ZNP1 (19),
75
 
the seminapthofluoroescein analog of ZP4, made use of the Zn
2+
-induced shift of the 
phenoxynaphthoquinone-naphthoxquinone tautomeric equilibrium.  This seminaphthofluoroescein 
analogue coordinates Zn
2+
 to ZNP which increases the overall intensity of the sensor, which then 
shifts the spectrum to one dominant peak indicative of the phenoxynaphthoquinone tautomer.   
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X 
   
 5-sub = H ZnAF - 1 15  
 6-sub = H ZnAF - 2 16  
 5-sub = F ZnAF - 1F 17  
 6-sub = F ZnAF - 2F 18  
Figure 1.11: ZnAF family. 
 
 
 
19 
Figure 1.12: Probes ZNP1. 
 
When bound to Zn
2+
, 19 exhibits only one absorption band at 547 nm and one dominant emission 
band at 624 nm with a minor band at 545 nm, affording a single excitation dual emission behaviour.  
The addition of Zn
2+
 saw a selective 18 - fold enhancement to the 624 nm emission band.  ZNP1 was 
also found to bind Zn
2+
 with nanomolar affinity with good selectivity over other biologically relevant 
cations.  Further derivitisation to form the ZNP1 diacetate derivative found it membrane permeable 
and used for ratiometric imaging of Zn
2+
 release in COS7 cells. 
 
 One of the main problems with simple ratiometric sensors is that they operate by interference of the 
chromophore upon Zn
2+
 binding.  In order to alleviate this problem a different approach to ratiometric 
Zn
2+
 sensing is a dual excitation and dual emission method, whereby a two-fluorophore system is 
involved.
76,77
 Woodroofe and Lippard introduced this innovative idea using a Zn
2+
 sensitive 
fluorescein-based sensor moiety and a Zn
2+
 insensitive component (a coumarin moiety) conjugated 
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via an ester functionality.  When these fluorophores are conjugated, the conjugate becomes non-
fluorescent due to intramolecular quenching and also able to permeate the cell-membrane.  Once in 
the cell, the non - fluorescent compound is hydrolysed by esterase, causing the chemosensor and the 
coumarin to separate, rendering them both active and fluorescent.  Since both fluorophores possess 
distinctive excitation and emission wavelengths, it was possible to probe them ratiometrically (Figure 
1.13).  Coumazin 1, CZ1, 20
76
 was the first generation probe of this type.  The excitation of the 
coumarin at 445 nm and measurement of the emission intensity at 488 nm provided information 
regarding the cleaved sensor.  Excitation of the fluorescein was at 505 nm and monitoring of the 
emission intensity at 534 nm gave information about the amount of Zn
2+
 present.  CZ1 had low 
nanomolar affinity for Zn
2+
 with good metal ion selectivity towards it as well.  The 2
nd
 generation 
probe, CZ2, 21,
77
 was found to cleave more quickly once in cells, whilst still being able to operate 
within cells.  
 
   
X =   
NH CZ1 20   
O CZ2 21   
Figure 1.13: The first dual wavelength ratiometric Zn
2+
 chemosensor.
76,77 
 
1.5.7. Other Fluorophore Groups 
Other fluorophores have been used to synthesise alternative Zn
2+ 
probes.  These include the BODIPY 
dyes.  BDA (22) is based on the boron dipyrromethene (BODIPY) framework appended to a DPA 
moiety that exhibits a 7-fold increase in integrated emission upon Zn
2+
 binding with a high quantum 
efficiency, desirable optical properties and nanomolar Zn
2+
 affinity (Figure 1.14).
78
  22 was also found 
to be cell-permeable and able to detect changes in labile Zn
2+
 concentrations in live TCA and PC12 
cells, following incubation with ZnCl2.  WZS (23) made use of a 4-aminonaphthalimide fluorophore 
appended to a DPA receptor for Zn
2+
 detection (Figure 1.15).
79
  23 displayed high Zn
2+
 affinity and a 
visible excitation profile.  The quantum yield of Zn
2+
 bound to WZS was found within useful ranges 
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and the dye reported increases in intracellular Zn
2+
 within Zn
2+
 incubated HeLa cells.  Both these 
probes were found insensitive to changes in pH, which is valued in biological settings. 
 
 
22 
Figure 1.14: F - BODIPY based Zn
2+ 
sensing probe BDA. 
 
 
23 
Figure 1.15: An aminonaphthalimide based sensor, WZS. 
 
A particular detail useful for in vivo applications is having fluorophores with the ability to absorb and 
emit light in the NIR region of the electromagnetic spectrum.  This is due to the optical window being 
between 650 and 900 nm, which is capable of penetrating skin and tissue with minimal cellular auto-
fluorescence (mentioned previously in the optical imaging section).  These features combined with the 
low scattering ability of emitted NIR photons means that molecular sensors of this sort are highly 
desirable, although NIR probes for the detection of Zn
2+
 are rare, and only a few exist.
80 
 
 
 
DPA - Cy 
24 
 
Figure 1.16: The only intensity - based probe that is NIR excitable. 
 
A propyl - substituted tricarbocyanine fluorophore attached to a DPA chelate has satisfied these 
requirements (Figure 1.16).  24 can be prepared by a one-step reaction of tricarbocyanine with 2, 2‟-
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dipicolylamine and absorbs at 606 nm and emits at 800 nm in acetonitrile, with a large Stokes shift of 
194 nm.  The fluorescence emission of the probe increases by 20-fold upon binding to Zn
2+
, whereas 
other cations such as Na
+
, Ca
2+
 and Mg
2+
 have no affect on the fluorescence.  24 also cell permeable 
and able to respond to Zn
2+
 in macrophage cells.  One limitation to 24 is that it is an intensity-based 
probe.   
Currently, one ratiometric sensor, with an NIR excitation and emission profile, exists in the literature,  
DIPCY (25) is made of a tricarbocyanine reporter dye with the DPA chelate (Figure 1.17).
81
  Upon 
Zn
2+
 binding, a large red shift in absorption maximum from 627 to 671 nm is observed.  The ratio of 
emission intensities calculated a 5-fold increase upon Zn
2+
 binding with high affinity.  Yet despite 
these desireable features, no biological applications of this probe have been reported.  
 
 
 
25 
Figure 1.17: Probe DIPCY. 
 
 
Other fluorophores that have been investigated for Zn
2+
 sensing also include coumarin derivatives.  
Lim and Brückner altered their coumarin - based sensor with the addition of a DPA moiety to yield 26 
(Figure 1.18).
82,83
  This saw an increase in fluorescence intensity by 23 - fold when one equivalent of 
Zn
2+ 
was added, compared to the 4.4 increase seen by the original probe.
82
 The lactone oxygen atom 
of the coumarin moiety may act as a donor and thus potentially chelates to the Zn
2+
, causing a change 
in the electronic properties of the chromophore.  This ensured the formation of the Zn
2+ 
- complex 27, 
involving the three nitrogen atoms of the DPA and the lactone carbonyl oxygen atom.  26 was 
selective towards Zn
2+
 during competition studies with biologically available cations (Figure 1.18). 
 
 
 
26 
 
 
 
 
27 
Figure 1.18: 2
nd
 generation probe based on a coumarin derivative. 
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Other fluorophores which have formed the basis of several types of Zn
2+
 sensors are based on a 
benzofuran - like derivative.
84
 These probes make use of the internal charge transfer mechanism in the 
electron donating DPA conjugated to the electron-withdrawing benzofuran derivative.  Both probes 
ZnAF-R1 (28) and ZnAF-R2 (29) (Figure 1.19) upon complexation with Zn
2+
,
84
 exhibited a blue shift 
in the excitation maxima, whereas the emission maxima remained unchanged.  The introduction of an 
oxazole moiety in 29 gave it a higher solubility and a better fluorescence quantum yield than 28 in 
water, giving it more use for biological applications.  However 29 is unable to cross the cell 
membrane, and a more lipophilic ethyl ester derivative was introduced to allow entry into the cell.  
This was then cleaved by esterase once in the cell to leave 29 in the cytosol and used to image labile 
Zn
2+
 in live macrophages.
84
   
 
 
ZnAF-R1 
28 
 
ZnAF-R2 
29 
Figure 1.19: 2
nd
 generation probes of the ZnAF series, ZnAF - R1 (28) and ZnAF - R2 (29). 
 
Other benzofuran derivatives (Figure 1.20) rely on the cation - induced inhibition of excited state 
intramolecular proton transfer (ESIPT) mechanism.  This mechanism with the help of benzimidazole 
and benzoxazole scaffolds
85,86
 makes use of a disruption of hydrogen bonds between the heterocyclic 
nitrogen atom lone pairs and those involved with Zn
2+
 chelation to give a ratiometric sensor.  Work 
done by Fahrni
87
 saw the development of similar probes varying only by a picolylamine moiety to 
give a variety of binding affinities (30-32), with evidence of selectivity towards Zn
2+
 over other 
biologically relevant cations with some response seen towards Cd
2+
. 
 
 
30 
 
31 
 
32 
Figure 1.20: Probes that follow the ESIPT mechanism. 
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A novel strategy for metal ion sensors makes use of fluorophores that have the ability to absorb two 
photons simultaneously of double the wavelength (half the energy) to reach the same excited state as a 
chromophore that absorbs one photon of a certain wavelength to reach the same excited state.  The 
fluorescence observed when the fluorophore returns to the ground state is exactly the same.  Some 
two-photon dyes have the ability to absorb in the range above 700 nm giving them a number of 
advantages including a minimization of photo - damage to the tissue and good tissue penetration of 
the excitation and emission photons.   O‟Halloran and co-workers were one of the first to introduce 
probes of this type.  Zinbo - 5, 33, a benzoxazole-based fluorescent sensor that does not use DPA as 
the Zn
2+
 sensor but exhibits a much higher affinity to Zn
2+
 than that of DPA, suggesting that the 
phenolate oxygen and benzoazole nitrogen atoms may provide extra chelating sites (Figure 1.21).  33 
exhibits a characteristic band at 407 nm that shifted to 443 nm upon binding with Zn
2+
.  Except for 
Zn
2+
 and Cd
2+
, all other transition metal cations quenched the fluorescence of 33.  33 shows 
significant Zn
2+ 
- induced changes in quantum yield when bound to free Zn
2+
.
86
 Neither high nor low 
concentrations of alkali- and alkaline-earth metal ions influenced the emission response of 33 to Zn
2+
.  
33 is cell permeable and also capable of detecting changes in intracellular Zn
2+
 concentrations in 
fibroblast cells.  This observation indicates that the probe may be useful in a wide range of biological 
and microscopic applications.   
 
 
 
33 
Figure 1.21: Two photon ratiometric sensor, Zinbo - 5. 
 
Moving away from traditional fluorophores, several lanthanide based Zn
2+
 sensors have been 
synthesized as fluorescent probes with long-excited state lifetimes, meaning that all background 
signals from biological samples can be achieved by gating the detector collection window, however 
very few have been applied successfully for live - cell imaging.
88-92
 It would be possible to continue 
discussing fluorescent Zn
2+
 probes which exist in the literature, but those mentioned above give an 
overview of the designs in the literature and show how initial probes have been developed further to 
become improved Zn
2+
 sensors.  With regards to MRI, far fewer probes have been synthesised.   
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1.5.8. MR Based Zinc Sensors 
Zn
2+
 responsive readouts for MR-based sensors can be produced by the variation in the longitudinal 
(T1) or the transverse (T2) relaxivity or both.  For an effective MR sensor, it must be able to maximize 
the relaxivity change in response to analyte.  Those that exist in the literature rely on the surrounding 
Zn
2+
 sensing moieties, which then alter the local environment around the metal contrast agent.  This 
idea was inspired by seminal work on reporting enzyme activity by Meade.
93
 
As discussed in the MRI section, two main ligands have been used for these Gd
3+ 
- based agents, the 
polyaminocarboxylate chain, DTPA or its cyclic analogue, DOTA.  The first MRI contrast agents 
designed for Zn
2+
 sensing featured the DTPA ligand modified with two DPA groups for external Zn
2+
 
chelation (34).
94
  This sensor was Zn
2+
 concentration dependant and it was found that after 1 
equivalent of Zn
2+
 was added, a decrease of 33 % in relaxivity (6.06 to 3.98 mM
-1
 s
-1
) was noted.  This 
was explained by the behaviour of the DPA moieties (Figure 1.22).  At 1 equivalent, all four pyridine 
moieties are bound to a single Zn
2+
, which blocked the site used by the Gd
3+
 centre for direct binding 
to water.  But once the concentration of Zn
2+
 went up to 2 equivalents, each DPA moiety became 
bound to a single Zn
2+
 ion forming a 2:1 adduct and causing the relaxivity to return to its original 
value.  In order to confirm this, an acetate group replaced a pyridine ring from each DPA moiety on 
either side of the DTPA ring (35).  As with 34 once one equivalent of Zn
2+
 was added a decrease in 
relaxivity was observed.  However once two equivalents of Zn
2+
 was added, the relaxivity value 
remained the same.
94 
 
 
Probe 34 
Figure 1.22: Mechanism toward Zn
2+
 sensing, as proposed by Meade et al.
95
  
 
Chapter 1: Introduction 
35 
 
 
Probe 35 
Figure 1.23: Removal of a pyridine ring for an acetate group for improved probe 35. 
 
De León - Rodriguez developed the cyclic analogue
96
 (36, Figure 1.24) to Nagano‟s DTPA ligand (35, 
Figure 1.23) bi - functionalised with DPA moieties.
94
  The eventual Gd
3+
 metal complex showed a 
relaxivity increase from 5.0 mM
-1 
s
-1 
of the free complex to 6.0 mM
-1 
s
-1 
once 2 equivalents of Zn
2+
 had 
been added in a buffer solution.  However, a remarkable increase was calculated in the presence of 
human serum albumin, the most abundant protein in blood and cerebral fluid, from 6.6 to 17.4 mM
-1 
s
-
1
.  A Zn
2+
 binding constant of 33.6 nM was estimated using a fluorescence competition method.  
Phantom MR images also indicated that Zn
2+
 concentrations as low as 30 μM in the presence of HSA 
could be detected by 36.  The sensor also displayed good selectivity for Zn
2+
 over Ca
2+
 and Mg
2+
.
96
  
 
 
 
Probe 36 
Figure 1.24: Cyclic derivative of probe 34.
96
 
 
 
Although the focus within the Chapter remains on Gd
3+
 based contrast agents, it is hard to ignore 
PARACEST (paramagnetic chemical exchange saturation transfer) MR contrast agents which also 
make use of the DOTA ligand and have an Eu
3+
 metal centre.  PARACEST contrast agents induce 
hyperfine shifts in the signals of proximal NMR-active nuclei.  These shifts can be modulated by 
changes in the lanthanide coordination environment.
97
 37, (Figure 1.25)
98
 contains two DPA moieties 
attached on opposing nitrogens of the DOTA derivative.  A linear decrease in its CEST effect was 
caused when Zn
2+
 bound to the agent.  The phantom MR images produced were able to show that 37 
was selective for Zn
2+
 over Ca
2+
 and Mg
2+
.  However despite the presence of two DPA moieties, only 
a 1:1 complex with Zn
2+
 was formed. 
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37 
Figure 1.25: PARACEST contrast agent based on the DOTA - ligand. 
 
 
38 
Figure 1.26: Smart agent developed by Meade.
95
  
 
Meade developed a smart MR - based contrast agent derived from a DO3A ligand (Figure 1.26).
95
  In 
the absence of Zn
2+
, the metal water coordination site is occupied by a carboxylate group of a 
diaminoacetate moiety appended through the fourth amino group of the macrocycle.
95
  In the presence 
of Zn
2+
, the diaminoacetate group binds to Zn
2+
, leaving the Gd
3+
 metal centre free to coordinate with 
a water molecule.  This behaviour has seen an increase in relaxivity value from 2.3 to 5.1 mM
-1 
s
-1
 
under physiological conditions.  Tests in blood serum did not bring about a greater change in 
relaxivity.  However initial in vitro studies demonstrated that the agent was able to detect 100 μM of 
Zn
2+
 via MRI.  
 
1.5.9. Dual - Based Imaging Agents 
The first dual imaging agent for sensing Zn
2+
 developed was based on a porphyrin platform for use in 
MRI and fluorescence imaging (Figure 1.27).
99
  The metal - free form was able to serve as a 
fluorescent Zn
2+
 sensor, and when Mn
3+
 was inserted into the porphyrin, the metal complex could act 
as an MRI Zn
2+
 sensor.  This agent works by using the water-soluble porphyrin (DPA - C2)2TPPS3 as 
the fluorescent sensor within cells, and the Mn
3+
 complex detects zinc using MRI.  Relaxivity values 
calculated a decrease in R1 relaxivity from 8.70 to 6.65 mM
-1
s
-1
 was calculated when Zn
2+
 was added, 
in conjunction with an increase in R2 relaxivity.  This differed when experiments were run in cell 
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pellets, where both R1 and R2 saw increases from cells that had been treated with Zn
2+
 to those that 
had not.   
 
39 
Figure 1.27: First dual-imaging probe reported for Zn
2+
 sensing.
99
  
 
Using this concept of displacement on a Zinpyr - 1 (ZP1) derivative
100
, the fluorescein based 
compound was pre-complexed with a paramagnetic ion, Mn
2+
, so that it could act as an acceptor for 
the nonradiative energy or electron - transfer process during fluorescence in order to quench it (Figure 
1.28).  This probe ([ZPMn2]) then allows for superior fluorescence contrast.  MRI studies also found 
that [ZP1Mn2] is zinc-responsive with T2 decreasing after the addition of Zn
2+
. 
 
 
Figure 1.28: Use of Mn
2+ 
displacement to provide a bi-modal imaging probe. 
Image obtained from You et al.
100
 
 
Recently, the first, to the best of the author‟s knowledge, a quinoline-based bi-modal agent has been 
synthesised (Figure 1.29).
101 
This Zn
2+ 
selective probe (40) had both its relaxivity and luminescence 
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properties examined.  In the presence of 0.5 equivalents of Zn
2+
, the longitudinal relaxivity increased 
from 3.8 mM
-1
s
-1
 to 5.9 mM
-1
s
-1
 and the fluorescence intensity increased by 7 - fold. 
 
 
40 
Figure 1.29: Quinoline - based bi - modal agent. 
 
1.6.  Criteria For Molecular Imaging Of Zinc In Living Systems 
The probes observed in the literature meet several requirements making them effective reagents for 
molecular imaging of zinc ions in living systems.
31,56,102,103
  The most important criteria is that the 
sensor should be selective for Zn
2+
 over other biologically abundant cations, such as Ca
2+ 
and Mg
2+
.  
Other essential properties include biological compatibility, whereby the Zn
2+
 sensors need to be 
water-soluble, non-toxic and quite stable to a potential shift in pH or ionic strength.  There should also 
be potential to probe extracellular, intracellular or subcellular regions.  
 
1.6.1. Basis of Dual Imaging Agent Design 
Taking all the criteria mentioned above into account, further traits required for an imaging agent are 
favourable pharmacokinetics, its respective imaging modality and ease of delivery to target systems.  
An ideal scenario would be that the cell impermeant probe will be „smart‟ and have the ability to 
specifically accumulate and detect Zn
2+
 at varying concentrations via MRI and fluorescence.  The 
design of our probe will require a fluorophore, MRI-chelating agent and a Zn
2+
 sensor. 
 
1.6.2. Zinc Sensing Agent Design 
A variety of Zn
2+
 sensors have been developed based on quinoline, fluorescein, coumarin, peptide and 
proteins with dissociation constants in the nanomolar range or higher being.
56
  However, these sensors 
are still unable to satisfy detecting demands for Zn
2+
.  In theory, an ideal sensor should have a 
compatible dissociation constant Kd with the concentration of Zn
2+
 ions in the target region, various 
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affinities that have been found suitable have been in the sub - nanomolar range or lower.  Of those 
sensors already in the literature, it is the small molecule sensors that have shown promising Kd 
values
56,104
 and which will remain the focus of this project. 
Generally speaking, the Zn
2+
 sensor for the target compounds could either be a polyamine, that is an 
open-chain type or macrocyclic based followed by attachment to the fluorophore.
31,56,102,103
 The 
popular dipicolylamine (DPA) is also part of a large proportion of the fluorescent probes in the 
literature
31,56,105
 and will be investigated.  Alternatively the Zn
2+
 sensor could be a fluorescent sensor 
such as the quinoline moiety.  Upon binding of Zn
2+
, the molecular or electronic changes that would 
occur would be detected primarily from the fluorophore.  Other examples of Zn
2+
 chelators are 
discussed in more detail in Chapter 3. 
 
1.7.  MRI and Optical Agent Design – The Rationale for this Research 
Due to the extensive research into T1 - contrast agents, contrast agents based on Gd
3+
 chelates were 
investigated.  Typical MRI contrast agent ligands are the cyclic polyaminocarboxylic acid ligand 
DOTA and its linear derivative DTPA.  The former macrocyclic ligand is considered to be a better 
chelator of Gd
3+
 compared to its linear counterpart due to the relatively higher combined 
thermodynamic and kinetic stability, reflecting the greater energy needed to remove the Gd
3+
 from the 
macrocycle in which it is held in
106 
and thus will be used as the basis of the probes designed. 
Metal complexes of 1,4,7,10 - tetraazacyclodecane (cyclen) and its derivatives are found ubiquitously 
throughout the literature.  This has led to their applications expanding beyond contrast agents towards 
luminescent probes, DNA cleavers and medicines for radioimmunotherapy.  Most approaches to MRI 
contrast agents have introduced specific functional groups into the cyclen to improve various factors 
such as tissue selectivity to modify bio - distribution or to give the molecule the ability to sense 
temperature, pH value and even enzymatic activity.   
Early derivatives of the cyclen macrocycle have had four identical coordinating pendant arms 
(DOTA) or have been based on a DO3A platform with only one different pendant arm.   This was 
mainly due to the synthetic challenge involved in synthesising selectively N-substituted 
polyazamacrocycles.  Pioneering work by Sherry
107,108
 catalysed work towards multi-substituted 
derivatives of cyclen and further interest in the regioselective N - functionalisation of cyclen.
109,110
  
Following the initial work on regioselective N - functionalisation of cyclen by Sherry, Yoo et al. 
reported the synthesis of various hetero-substituted cyclen isomers which were synthesised using two 
different pendant arms and mono-protected cyclen for help in preparing a variety of DO3A 
Chapter 1: Introduction 
40 
 
derivatives.
110
 The main strategy towards regioselective N-functionalisation of cyclen generally 
follows the same pattern of regioselective protection, first alkylation, deprotection then second 
alkylation.
110
 Researchers found the protection followed by functionalisation is a more reliable and 
efficient method towards target compounds, however direct functionalisation of N-alkylated 
precursors have been applied in some cases avoiding protecting groups.
111
 For this project, it was 
necessary to design a simple synthesis towards a bioconjugable lanthanide chelate, which would then 
allow for large scale and facile synthesis with clinical applications in mind.  A synthesis that was not 
too synthetically challenging was the main motivation and therefore attempts to avoid protecting 
groups as much as possible to decrease the number of synthetic steps and prevent use of harsh 
deprotecting conditions was designed.   
The optical component of the imaging probe needs to be photostable, with good fluorescence 
selectivity and sensitivity.  Initial work will start on F-BODIPY dyes, the Rhodamine B dye and 
dansyl fluorophores.  Successful work on these fluorophores will lead to the use of more elaborate 
fluorophores or those that excite in the near-IR region will be used, for further cellular studies.  The 
fluorescent sensors need to have excitation and emission profiles in the visible range or lower energy, 
in order to minimise photodamage to cells and tissue and minimize any autofluorescence experienced 
by the cell.  Probes that carry near-infrared (NIR) profiles would be even more desirable with the 
added ability of penetrating through the skin and thicker specimens.  Fluorescent reporters for 
biological imaging also need large extinction coefficients and quantum yields to maximise optical 
brightness. 
1.7.1. Target Compounds 
Taking into consideration all the aspects required for a successful multi-modal imaging agent with 
Zn
2+ 
responsive properties, the following compounds in Figure 1.29 were designed and will be 
explained in more detail in subsequent chapters. 
  
 
Figure 1.29: Target compounds taking into account the various criteria. 
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1.8.  Thesis Synopsis 
Despite the large array of Zn
2+
 sensors that have been designed and synthesised over the past decade, 
Zn
2+
 sensors with greater sensitivity, selectivity and reliability especially with in vivo applications are 
still being sought.  This would ultimately allow for the detection of Zn
2+
 in organisms to allow for a 
greater understanding of its biological role, and also potentially lead to the development of a 
diagnostic tool for Zn
2+
-mediated diseases.  Thus far, the major setback has been that the majority of 
Zn
2+
 sensors suffer from poor water solubility and recognition of metal ions.   
The aims for this study are to develop and synthesise chemical probes based on Gd
3+ 
agents with the 
ability to sense Zn
2+ 
levels intra - and extra - cellularly via optical - MRI methods, thus respectively 
giving in vivo biomarkers of β - cells and their function.  In order to synthesise a novel optical-MRI 
Zn
2+
 imaging probe, both an MRI contrast agent and chromophore need to be incorporated, for MRI 
and fluorescence visualization respectively.  As said before, despite the high resolution anatomical-
functional information MRI provides, it is relatively insensitive when compared to all other 
modalities, and therefore the inclusion of the high sensitive optical methods is advantageous. 
And so, for this project novel dual - modal imaging agents that will target Zn
2+
 shall be designed 
bearing in mind that the combination of MRI and optical imaging will require certain properties.  The 
chemistry involved will potentially allow the exploration of previously unexplored aspects of body 
functions and diseases, which will inspire a new generation of probes to study Zn
2+
 ion function. 
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2. Design and Synthesis Towards A Gd3+ - Based DO3A-Derivative 
2.1.  Introduction 
Due to their high sensitivity, fluorescence sensors have been widely used to detect metal ions of 
biological and environmental interest.  The quinoline fluorophore was one of the first platforms used 
to form early Zn
2+
 fluorescence sensors due to its high selectivity, low toxicity, cell permeability and 
facility towards functionalisation.
1,2
  Following attempts to make these sensors more biologically 
compatible with the introduction of additional groups such as the sulphonamide group, a set of 
Zinquin homologues were prepared,
3,4
 which led to a further understanding towards Zn
2+
 behaviour in 
live-cell imaging.
3,4
 Although these quinoline dyes have increased the understanding of Zn
2+
 biology 
they are still limited by their optical brightness and unstable partition coefficients and as a 
consequence, alternative fluorophores have been used and more recently other imaging modalities 
have been investigated.
5
 
Yet despite these limitations, probes based on the quinoline platform are still being synthesised and 
tested.  Focusing on small molecules, and in particular the one designed by Zhang et al.
6
 Zhang 
synthesised a Zn
2+
 sensing fluorescent sensor with a carboxamidoquinoline attached to an 
alkoxyethylamino chain (mentioned in Chapter 1), however no further functionalization for use as a 
bimodal imaging probe has yet to be reported, to date.   
 
 
 
Figure 2.1: Quinoline - based Zn
2+ 
sensing probe by Zhang.
6
 
 
The introduction of the carboxamido group was advantageous towards the deprotonation of the 8-
amino group for fluorescence enhancement
7
 and based on the photo-induced electron transfer (PET) 
mechanism.  Once the Zn
2+ 
was bound to the sensor, the intramolecular hydrogen bond of the 8-
aminoquinoline was broken rendering the intramolecular electron - transfer process forbidden,
8
 and so 
enhancing the fluorescence emission.  At the same time, the deprotonation process strengthened the 
electron donating ability from the nitrogen atom of the 8 - amino group to the quinoline ring, and the 
electron transfer from the nitrogen atom of the heterocycle to the metal ion further enhances the 
intramolecular charge transfer (ICT) process and fluorescence.  The short alkoxyethylamino chain 
introduces two additional metal coordination sites as well as a hydrophilic group giving enhanced 
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binding properties and water solubility properties.  The probe was also found to be selective towards 
Zn
2+
 and able to penetrate the cell membrane of living cells. 
A tetraazacyclododecane - 1,4,7-triacetic acid (DO3A) moiety was to be introduced to this Zn
2+
 
sensor, followed by complexation to a lanthanide centre, in particular Gd
3+
 to give a bimodal MRI and 
fluorescence imaging probe.  The dual - modality concept considered in the synthesis of this new 
paramagnetic and fluorescent Zn
2+
 sensor is valuable as both anatomical information (MRI) as well as 
very sensitive localisation is achievable (ex vivo fluorescence microscopy).  The idea of introducing a 
quinoline derivative to a Gd
3+
.DO3A moiety has been confirmed with the recent synthesis of a 
bimodal MRI and fluorescent imaging probe based on an 8 - sulfonamidoquinoline fluorophore and a 
Gd
3+
.DO3A moiety.
9
 This probe exhibited turn - on behaviour in the presence of Zn
2+
 and displayed 
relaxivity enhancement with improved signal contrast.  The sensor also displayed good 
biocompatibility and cell membrane permeability.   
This chapter will focus on the synthetic route towards complex Gd.1 (Figure 2.2).  This cyclic 
derivative was chosen in place of the linear derivative of the ligand, DTPA, as it has been seen to be a 
more effective chelator of Gd
3+
, with the capability of retaining the metal ion even in the acidic 
environment of endosomes.  Also, the majority of the clinically approved MRI agents that are based 
on this cyclic polyamine macrocycle have shown high in vivo stability and exhibit minimal toxicity.
10
 
Although the main focus is forming the Gd
3+
- complex, other lanthanide (Ln
3+
) metal centres will be 
considered, mainly europium (Eu
3+
) so that physical measurements, in particular NMR experiments 
can be carried out.  For the purpose of simplicity, Gd
3+
 is used in schemes throughout the synthesis 
towards the complex.  The Gd
3+
 centre provides the ligand with MRI properties which could lead to 
tests in clinical settings if successfully synthesised.   
 
 
 
Gd.1 
 
 
Figure 2.2: Target compounds (see chapter 1). 
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2.2.  Synthesis Development Towards Gd.1 
A retrosynthetic analysis of target compound 1 is shown in Scheme 2.1.  Firstly, the Gd
3+ 
complex is 
made from the metal-free ligand 2 by the addition of a Gd
3+
 source such as GdCl3 or Gd(OTf)3.  
Ligand 2 is formed by the removal of the tert - butyl groups of the acetate groups of macrocycle 3 
under acidic conditions.  Most applications that involve the conjugation to the DO3A macrocyclic 
ring are carried out through covalent linkage of a suitable synthon.  Thus, disconnection between the 
alkylethoxyamino - quinoline probe and the protected-DO3A gives the protected - DO3A 4 and probe 
5, with X being an improved leaving group to the OH group of the original probe for facile addition 
towards the target compound.   
 
 
1 
 
 
2 
 
 
 
 
 
 
 
3 
 
 
4 
+ 
 
5 
 
  
 
 
 
 
  
 
6 
 
 
7 
+ 
 
8 
 
   
 
 
 
+ 
 
+  
9 
Scheme 2.1: Retrosynthetic analysis of target compound Gd.1 
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As per the literature
6
 the quinolone-based Zn
2+
 probe 5 can be disconnected between the secondary 
amine of the alkoxyethylamino chain and the CH2 adjacent to the carbonyl group to give 7 and 8.  The 
quinoline derivative can be further disconnected at the amide bond to give the starting 8-
aminoquinoline and chloroacetyl chloride.  Linker 8 would be derived from the starting 2-(2-
aminoethoxyethanol) with initial efforts concentrated towards X being a Cl. 
 
2.2.1. Synthesis Of Cyclen 
Cyclen was synthesised, as in Scheme 2.2 using the protocol developed by Athey and Kiefer.
11
 
Previously, the main procedure used towards the synthesis of cyclen has been the Richman-Atkins 
procedure,
12
 with various modifications of this method being observed over the years.
13-15
 Several 
methods have now deviated away from the use of tosylate chemistry required for the Richman-Atkins 
procedure, for safer and easier replication.
16-18
 
 
 
a 
  
 
10 
b 
 
 
 
11 
c 
  
 
6 
Scheme 2.2: Synthesis of cyclen 
Reagents and Conditions: a) (CH3)2NCH(OCH3)2; b) 1,2 - dibromoethane, K2CO3, MeCN; c) > 90 ˚C, KOH(aq) 
 
Athey and Kiefer made use of bis-imidazoline intermediates towards the synthesis of cyclen following 
work initially done by Weisman and Reed.
16
 Athey and Kiefer made use of a different bis-imidazoline 
intermediate to that of Weisman, the three step synthesis developed exhibited suitability for laboratory 
scale quantities and was found appealing due to the rapid nature of the individual steps.  The reaction 
started with the formation of bis - imidazoline 10 from triethylenetetramine and N,N-
dimethylformamide (Scheme 2.2(a)).  The dielectrophilic substrate, 1, 2 - dibromoethane was reacted 
with 10, which following attack on one of the CH2 groups from one of the nitrogen atoms in the bis -
imidazoline compound, led to the loss of HBr and formation of an intermediary carbene, which 
underwent an intramolecular carbene carbon - hydrogen insertion.  This formed an electronically 
neutral amidine which readily displaced the remaining bromide to yield the monoimdazolinium 
compound 11.  The desired cyclen (6) was released following treatment with an alkali solution.  
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2.2.2. Synthesis of Protected - DO3A 
MRI contrast agents based on the DO3A platform are generally synthesised from the alkylation 
between the tris - tert - butyl ester of DO3A and an appropriate pendant arm.  1,4,7,10 –
Tetraazacyclododecane - 1,4,7 - triacetic acid (DO3A) is a triacetic derivative of cyclen and can be 
synthesised from 1,4,7 - tris(tert - butoxycarbonylmethyl) - 1,4,7,10 - tetraazacyclododecane or the 
corresponding hydrobromide or hydrochloride salt.  The synthesis of the tris - tert - butyl ester of 
DO3A has generally been employed via two methods.  The first method uses cyclen with tert - butyl 
bromoacetate and dimethylacetamide with reaction times varying between 60 h and 19 days and 
yields ranging between 56 - 80 %.
19-22
  Most recently, through decreasing the reaction temperature and 
altering the work-up procedure, Jagadish et al.
23
 were able to obtain yields of 95 % indicating that 
improvements towards the synthesis of the protected - DO3A is something of great interest due to its 
key role in the synthesis of many compounds.  The second method employed also makes use of tert-
butyl bromoacetate and a base such as sodium hydrogen carbonate or triethylamine in acetonitrile 
with cyclen.  This simple procedure gave yields between 42 - 77 %, but is limited to relatively small 
scale syntheses.
24-27
 
 
 
a 
 
4 
 
Scheme 2.3: Synthesis towards protected-DO3A 4 
Reagents and Conditions: a) 
t
BuOCOCH2Br, NaHCO3, MeCN, KI 
 
The second method towards the synthesis of tris – tert - butyl ester of DO3A was followed as work by 
Jagadish et al. has only being published recently and with the disadvantageous wide range of reaction 
times of the first method.  The reaction conditions used by Dadabhoy et al.
24
 were replicated.  Cyclen 
and sodium hydrogen carbonate were left to stir as tert - butyl bromoacetate was added dropwise at 
0 ˚C.  Following, complete addition, the product was obtained via recrystallisation of the solution 
from toluene.  The product was confirmed via 
1
H NMR spectroscopy and ESI
+
 mass spectrometry and 
results compared to those to the literature.
24
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2.2.3. Attempts Towards Synthesis Of The Carboxamidoquinoline Derivative 
The terminal OH group of the original probe
6
 was subject to manipulation, as it was not observed to 
have any participation in the Zn
2+
 binding.  An extensive literature search revealed that halides were 
used frequently to aid attachment to protected - DO3A moieties.  In order to introduce a terminal Cl, a 
retrosynthetic analysis of the desired compound is shown in Scheme 2.4 and exhibits two possible 
approaches. 
 
 
 
12 
 
 
 Method 1 
 
 
 
Method 2 
 
+   
 
13 
Scheme 2.4: Retrosynthetic analysis for Cl derivative 12:  
a) disconnection between 2˚ amine and acetamide (method 1 - dotted line);  
b) conversion to Cl from starting OH group (method 2 - bold line) 
 
Method 1 (Scheme 2.5) converted the terminal OH of the alkoxyethylamino chain to a Cl.  This Cl 
derivative of the alkoxyethylamino chain had previously been synthesised
28
 and used for reacting with 
a 2 - (chloroseleno)benzoyl chloride.
29
 The methods employed for this could allow for the Cl 
derivative to be treated with acetamide intermediate 7, which itself was made from the literature and 
broken down further as seen previously in Scheme 2.1.  Method 2 (Scheme 2.6) would synthesise the 
probe as per the literature and convert the terminal OH group to a Cl. 
 
 
 
b 
 
 
 
 
a 
 
 
 
 
  
C 
Scheme 2.5: Attempted synthesis towards the Cl derivative: 
Reagents and Conditions: a) ClCH2COCl, C5H5N, CHCl3, rt 2 h; b) HCl(g), SOCl2; c) failed 
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Method 1 made use of previous work where the terminal OH of the alkoxyethylamino chain had been 
to a Cl for subsequent addition to an amine.
28
  The alkoxyethylamino chain was converted to its 
corresponding chloride salt via conditions originally used by Lown and McLaughlin (Scheme 
2.5(b)).
28
 The only adjustment made to the original protocol was that recrystallization from 
ethanol/ether was deemed unnecessary as the product was pure enough and yields comparable to the 
literature.  The 
1
H NMR spectrum was consistent with the literature values.  The 
carboxamidoquinoline derivative 7 was synthesised as per the literature via chloroacetyl chloride and 
8-aminoquinoline.  The nucleophilic nature of the primary amine led to attack on the carbonyl group 
of the acyl chloride which led to the formation of an amide bond.  The resultant quinoline derivative 7 
(Scheme 2.1) was confirmed by the emergence of a singlet peak at 4.34 ppm in the 
1
H NMR spectrum 
indicating the CH2 group, and the compound was further confirmed by LC/MS spectrometry.
6
   
Liu had made use of this 2 - (2 - chloroethoxyl)ethylamine salt for addition to 2 -
(chloroseleno)benzoyl chloride, as mentioned previously, with reaction conditions suited to the 
desired product.
29
 The conditions made use of 10 equivalents of the chloride salt to 1 equivalent of 7.  
Both these reagents were left to stir with Hünig‟s base to give a brown sticky oil, which was passed 
through a silica column using MeOH in DCM in an attempt to isolate the products formed.  The 
compounds that were analysed via 
1
H NMR spectroscopy exhibited the chloride salt starting material 
and Hünig‟s base.   
A variety of conditions were explored in an attempt to synthesise and isolate the desired compound.  
These included an increase in reaction temperature, a change in solvent and a modification in 
stoichiometry to 1:1.  These changes did not give a positive change whilst the reaction was monitored 
via 
1
H NMR.  The reaction was heated under reflux, having initially been left stirring with an excess 
of triethylamine to remove interfering salts, and monitored over 48 hours.  Both TLC and the 
1
H 
NMR spectrum indicated that the singlet peak of starting acetamide 7 had shifted upfield from 4.34 
ppm to 3.31 ppm.  This was hypothesised as the new CH2 bond adjacent to the NH group of the 
previously synthesised 2 - (2 - (chloroethoxy)ethylamine salt.  Following purification by column 
chromatography to remove the excess triethylamine, a yellow powder was obtained and recrystallised 
from toluene and heptane to give pale yellow crystals.  Subsequent analysis of this product led to the 
conclusion that a number of side reactions had occurred due to the increased reactivity of Cl when 
compared to the OH.   
After various attempts at method 1, method 2 was employed in an attempt to improve results.  The 
terminal OH group was treated with thionyl chloride and HCl gas for conversion to a Cl, as shown in 
Scheme 2.6.  The quinoline derivative 7 was treated with an excess of the alkoxyethylamino chain and 
Hünig‟s base.  The mixture was heated under reflux in MeCN for 18 h to form probe 13.  The high 
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heat allowed the primary amine to react with the CH2 group adjacent to the carbonyl of the acetamide 
7 in the presence of Hünig‟s base.  The synthesis of 13 was confirmed by both 1H and 13C NMR 
spectra and comparable to the literature.
6
 Compound 13 was saturated with HCl gas, which could be 
prepared in two ways.  The first made use of the reaction between HCl acid and H2SO4 acid.  HCl acid 
was added dropwise to H2SO4 acid to give off HCl gas, which was bubbled through a solution 
containing 13.  The second method added HCl(aq) dropwise onto CaCl2 forming the gas which was 
bubbled through a solution containing the probe.  The second method was safer and produced 
minimal waste.  After saturation of the original probe with HCl gas, thionyl chloride was slowly 
added (Scheme 2.6) to form the Cl derivative of the original probe as a red solid in low yield.   
 
 
7 
a 
 
 
13 
b  
 
 
12 
Scheme 2.6: Synthesis towards Cl derivative 12  
Reagents and Conditions: a) NH2CH2CH2OCH2CH2OH, DiPEA, CH3CN, heated under reflux, 18 h;  
b) HCl(g), SOCl2, ClCH2CH2Cl. 
 
Both 
1
H and 
13
C NMR spectra exhibited the same pattern of shifts as expected for compound 13.  The 
ESI
+
 mass spectrum displayed dominant peaks at m/z = 308 amu and 330 amu indicating [M + H]
+ 
and [M + Na]
+ 
respectively, this compared to peaks for the OH derivative which were seen at m/z = 
290 amu and 312 amu, indicative of [M + H]
+ 
and [M + Na]
+ 
ions respectively.  
 
 
4 
a 
 
3 
 
Scheme 2.7: Attempted synthesis of probe 3 
Reagents and Conditions: a) various conditions tested 
 
 
The synthesis of Cl - derivative 12 led to several attempts using different bases 
(NaHCO3/K2CO3/Et3N) to try and synthesise 3.  Following unsuccessful attempts to prepare 3, the 
protected DO3A 4 was retrieved following column chromatography along with a second unknown 
substance.  After further analysis of the unknown substance via 
1
H NMR and ESI
+
 mass spectrometry, 
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it was deduced that the NH group positioned at the β-position had undergone cyclization to form a 
thermodynamically favourable six - membered ring compound, observed as 14 in Figure 2.3.  
 
 
14 
Figure 2.3: Hypothesised product 14 
 
With this in mind it was necessary to protect the NH group positioned at the β - position of the 
carbonyl.  The NH of the amide group was protected via tautomerisation with the carbonyl group so 
did not need further protection.  By protecting the NH group at the β-position of the carbonyl, this 
would eliminate the production of product 14 which was detrimental to any potential formation of the 
desired compound. 
 
2.2.4. Synthesis Towards Free Ligand 2 
Various methods for amine protection exist in the literature.  Methods using the tert -
butyloxycarbonyl (Boc) group were investigated.  The first method used Boc2O, 4 -
dimethylaminopyridine (DMAP) (catalytic amounts) in DCM.  No change was observed in this 
reaction as the chemical shift expected at about 1.50 ppm in the 
1
H NMR spectrum, indicative of the 
Boc group, was not observed.  The results remained the same when the reaction temperature was 
gently increased and the amount of DMAP increased.  The second set of conditions explored, left the 
Cl derivative 12 stirring with triethylamine and Boc2O in DCM at room temperature.  Following small 
scale column chromatography, the 
1
H NMR spectrum exhibited peaks indicative of the final 
compound with the Boc peak occurring at 1.56 ppm.  The protected Cl derivative recorded peaks in 
the ESI
+
 mass spectrum at m/z = 408 amu and 430 amu representing [M + H]
+
 and [M + Na]
+
 
respectively with no peak at m/z = 308 amu representing [M+H]
+
 of the unprotected compound being 
seen.  This successful Boc-protection of 12 was used in reactions with DO3A 4.  Unfortunately, 
formation of the desired product was not observed and the general synthetic method had to be re -
addressed. 
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Despite developing methods for synthesis of the intermediates towards the final target compound, the 
yields were too low to repeat the reactions at a decent scale.  Although the reaction conditions to form 
the desired product in a reasonably pure form had been established, the critical chlorination step was 
extremely low yielding, and not economically viable in obtaining sufficient amounts for further 
reactions.   With the chlorination being the lowest yielding step, a new active group was explored.  
Activating the OH group via a mesyl group was investigated (Scheme 2.8).  With the knowledge that 
the secondary amine needed protection, 13 was synthesised, followed by protection of the secondary 
amine with a Boc group, using the same reaction conditions used to protect 12.  The 
1
H NMR 
spectrum of this novel intermediate 15 exhibited the same pattern as 13 as well as a Boc peak at 1.47 
ppm.  The ESI
+ 
mass spectrum gave a peak at m/z = 490 amu for [M+ H]
+
.  15 was further 
characterised via 
13
C NMR spectroscopy, IR spectroscopy and elemental analysis.  Compound 15 was 
left to stir with methanesulfonyl chloride in DCM.  The mesylation reaction was monitored via TLC, 
and the eventual product 16 was isolated in an 85 % yield following purification via column 
chromatography.   
 
 
a
 
 
15 
b
 
 
16 
    c 
 
1 
e
 
2 
d
 
3 
Scheme 2.8: Synthesis towards Gd.1  
Reagents and Conditions: a) Boc2O, Et3N, DCM, rt; b) MsTs, rt;  
c) 4, Et3N, CH3CN, heat; d) TFA:DCM; e) GdCl3.6H2O, H2O 
 
The 3.68 ppm peak present due to the CH3 of the mesyl tosylate starting material was shifted upfield 
to 2.97 ppm and indicated that the mesyl group had activated the OH giving 16.  This novel 
compound was fully characterised via 
13
C NMR spectroscopy and ESI
+
 mass spectrometry.  
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Following the successful activation of the OH group, 16 was left to stir with the protected - DO3A, in 
a stoichiometry of 1:1, and triethylamine in THF.
30
 After a few days, and an increase in temperature, 
the product could not be observed.  A change in solvent to MeCN was only successful once the 
reaction mixture was heated to elevated temperatures.  The formation of 3 was not possible at room 
temperature due to steric crowding, most likely as a result of the bulky Boc groups on both the 
protected-DO3A and 16.  In order to circumvent this problem an increased amount of triethylamine 
and the elevated reaction temperature led to an improvement in yields following column 
chromatography (57 - 65 %).  At room temperature, the protected-DO3A cyclic ring can become a 
conformationally strained system, but upon heating can adopt a more flexible conformation, rendering 
improved access to the free secondary amine of the macrocycle to yield compound 3.  Purification via 
column chromatography had early fractions containing a portion of unreacted 16.  Following a repeat 
of the reaction with a decrease of the stoichiometry from 1:1 of 16 to 4 to 0.90:1, to ensure that all of 
16 had reacted, still saw it being isolated via column chromatography.  This may be due to the 
equilibrium of the reaction, whereby once a certain amount of 16 had reacted, no further reaction can 
take place.  The novel protected-DO3A derivative 3 was fully characterised via NMR, mass 
spectrometry, IR and elemental analysis.  The protected 3 was treated with a mixture of TFA:DCM, to 
free the carboxylic acids.  The 
1
H NMR spectrum exhibited the disappearance of the peak at 
1.45 ppm, indicative of the Boc group and confirming completion of the reaction.  Further analysis via 
13
C NMR and ESI
+
 mass spectrometry confirmed formation of the novel free ligand 2, which was 
subsequently fully characterised. 
 
2.2.5. Synthesis Towards Gd.1 
The first aim was to obtain a Gd
3+ 
complex in order to introduce MRI properties to the probe.  If 
successful upon complexation, attempts to Eu
3+
 complexes will also be tried which would enable a 
number of luminescent and NMR studies for biomedical imaging. 
Numerous methods of stirring the desired DO3A - based ligand in H2O and GdCl3 have been 
successful in the literature,
31,32
 but were not suited to ligand 2.  Initially an excess of the ligand was 
left to react with Gd
3+
 giving a complex free of Gd
3+
 ions.  Several days of stirring and heating to 
elevated temperatures saw Gd
3+
 ions still being detected via the xylenol orange test.
33
  The xylenol 
orange assay is a colourimetric test whereby a colour change from orange to purple is indicative of 
Gd
3+
 complexation to the xylenol orange dye and an indication that free Gd
3+ 
are still present.  If 
however the assay remains orange then no free Gd
3+
 ions are present. 
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Spectrum 2.1: ESI
+
 spectrum of Gd.1 with 
m/z = 773 amu for [M + H]
+
 and 618 amu for [free ligand + H]
+
. 
 
The method employed by Esqueda
32
 gave complex Gd.1.  The reaction mixture was adjusted to pH 
6.5 with NaOH once the reactants had been mixed together.  The pH of the resultant solution was 
maintained between 6 - 6.5 throughout the reaction time.  This method made use of an excess of 
GdCl3, which meant that free Gd
3+
 was still present once the complex had formed.  This free Gd
3+ 
was 
eliminated through precipitation as Gd(OH)3, by adjusting the pH of the reaction mixture to 10.9 and 
leaving to stir.  The supernatant was separated from the Gd(OH)3 precipitate and found absent of any 
free Gd
3+
 ions.  Once the supernatant was concentrated a white powder with a turquoise fluorescence 
was formed and the ESI
+
 mass spectrum exhibited isotopic peaks which gave a pattern indicative of 
the presence of Gd
3+
 with a dominant leak at m/z = 773 amu indicative of [M + H]
+ 
showing that 
complex Gd.1 had formed. 
This method of complexation leads to a number of salt residues such as NaCl in the final complex.  
Several attempts were made to de-salt the complex with Sephadex, however, each time the 
fluorescence of the complex was fully quenched once passed through the Sephadex column.  The 
complex was subsequently used in its salt form and the concentration calculated via the magnetic 
 
 
 
m. wt: 617.69 
m/z = 773 amu 
m/z = 618 amu 
m. wt: 771.02 
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susceptibility shift in the 
1
H NMR spectrum.
33 
This is where the concentration is determined by the 
shift of the bound from the unbound water in the 
1
H NMR using the equation derived by Chu et al.
34 
and used by Peters et al.
33
 In the case of Gd.1, a calculated concentration value of 17.1 mM gave an 
experimental concentration value of 10.2 mM. 
 
2.3.  Photophysical Properties Of Gd.1 
2.3.1. UV/Vis and Fluorescence Spectral Changes Induced by Zn2+ 
The complexation properties of Gd.1 were investigated in H2O.  The amount of Gd.1 was kept 
constant and the absorption and emission spectra were recorded in the presence of increasing amounts 
of Zn
2+
.  Experimental details on the titrations can be found in Chapter 7, section 7.3. 
2.3.2. UV/Vis Absorption of Gd.1 with Zn2+ 
The absorption spectrum of Gd.1 (Figure 2.4) alone shows two broad absorption bands with maxima 
displayed at 205 nm and 230 nm.  These peaks were attributed to the π - π* transitions of the phenyl 
and pyridyl ring present in the quinoline groups.  A band in the region of 290-300 nm, usually seen in 
quinoline based compounds, and attributed to the n - π* transition from the lone pair in the pyridyl 
ring contributing to the quinoline, was not observed.  The absence of the band was postulated as a 
result of the lone pairs of the nitrogen in the quinoline ring being involved in capping the DO3A unit 
and thus limiting the detection of the n - π* transition. 
 
 
Figure 2.4: Absorption spectrum of Gd.1 upon Zn
2+
 titration (0 - 2 equivalents).   
Inset: Close-up of peak between 220 - 250 nm showing an enhancement of absorption with an increasing 
amount of Zn
2+
 ions.  
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The addition of Zn
2+
 (0 - 2 equivalents) gave a pronounced hyperchromic effect (Figure 2.4).  The 
absorbance of all three bands increased sequentially until 0.5 equivalents of Zn
2+ 
was added, whereby 
the absorption continued to increase at smaller increments until 1 equivalent of Zn
2+
 was reached.  
This increase in the absorption was due to Zn
2+
-complex formation.  The band around 290 nm, usually 
observed in absorption spectrum of quinoline based compounds, which was absent in the absorption 
spectrum of the complex became more prominent as more Zn
2+
 ions added.  The change in bands was 
due to the the π - π* transitions between the now present Zn2+ ions with the quinoline ring.  The band 
at 290 nm is induced via the ligand - to - metal charge transfer (LMCT) transition between Zn
2+ 
and 
Gd.1, instead of the free lone pair contributing to the quinoline ring as in the original probe.
6
  By 
fitting the UV/Vis titration curve (Figure 2.5) of Gd.1 with a binding model with Origin 10.0 
software, a 1:1 complex was seen to form giving Gd.1 - Zn
2+ 
species with an association constant of 
2.15 x 10
-3
 M
-1
. 
 
 
Figure 2.5: Absorption titration profile of Gd.1 upon addition of Zn
2+
 showing absorption intensities at 
300 nm and calculated association constant (K). 
 
2.3.3. Fluorescence Emission of Gd.1 with Zn2+ 
Gd.1 displays a fluorescence band centred at around 395 nm and a shoulder band at around 450 nm 
before titration with Zn
2+ 
ions (Figure 2.6).  An addition of Zn
2+
 ions gave no clear trend in 
fluorescence change at 395 nm.  However the shoulder band at 450 nm began to increase in 
fluorescence intensity.  The fluorescence at this band saw a 3.7 enhancement and is specific for Zn
2+
-
complexes due to the energy transfer that occur in Zn
2+
 complexes.
36,37
 The fluorescence enhancement 
at 450 nm was also attributed to the Zn
2+ ion‟s ability to displace the quinoline from capping the 
DO3A unit and interrupting the bond between the two to stimulate fluorescence.  The enhanced 
fluorescence follows a different mechanism to the original probe and bonding between the Gd.1  and 
nitrogen of the quinoline is responsible for a photo-induced electron transfer (PET) process which can 
take place through electron transfer from the donor to the acceptor as opposed to the presence of 
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hydrogen bonding in the original probe.  By the strong coordination of Zn
2+
 to the quinoline unit, the 
PET effect is blocked and the fluorescence is stimulated.  The energy of the non-bonding nitrogen 
electron pair is also lowered and the fluorescence emitting π - π* state becomes excited with the 
lowest energy level instead of the n - π* state.38 
 
 
Figure 2.6: Fluorescence spectra exhibiting emission of Gd.1 (39.87 μM) upon addition of Zn2+  
(0 – 2 equivalents) in H2O (λex= 330 nm). 
 
 
Figure 2.7: Emission titration profile of Gd.1 upon addition of Zn
2+
 showing emission intensities at 
500 nm and calculated association constant (K). 
 
The titration curve of the emission spectrum (Figure 2.7) follows a similar pattern observed with the 
titration curve of the absorption spectrum with a plateau being reached by 1 equivalent of Zn
2+
.  
Fitting the fluorescence titration curve of Gd.1 (39.87 μM) revealed a 1:1 complex of Gd.1/Zn2+ 
species with an association constant of 1.27 x 10
-3 
M
-1
.  The related lower association constant 
calculated from the fluorescence titration than that from the UV/Vis titration might be due to the fact 
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that the free Zn
2+ 
ions can also induce an enhancement in fluorescence.  Energy may also have 
dissipated through molecular collisions, vibrational relaxation or other photophysical processes such 
as phosphorescence. 
The titration curves obtained from the UV/Vis and fluorescence titration experiments gave initially 
indications that the probe was interacting with Zn
2+
.  In order to further confirm this and also reduce 
the amount of experimental error that could be present, each titration will need to be repeated at least 
once so that a mean value can be obtained with errors given as standard deviation (±1σ).  The 
bindging model can also be confirmed via a method of continuous variations (Job‟s plot).46 
 
2.3.4. Preliminary Relaxivity Measurements 
The ability of Zn
2+ 
to affect the longitudinal relaxivity (r1) of Gd.1 was initially determined via an 
NMR titration experiment using T1 measurements at a frequency of 500 MHz at 25 ˚C.  The study was 
performed in H2O, whereby the exact concentration of Gd.1 was calculated via magnetic 
susceptibility shifts in the 
1
H NMR spectrum.  A value of 17.2 mM was initially estimated.  Following 
1
H NMR spectrum, an experimental concentration value of 10.2 mM was calculated.  This solution of 
Gd.1 in H2O was placed into a capillary tube, which was then inserted into a regular sized NMR tube 
with D2O and measurements taken by magnetic susceptibility.  Relaxivity measurements, summarised 
in Table 2.1, were performed at 25 ˚C in H2O at a proton Larmor frequency of 500 MHz.  In the 
absence of Zn
2+
 ions, the complex Gd.1 exhibited a relaxivity value of 1.43  mM
-1
s
-1
, which gradually 
increased upon addition of Zn
2+
.  At 0.5 equivalents of Zn
2+
, the r1 increased by 30 % to 1.86 mM
-1
s
-1
.  
At 1 equivalent of Zn
2+
, the r1 was measured as 1.93 mM
-1
s
-1
.
  
Following addition of two equivalents 
of Zn
2+
, a further increase to 2.23 mM
-1
s
-1 
was observed.  Figure 2.8 shows behaviour in graph form. 
The low relaxivity value observed in Gd.1 is consistent with Gd
3+ 
complexes possessing limited inner 
- sphere water access.
39,40
  
 
Equivalents of Zn
2+
 T1 (s) r1 (mM
-1
.s
-1
) 
0 66.31 1.43 
0.5 51.22 1.87 
1 49.67 1.93 
2 43.06 2.23 
Table 2.1: T1 measurements and relaxivity values (r1) of Gd.1 at 500 MHz in the  
absence and presence of Zn
2+
. 
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Figure 2.8: Relaxivity response of Gd.1 (10.2 mM) to various equivalents of Zn
2+
. 
 
This is a result of the pyridyl N of the quinoline capping the Gd
3+
 centre of the DO3A unit in the 
absence of competing ions.  As Zn
2+
 is added, the r1 value increases due to the preferential binding of 
the quinoline moiety towards Zn
2+
, and thus reducing the binding with Gd
3+
 and steric bulk around the 
Gd
3+
 centre, and affording greater inner - sphere water access to the f
7
 metal ion resulting in an 
increase in relaxivity.  This behaviour supports the hypothesis initially made following the UV/Vis 
titration when the absorption band around 290 nm was extremely weak and thought to be due to the 
nitrogen of the quinoline being involved in coordination with the Gd
3+ 
metal centre.  This increase in 
relaxivity following addition of a metal ion which results in an uncapping of the Gd
3+
 metal centre has 
been observed elsewhere for Cu
2+
 sensors.
39,40
 Relaxivity values can also be affected by the magnetic 
properties of paramagnetic molecules depending on the local geometry at the magnetic centre and 
chemical links between metal centres.  The relaxivity value was not as high as typical values 
exhibiting direct interaction of H2O with the f - shell of the Gd
3+
 ion. It is hypothesised that in the 
presence of Zn
2+ 
although the quinoline moiety uncaps the Gd
3+ 
centre and releases some of the steric 
bulk, however the carbonyl adjacent to the quinoline unit may interfere with the space above the Gd
3+
 
ion and thus preventing some of the direct H2O interaction and thus giving low relaxivity values. 
 
 
 
 
Scheme 2.9: Schematic binding mode of Gd.1 bound to Zn
2+ 
Chapter 2: Design and Synthesis Towards a Gd
3+
-based DO3A Derivative 
65 
 
To make a mechanistic elucidation of Gd.1 complex with the addition of Zn
2+
 ions, a proposed 
schematic diagram is depited in Scheme 2.9.  In the absence of Zn
2+
 ions the lone pair of the nitrogen 
of the quinoline group is involved in bonding with the Gd
3+
 metal centre.  Following addition of Zn
2+
 
the quinoline derivative forms a 1:1 complex, as postulated following UV/Vis and fluorescence 
titrations and acts as a tetradentate ligand to chelate the Zn
2+
 through the quinoline N, amide N donor, 
amine N donor and O from the linker chain.   
This positive response to Zn
2+
 lays the foundation towards a novel quinoline based bi - modal imaging 
agent, however it is also important to remember that although Gd - chelates are thermodynamically 
stable, they are kinetically labile enough to undergo transmetallation by endogenous ions such as 
Zn
2+
, Cu
2+
 or Ca
2+
.
41-44
 Transmetallation can be assessed via a simple relaxometric protocol previously 
developed to study the in vitro transmetallation processes of Gd-complexes.
45
 This method measures 
the evolution of the paramagnetic longitudinal relaxation rate of water protons at physiological 
conditions in a phosphate buffer solution containing an equal concentration of Gd - complex and 
ZnCl2 (or other cations).  If transmetallation were to occur the Gd
3+
 would precipitate out as GdPO4 
and have a negligible influence on the longitudinal relaxation rate of water
45
 thus reducing the original 
value of the longitudinal relaxation rate of water.  This test could be applied to Gd.1 to measure its 
susceptibility towards transmetallation. 
 
2.4.  Conclusions 
Complex Gd.1 is a novel Zn
2+
-responsive multi-functional imaging agent that has been designed and 
synthesised, using the fluorescent probe initially synthesised by Zhang.
6
 Initial efforts to functionalise 
the original probe were challenging but after different synthetic attempts and synthesis of novel 
intermediates, a reliable synthesis for the Gd
.
1 has been demonstrated.   
The Gd.1 sensor combines a Gd.DO3A core with a carboxamido-quinoline unit attached via an 
aminoethoxyethyl linker.  Complex Gd.1 exhibits fluorescence enhancement upon addition of Zn
2+
 at 
460 nm due to the energy transfer associated with Zn
2+ 
complexes with a binding association constant 
calculated at 2.15 x 10
-3
 M
-1 
from the fluorescence titration curve and 1.27 x 10
-3
 M
-1
 from the UV/Vis 
titrations curve.  Through the introduction of a Gd.DO3A core to the fluorescent probe, the 
coordination ability of the quinoline was restricted by the Gd
3+
 centre which resulated in a low 
relaxivity value.  Once Zn
2+ 
was added, it broke the bond between the Gd
3+
 and the quinoline to leave 
the inner-sphere of the Gd
3+
 free for access of H2O molecules which led to a subsequent increase in 
relaxivity. 
 
Chapter 2: Design and Synthesis Towards a Gd
3+
-based DO3A Derivative 
66 
 
2.5.  References 
1. Leroux, N., Goethals, M., Zeegers - Huyskens, T. Infrared Study of the Hydrogen Bonding 
Ability of 3 - Aminoquinoline and 8-Aminoquinoline. Vibrational Spectroscopy  9, 235 - 243 
(1995). 
2. Van Meervelt, L., Goethals, M., Leroux, N., Zeeger - Huyskens, T. X - Ray and Vibrational 
Studies Of 8 - Aminoquinoline.  Evidence For a Three-Center Hydrogen Bond. Journal Of 
Physical Organic Chemistry 10, 680 - 686 (1997). 
3. Zalewski, P. D., Forbes, I. J., Betts, W. H. Correlation of Apoptosis with Change in Intracellular 
Labile Zn(II) Using Zinquin [(2 - methyl - 8 - p – toluenesulphonamido - 6 - quinolyloxy)acetic 
acid], A New Specific Fluorescent Probe for Zn(ll). Biochemical Journal 296, 403 - 408 (1993). 
4. Mahadevan, I. B., Kimber, M. C., Lincoln, S. F., Tiekink, E. R. T., Ward, A. D., Betts, W. H., 
Forbes, I. J., Zalewski, P. D.  The Synthesis of Zinquin Ester and Zinquin Acid, Zinc(II) - 
Specific Fluorescing Agents for Use in the Study of Biological Zinc(II) Australian Journal of 
Chemistry 49, 561 - 568 (1996). 
5. Que, E. L., Domaille, D. W., Chang, C. J. Metals in Neurobiology: Probing Their Chemistry and 
Biology with Molecular Imaging. Chemical Reviews 108, 1517 - 1549 (2008). 
6. Zhang, Y., Guo, X., Si, W., Jia, L., Qian, X.  Ratiometric and Water - Soluble Fluorescent Zinc 
Sensor of Carboxamidoquinoline with an Alkoxyethylamino Chain as Receptor. Organic Letters 
10, 473 - 476 (2008). 
7. Hiratmi, K., Hirose, T., Kasuga, K., Saitof, K. N - (8 - Quinolyl) - N' - (2 -
pyridylmethyl)malonamide Derivatives as a Novel Cu(II) Carrier with High Efficiency and 
Selectivity for Proton - Driven Uphill Transport through Liquid Membranes. The Journal of 
Organic Chemistry 57, 7083 - 7087 (1992). 
8. Jiang, P., Guo, Z. Fluorescent Detection of Zinc in Biological Systems: Recent Development on 
the Design of Chemosensors and Biosensors. Coordination Chemistry Reviews  248, 205 - 229 
(2004). 
9. Luo, J., Li, W. -S., Xu, P., Zhang, L. -Y., Chen, Z. -N. Zn
2+
 Responsive Bimodal Magnetic 
Resonance Imaging And Fluorescent Imaging Probe Based On A Gadolinium(III) Complex. 
Inorganic Chemistry 51, 9508 - 9516 (2012). 
10. Aime, S., Fasano, M., Terreno, E. Lanthanide(III) Chelates for NMR Biomedical Applications. 
Chemical Society Reviews 27, 19 - 29 (1998). 
11. Athey, P. S., Kiefer, G. E. A New, Facile Synthesis of 1,4,7,10 - Tetraazacyclododecane: Cyclen. 
The Journal of Organic Chemistry 67, 4081 - 4085 (2002). 
12. Richman, J. E., Atkins, T. J. Nitrogen Analogs of Crown Ethers. Journal of the American 
Chemical Society 96, 2268 - 2270 (1974). 
13. Vriesema , B. K., Buter , J., Kellogg, R. M. Synthesis of Aza Macrocycles by Nucleophilic Ring 
Closure with Cesium Tosylamides. The Journal of Organic Chemistry 49, 110 - 113 (1984). 
14. Chavez , F., Sherry, A. D.  A Simplified Synthetic Route to Polyaza Macrocycles. The Journal of 
Organic Chemistry 54, 2990 - 2992 (1989). 
15. Panetta, V., Yaouanc, J. J., Handel, H. Triflamides for Protection and Cyclization of Tetraamines 
to Tetraazamacrocycles. Tetrahedron Letters 33, 5505 - 5508 (1992). 
16. Weisman, G.R., Reed, D. P. A New Synthesis of Cyclen (1,4,7,10 - Tetraazacyclododecane). The 
Journal of Organic Chemistry 61, 5186 - 5187 (1996). 
17. Hervé, G., Bernard, H., Toupet, L., Handel, H. Condensation of Glyoxal with 
Triethylenetetraamine; Isomerization and Cyclization. European Journal of Organic Chemistry, 
33 - 35 (2000). 
18. Ferrari, M., Giovenzana, G. B., Palmisano, G., Sisti, M. A Practical Synthesis of 1,4,7,10 -
Tetraaza - Cyclododecane, A Pivotal Precursor for MRI Contrast Agents. Synthetic 
Communications 30, 15 - 21 (2000). 
19. Himmelsbach, R.J., Rongved, P., Klaveness, J., Strande, P., Dugstad, H. PCT WO 93/02045. US 
(1991). 
20. Berg, A., Almen, T., Klaveness, J., Rongved, P., Thomassen, T. US Patent 5,198,208. (1993). 
Chapter 2: Design and Synthesis Towards a Gd
3+
-based DO3A Derivative 
67 
 
21. Axelsson, O., Olsson, A. WO 2006/112723 (2006). 
22. Moore, D.A. Selective Trialkylation of Cyclen with tert - Butyl Bromoacetate. Organic Syntheses     
85, 10 (2008). 
23. Jagadish, B., Brickert - Albrecht, G. L., Nichol, G. S., Mash, E. A., Raghunand, N. On The 
Synthesis of 1,4,7 - tris(tert - butoxycarbonylmethyl) - 1,4,7,10 - tetraazacyclododecane. 
Tetrahedron Letters 52, 2058 - 2061 (2011). 
24. Dadabhoy, A., Faulkner, S., Sammes. P. G. Long Wavelength Sensitizers For Europium(III) 
Luminescence Based On Acridone Derivatives. Journal of the Chemical Society, Perkin Transaction 
2, 348 - 357 (2002). 
25. Prasuhn, J., Yeh , R. M., Obenaus , A., Manchester, M., Finn, M. G. Viral MRI Contrast Agents: 
Coordination of Gd by Native Virions and Attachment of Gd Complexes by Azide–Alkyne 
Cycloaddition. Chemical Communications, 1269 - 1271 (2007). 
26. Mizukami, S., Tonai, K., Kaneko, M., Kikuchi, K. Lanthanide-Based Protease Activity 
Sensors for Time-Resolved Fluorescence Measurements. Journal of the American Chemical Society 
130, 14376 - 14377 (2008). 
27. Li, C., Wong, W. -T. A Selective One - Step Synthesis of Tris N - alkylated Cyclen. 
Tetrahedron 60, 5595 - 5601 (2004). 
28. Lown, J. W., Joshua, A. V., McLaughlin, L. W. Novel Antitumor Nitrosoureas And Related 
Compounds And Their Reactions With DNA. Journal of Medicinal Chemistry 23, 798 - 805 (1980). 
29. Liu, X. -F., Guan, W. -C., Ke, W. -S. Synthesis and Enhanced Neuroprotective Activity of C60 
- Based Ebselen Derivatives. Canadian Journal of Chemistry 85, 157 - 163 (2007). 
30. Perouzel, E., Jorgensen, M. R., Keller, M., Miller, A. D. Synthesis and Formulation of 
Neoglycolipids for the Functionalization of Liposomes and Lipoplexes. Bioconjugate Chemistry 14, 
884 − 898 (2003). 
31. Kamaly, N., Kalber, T., Ahmad, A., Oliver, M. H., So, P. -W., Herlihy, A. H., Bell, J. D., 
Jorgensen, M. R., Miller, A. D. Bimodal Paramagnetic and Fluorescent Liposomes for Cellular and 
Tumor Magnetic Resonance Imaging. Bioconjugate Chemistry 19, 118 - 129 (2008). 
32. Esqueda, A.C., López, J. A., Andreu-de-Riquer, G., Alvarado - Monzón, J. C., Ratnakar, J., 
Lubag, A. J. M., Sherry, A. D., De León-Rodriguez, L. M. A New Gadolinium-Based MRI Zinc 
Sensor. Journal of the American Chemical Society 131, 11387 - 11391 (2009). 
33. Corsi, D. M., Platas - Iglesias, C., Van Bekkum, H., Peters, J. A. Determination of 
Paramagnetic Lanthanide(III) Concentrations from Bulk Magnetic Susceptibility Shifts in NMR 
Spectra. Magnetic Resonance in Chemistry 39, 723 – 726 (2001). 
34. Chu, K. -C., Xu, Y., Balschi, J. A., Springer, J. R. Bulk Magnetic Susceptibility Shifts In 
NMR Studies Of Compartmentalized Samples: Use Of Paramagnetic Reagents. Magnetic Resonance 
in Medicine 13 (2), 239 – 262 (1990). 
35. Barge, A., Cravotto, G., Gianolio, E., Fedeli, F. How To Determine Free Gd And Free Ligand 
In Solution Of Gd Chelates. A Technical Note. Contrast Media & Molecular Imaging 1, 184-188 
(2006). 
36. Mikata, Y., Kawata, K., Iwatsuki, S., Konno, H. Zinc-Specific Fluorescent Response of 
Tris(isoquinolylmethyl)amines (isoTQAs). Inorganic Chemistry 51, 1859 − 1865 (2012). 
37. Liang, J., Zhang, J., Zhu, L., Duarandin, A., Young, Jr., V. G., Geacintov, N., Canary, J. W. 
Structures, Metal Ion Affinities, and Fluorescence Properties of Soluble Derivatives of Tris((6-
phenyl-2-pyridyl)methyl)amine. Inorganic Chemistry 48, 11196 - 11208 (2009). 
38. Kubin, J., Testa, A. C. Excited State Protonation of Phenylpyridines. Journal of 
Photochemistry and Photobiology A: Chemistry 83, 91 - 96 (1994). 
39. Que, E. L., Gianolio, E., Baker, S. L., Wong, A. P., Aime, S., Chang, C. J. Copper-
Responsive Magnetic Resonance Imaging Contrast Agents. Journal of the American Chemical Society 
131, 8527 – 8536 (2009). 
40. Zhang, X., Jing, X., Liu, T., Han, G., Li, H., Duan, C. Dual - Functional Gadolinium-Based 
Copper (II) Probe for Selective Magnetic Resonance Imaging and Fluorescence Sensing. Inorganic 
Chemistry 51 2325 - 2331 (2012). 
Chapter 2: Design and Synthesis Towards a Gd
3+
-based DO3A Derivative 
68 
 
41. Puttagunta, N. R., Gibby, W. A., Puttagunta, V. L. Comparative Transmetallation Kinetics 
and Thermodynamics Stability of Gadolinium - DTPA Bis-Glucosamide and Other Magnetic 
Resonance Imaging Contrast Media. Investigative Radiology. 31 (10), 619-624 (1996). 
42. Corot, C., Idee, J. M., Hentsch, A. M., Santus, R., Mallet, C., Goulas, V., Bonnemain, B., 
Meyer, D. Structure-Activity Relationship of Macrocyclic and Linear Gadolinium Chelates: 
Investigation of Transmetallation Effect on the Zinc - Dependent Metallopeptidase Angio – Tension -
Converting Enzyme. Journal of Magnetic Resonance Imaging. 8 (3), 695 - 702 (1998). 
43. Corot, C., Hentsch, A. –M., Curtelin, L. Interaction of Gadolinium Complexes with Metal -
Dependent Biological Systems. Investigative Radiology. 29 (Supplement 2), S164 - S167 (1994). 
44. Gu, S., Kim, H. –K., Lee, G. H., Kang, B. – S., Chang, Y., Kim, T. –J. Gd-Complexes of 
1,4,7,10 – Tetraazacyclododecane - N,N’N’’,N’’’ - 1,4,7,10 - Tetraacetic Acid (DOTA) Conjugates of 
Tranexamates as a New Class of Blood - Pool Magnetic Resonance Imaging Contrast Agents. Journal 
of Medicinal Chemistry. 54 (1), 143 - 152 (2011). 
45. Laurent, S., Vander Elst, L., Copoix, F., Muller, R. N. Stability of MRI Paramagnetic 
Contrast Media: A Proton Relaxometric Protocol for Transmetallation Assessment. Investigative 
Radiology. 36 (2), 115 - 122 (2001). 
46. Job, P. Annali di Chimica Applicata. 9, 113 - 203 (1928). 
 
 69 
 
 
Chapter 3 
 
Synthetic Routes Towards The Pendant Groups 
For  
Multi - Functional Imaging Compounds 
 
 
 70 
 
3. Synthetic Routes Towards Pendant Groups 
3.1.  Introduction 
The pendant groups of the final multi - modal imaging agents comprise a fluorophore as the 
fluorescent component and a Zn
2+
 sensing group to allow for Zn
2+
 detection.  The complexation to 
Gd
3+
 specifically will provide the final chelate with MRI properties.  This chapter consists of two 
bodies of work regarding the pendant groups required for the macrocycle towards the target 
compounds.  The first part of this chapter will detail the synthesis carried out with the optical probes 
and the second part of this chapter will explain the various methodologies used with the Zn
2+
 sensing 
moieties investigated. 
 
3.2.  Fluorescent Moiety of the Dual - Imaging Agent 
Fluorescence imaging is an indispensable tool in various fields of modern science and medicine, 
including clinical diagnostics, biotechnology, molecular biology and analytical chemistry.
1,2
 The 
fluorophore translates the binding between the analyte and the recognition site into a fluorescence 
output signal, which can often be detected via microscopy.   
Fluorophores are not only highly sensitive and specific but have been used in intracellular 
measurements with great spatial and temporal sampling capability.  In addition, they are simple to use 
and generally are minimally disruptive to cells.  The design, development and application of novel 
fluorophores remains a highly multi - disciplinary research area and a considerable amount of time 
has been invested in developing selective fluorescence sensors for cation detection due to the several 
distinct advantages of these sensors in terms of sensitivity, selectivity, response time and local 
observation.  The introduction of a pendant fluorophore to the macrocyclic ring would allow these 
compounds to be used in a qualitative and quantitative manner for analysis of metal ions in solution 
by means of absorption or emission spectroscopy.  
 
3.3.  Synthesis Towards Novel Metal Chelators and F - BODIPY Dye Derivatives 
3.3.1. F - BODIPY Dyes 
The 4,4 - difluoro - 4 - bora - 3a,4a - diaza - indacene (F - BODIPY) dye is a synthetically versatile 
class of fluorophore,
3-5
 first discovered in 1968 by Treibs and Kreuzer.
6
 This common fluorophore is 
composed of a dipyrromethene core unit linked via a sp
2
 hybridized carbon centre complexed with a 
disubstituted boron atom, typically a BF2 unit. (Figure 3.1) The intermediate of the F - BODIPY dye 
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before complexation of the BF2 moiety is known as a dipyrrin, and will be mentioned more in 
subsequent paragraphs. 
 
 
Figure 3.1: ‘F - BODIPY dye core’ framework and its IUPAC numbering system. 
 
F - BODIPY dyes have been found to be extremely versatile due to their desirable and tunable 
properties including high quantum yields, intense absorption and fluorescence spectroscopic 
properties.
4,7,8
 Varying substituents around the F - BODIPY core, such as including aromatic groups 
and heterocyclic moieties has been advantageous by seeing wavelengths being tuned leading to a shift 
in the absorption and emission maxima by as much as 100 nm.
9,10
 The reasonable stability to different 
solvents and varying pH values coupled with a chemical robustness when in physiological conditions 
has also seen them being used for biological labelling, examining of biological processes,
4,5,11
 and 
more recently for molecular imaging.
12,13
  
The robust nature of the F - BODIPY core towards various chemical transformations has been the 
main driving force for the number of derivatives synthesised.  These transformations include the 
attachment of various secondary units at the pyrrole,
12,14,15
 meso
16,17
 and N-ortho positions
18
 without 
significant decomposition of the dye.  Due to the intricate nature of synthesising unsymmetrically 
substituted F - BODIPY dyes, the focus of this work was the synthesis of symmetrically substituted F 
- BODIPY dyes.   
 
3.3.2. Substitution Around the F - BODIPY Dye 
The most suitable positions for synthesising novel symmetric F - BODIPY dyes are at the 2,6 -
positions,
4,19
 3,5 - positions
20,21
 and 1,7 - positions
22
 (positions can be seen in Figure 3.2).   
 
 
Figure 3.2: F - BODIPY dye delocalised structures with formal charges indicated.   
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Due to the number of positions available for functionalisation of these compounds, work towards 
synthesis of an F - BODIPY dye with novel substituents at the 3,5 - position commenced due to the 
effect on spectral properties whereby a shift in wavelengths have been observed when different 
functional groups have been placed there.  Substitution at the 3,5 - positions have also been observed 
to have pronounced effects on the spectral properties when functionalised via attachment of 
auxochromic substituents at these positions
15
 of the eventual F - BODIPY dye.   
 
3.3.3. Methodologies Towards F - BODIPY Dyes 
The most direct and convenient method to obtain a symmetrically substituted F - BODIPY dye is 
either via condensation of acyl chlorides or other activated carboxylic acid derivatives with pyrroles 
(Figure 3.3).
4,16,23
 F - BODIPY dye derivatives can be achieved by varying the starting pyrrole or 
carbonyl derivative (aldehyde, acid chloride or anhydride), as well as by post - functionalisation at the 
positions mentioned above.   
 
 
+ 
 
 
 
Figure 3.3: General Route of F - BODIPY Synthesis, X = H, Cl, R = alkyl/aryl groups. 
 
3.3.4. Design and Attempted Synthesis of Novel Metal Chelators and BODIPY Dyes 
F - BODIPY dyes have not, to the best of the author‟s knowledge, been synthesised with pyridyl 
substituents anywhere across the F - BODIPY scaffold.  F - BODIPY dyes with heterocyclic moieties 
have them fused to the pyrrole moiety with none being found with a „free‟ heterocyclic ring attached 
to a pyrrole.
14
  
 
 
17 
 
 
18 
Figure 3.4: Pyrroles used within F - BODIPY dye synthesis. 
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While researching the various pyrroles that could be used in the final compound and possible modes 
of attachment to the final polyamine macrocycle, it was hypothesised that pyrroles 17 and 18 would 
provide good candidates as starting materials (Figure 3.4).  The pyridyl ring could not only affect the 
photochemical properties of the final F - BODIPY dye but also, if the intermediate is isolated, would 
form as its respective dipyrrin. 
 
 
A 
 
b 
Figure 3.5: Skeletal structures of a) dipyrrins and b) F - BODIPYs. 
 
The precursor of the F - BODIPY dye before complexation of the BF2 moiety is the structurally 
related dipyrrin.  Derivatives of dipyrrins have been complexed with a variety of metal cations, 
including Zn
2+
 due to the favourable electrochemical and fluorescent properties
24-26
 (Figure 3.5). The 
dipyrrin would provide an additional binding site for a metal ion and act as a ligand with the potential 
of chelating to metal ions.  The use of both the reduced and unreduced pyrroles would also have 
potential in aiding investigations as to whether the presence of the imine bond had any effect on the 
photochemical properties for the F - BODIPY dye or potential binding properties for the dipyrrin.
24
   
 
 
19 
 
20 
  
 
21 
 
22 
Figure 3.6: Target F - BODIPY dyes and their respective dipyrrins. 
 
 
The aim of synthesising a novel F - BODIPY dye and a novel metal chelator was for attachment to the 
polyamine macrocycle of the final compound.  A terminal chlorine (Cl) was seen as a common 
method towards aiding this bond formation of the final compound and thus chloroacetyl chloride was 
used so that the subsequent terminal Cl from the condensation reaction joining the two pyrrole 
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moieties could be used to aid addition to the final polyamine macrocycle.  This led to the design and 
attempted synthesis of two elaborate F - BODIPY dyes 19 and 21 and their respective dipyrrins 20 
and 22 through the induction of a picolylamine group at the 3, 5 - positions.   
 
 
3.3.5. Pyrrole Synthesis 
The first step towards preparation of the novel metal chelates (20 and 22) and F-BODIPY dyes (19 
and 21) was synthesis of the pre - requisite pyrrole.    Pyrrole 17 had previously been made in the 
literature and used as an intermediate towards a Cu
+
 catalyst complexes.
27
 Pyrrole 18 is the precursor 
of pyrrole 17 and was to be isolated whilst synthesising 17. 
 
 
 
 
19 
a 
 
 d 
 
 
 
18 
c 
 
20 
 
b 
 
  
 
 
17 
e 
 
22 
 
  f 
 
  
 
21 
Scheme 3.1: Synthesis towards desired F-BODIPY dyes and intermediates:  
Reagents and Conditions: a) Pyrrole-2-carboxyaldehyde, MeOH; b) NaBH4; c) ClCOCH2Cl, DCM; d) 
BF3.OEt2, Et3N, DCM; e) ClCOCH2Cl, DCM; f) BF3.OEt2, Et3N, DCM 
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Pyrroles 17 and 18 were synthesised via a condensation reaction between 2 - pyridyl - methylamine 
and pyrrole - 2 - carboxyaldehyde to form 18, which could then be reduced with NaBH4 to yield 17
28
 
(Scheme 3.1). Following protonation of the carbonyl group on the pyrrole-2-carboxyaldehyde, the 
amine group of the 2 – pyridyl - methylamine was able to attack the carbon of the CO group to give 
18 and water as a side-product.  A portion of 18 was reduced by NaBH4 to give pyrrole 17.     
Compound 18 was isolated from the initial reaction between pyrrole-2-carboxaldehyde and 2 - pyridyl 
- methylamine, following drying with MgSO4 and concentrating under reduced pressure.  The 
1
H 
NMR spectrum of 18 exhibited an expected shift of the proton of the starting aldehyde, now the CH in 
the imine group from 9.50 ppm to 8.26 ppm due to the less inductive effect now caused by the present 
nitrogen instead of the previous oxygen.  The CH2 adjacent to the pyridyl group was downshifted 
from 3.90 ppm in the starting material to 4.88 ppm in pyrrole 18.  The 
13
C NMR spectrum exhibited a 
downfield shift of the C in the imine group of 18 from 179.0 ppm in the carbonyl group of the starting 
aldehyde to 154.0 ppm in the imine.  The CH2 of the 2 - pyridylmethylamine also shifted from 
48.0 ppm to 66.1 ppm again due to the more electronegative imine group.  The ESI
+
 mass spectrum 
gave m/z = 186 and 198 amu indicating [M + H]
+
 and [M + Na]
+
 respectively further confirming 
isolation of pyrrole 18.  In order to obtain pyrrole 17, the intermediate imine was reduced via NaBH4, 
precipitating borate salts which were separated via extracting the product with diethyl ether from 
water.  The hypothesised mechanism towards the synthesis of 17 and 18 is proposed in Figure 3.7.   
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
    
 
18 
 
 
 
 
17 
 
Figure 3.7: Hypothesised mechanism for the formation of both pyrroles. 
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Pyrrole 17 was confirmed via a 
1
H NMR spectrum where two singlets at 3.92 ppm and 3.84 ppm were 
observed and attributed to both CH2 groups.  The largest shift observed came from the CH2, which 
was previously part of the starting aldehyde at 9.50 ppm and now shifted down to 3.84 ppm.  The CH2 
of the starting 2-picolylamine did not shift much in pyrrole 17 compared to the pyrrole 18 imine 
intermediate.  The secondary amine group had similar electronegative behaviour to the primary amine 
present in the starting material compared to that of the imine group in the product.  The NH on the 
pyrrole was also observed as a broad peak at 9.34 ppm.  The 
13
C NMR displayed two peaks at 53.9 
ppm and 45.8 ppm indicative of both carbons of the CH2 groups.  This shift from 179.0 ppm of the 
carbonyl group to 53.9 ppm also implied the formation of pyrrole 17.  An ESI
+
 mass spectrum showed 
a peak at m/z = 397 amu indicating [2M + Na]
+
.  All this was consistent with literature values.
27,28
 
 
3.3.6. Attempted Synthesis Of F - Bodipy Dye 21 
 
 
21 
Figure 3.8: Target F - BODIPY dye 
 
Once both pyrroles had been synthesised, the dipyrrin intermediate and eventual F-BODIPY dye were 
prepared using the method outlined by Wu et al.
16
 Pyrrole 17 was left to stir in DCM with 
chloroacetyl chloride in order to generate intermediate 22 as an HCl salt.  Analysis by 
1
H NMR 
spectroscopy indicated that the pyrrole peaks expected were present and that the CH2 adjacent to the 
nitrogen of the pyrrole had shifted from its starting position.  Initial integrations did not provide 
anything conclusive and the ESI
+ 
mass spectrum did not give conclusive results as to whether the 
intermediate had been made, but instead potential fragments of the desired product and the starting 
pyrrole material were observed.  This indicated that the reaction may not have gone to completion and 
that some of the desired product had been made, but that the instability of the intermediate as 
specified in the literature
4
 meant that it could not be isolated under normal conditions and perhaps air 
sensitive techniques were required for further investigations. 
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22 
Figure 3.9: Target dipyrrin intermediate 
 
Although the dipyrrine intermediate could not be isolated, it was used in situ to generate the F-
BODIPY dye as observed in multiple literature procedures.  The intermediate was treated 
immediately with Et3N to remove the pyrrole proton, followed by quenching the anionic N atom with 
BF3.OEt2, which upon aqueous work - up should have furnished the F - BODIPY dye 21.  The crude 
LC/MS spectrum indicated that the desired F - BODIPY dye was present.  A peak at m/z = 487 amu 
represented the loss of an F
-
 ion and the addition of a Na
+
 ion, a peak seen previously in the 
literature.
17
 Due to the chemical robustness of F - BODIPY dyes, a common method of purification is 
via column chromatography.  However, this particular F - BODIPY dye was not as robust as previous 
dyes synthesised in the literature when attempts were made to purify the crude sample using silica.  
Both alumina and deactivated alumina were also tested as purification media for column 
chromatography, but as with the silica, no final product was observed.  Also, changes to the solvent 
system did not isolate the final product.  Other reaction conditions attempted included changing the 
base to DiPEA and again testing out various column chromatography media.  However DiPEA was 
more difficult to separate from the reaction mixture and found to be a major contaminent. 
 
3.3.7. Attempted Synthesis of F - BODIPY Dye 19 
 
 
19 
Figure 3.10: Target F - BODIPY dye 
 
It was unknown whether the NH group between the pyrrole and pyridyl group was a cause for side 
reactions or had led to the failure of the reaction due to its potential as a reaction site.  Therefore, the 
unreduced pyrrole 18 was used to investigate whether the F - BODIPY dye 19 could be synthesised 
and the novel metal chelator could be isolated.  Pyrrole 18 was left to stir in DCM with chloroacetyl 
chloride.  As previously seen, the 
1
H NMR spectrum indicated that some of the pyrrole peaks were 
observed in the resonances expected but nothing conclusive could be obtained from the integrations of 
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the protons relative to each other.  The ESI
+
 mass spectrum indicated that the intermediate had been 
synthesised, but could not be isolated as found previously.   
 
 
20 
Figure 3.11: Target dipyrrin intermediate 
 
As before the intermediate was used in situ and initial analysis was carried out with ESI
+
 mass 
spectrometry.  Peaks synonymous to the previously used pyrrole were observed.  
Although the synthesis of these derived F - BODIPY compounds would have established novel 
fluorophores and with regards to the intermediate dipyrrins a novel chelator, time constraints meant 
that this part of the project was suspended in favour of investigating the more promising rhodamine 
dyes. 
 
3.4.  Attempted Synthesis Towards Rhodamine Dye Derivatives 
3.4.1. Rhodamine Dyes 
Rhodamine dyes are amongst the oldest and most commonly used synthetic dyes.  Originally used for 
cloth colouration, their unique optical properties has made them useful as water tracing agents, 
fluorescent markers for microscopic structure studies, photosensitizers, and laser dyes.
29
 Rhodamine 
dyes belong to the family of xanthenes along with fluorescein and eosin dyes.    Rhodamine dyes can 
be used in their free forms, but generally the dye molecule has been attached, most often covalently, 
to another molecule (biomolecule, ligand, polymer, etc.) or surface to give it a wider application.
30
 
Due to the high cost of rhodamine dye derivatives, it has become common practice to modify less 
expensive unfunctionalised commercially available rhodamines.  Thus, great interest in the 
development of new synthetic procedures for preparation of novel rhodamine derivatives has arisen in 
recent years.  
 
3.4.2. Methods Towards Rhodamine Derivatives 
Of the various cheap rhodamine starting materials, rhodamine B (Figure 3.12) was chosen for 
investigation.  Its conjugated fluorescent xanthene ring and free benzoic acid moiety for derivatization 
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renders it an attractive prospect for various manipulations.  Rhodamine B is known for its relatively 
high photostability and acceptable water solubility.  Its protected amines, whereby R1, R2 are alkyls 
prevent side reactions, which would otherwise be a cause for concern where any active group could 
react with unprotected amines. 
There have been three main methods for forming new rhodamine derivatives.  These include either 
modification of the amino groups of the xanthene moiety (positions 3 and 6), modification of the 
carboxyphenyl ring at position 4‟ and 5‟ or modification of the carboxylic acid group (position 2‟).   
 
 
 
Figure 3.12: Molecular structure of rhodamine dyes with positions highlighted.   
Rhodamine B (R1, R2 = CH3; R3, R4 = H; Z = OH; G = n/a) 
 
 
Functionalisation at positions 3 and 6 (amino groups of xanthene rings) has led to a loss of 
fluorescence of the rhodamine derivative and thus is more useful if a latent fluorophore is desired.
30
 
The other common position where functionalisation can take place is at the 4‟ and 5‟ position of the 
carboxyphenyl ring, which is less sterically hindered than position 3‟ and 6‟ of the carboxyphenyl 
ring.  Commercially available rhodamine derivatives are generally functionalised at either one or both 
of these positions, however are extremely expensive and usually sold as mixtures. 
Although position 2‟ appears an obvious choice for Rhodamine B functionalisation due to the 
presence of a carboxylic acid, the reaction between the carboxylic acid group of rhodamines and 
amines have attracted little interest, with methods only really appearing in the literature after the year 
2000.  Pioneering work by Czarnik and co-workers
31
 has given rise to further work regarding the 
activation at the 2‟ position of the rhodamine unit.  Also, Adamczyk et al.32 found that rhodamine 2‟ 
esters could readily react with primary containing substrates to form a variety of fluorescent 
rhodamine conjugates under mild, chemoselective conditions.  Simultaneously, Roy et al.
33
 made use 
of the BOP reagent to activate the carboxylic acid of the rhodamine, followed by use of triethylamine 
as a catalyst to aid conjugation with N - mono(tert - butyloxycarbonyl)ethylenediamine to yield a 
fluorescent rhodamine conjugate whilst avoiding a non - fluorescent intermediate (spirolactam) that 
has a tendency to form
31
. More recently Meng et al.
34
 activated the carboxylic acid of the rhodamine 
Chapter 3: Synthetic Routes Towards Pendant Groups 
80 
 
B to yield an N-hydroxysuccinimidyl ester for further coupling with glycine.  The idea of activating 
the carboxylic acid group followed by formation of the ester group has been seen by Chen et al.
35
 who 
built a small library of functionalised rhodamine B probes carrying an ester or thioester bond linkage. 
These investigations demonstrate that chemoselectivity can be achieved in substrates containing 
different types of amines.  Bearing the various points for derivatisation in mind, work towards 
functionalisation at the 2‟ position started and attempts were made to avoid any possible formation of 
the spirolactam intermediate, to allow for further functionalization whilst leaving the fluorophore 
fluorescent.  The best way to achieve this was by activating the carboxylic acid to yield an ester, 
which would be attached to a linker, which should allow for facile addition to the eventual polyamine 
macrocycle.  The linker had to incorporate a carbonyl group to act as a metal coordinating site for the 
lanthanide metal centre once attached onto the macrocycle.  Compound 23 was designed and 
contained all the traits required for an effective fluorophore and the desired properties for the final 
compound. 
 
 
23 
Figure 3.13: Target derivative of Rhodamine B. 
 
3.4.3. Attempted Synthesis of the Target Rhodamine Derivative 23  
The synthetic route employed for the preparation of the various precursors of the desired rhodamine 
derivative 23 is described in Scheme 3.2.  Work commenced with the formation of rhodamine ester 24 
using a literature procedure by Meng et al.
34
 The carboxylic acid at the 2‟ position of the starting 
rhodamine B was activated with N - hydroxysuccimide via a one-step condensation reaction.  The 
coupling reagent dicyclohexylcarbodiimide (DCC) was introduced to the rhodamine B to activate the 
carboxylic acid.   
The product ester formed due to the eventual formation of the very stable urea group rendered any 
nucleophile suitable for substitution.  This urea side - product precipitated as a white solid which was 
filtered off.  A mixture of acetonitrile and diethyl ether was used for recrystallization instead of 
absolute ethanol as quoted in the literature.  This saw the yield increase from the 35 %
34
 reported to 
73 %.  
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The rhodamine B ester 24 prepared exhibited a singlet at 2.80 ppm corresponding to the CH2 groups 
of the N - succinimide group.  All other protons of the rhodamine B were assigned accordingly to the 
literature on the 
1
H NMR spectrum.  The 
13
C NMR spectrum gave two peaks of the two different CO 
groups at 168.7 ppm and 157.8 ppm representing the ester and the succinimide carbonyls.  The ESI
+
 
mass spectrum was consistent with the literature value at m/z = 540 amu indicating [M]
+
.
34 
 
 
a 
 
 
24 
  b 
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23 
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26 
Scheme 3.2: Synthesis route for rhodamine derivative 23 
Reagents and Conditions: a) i) DCC, MeCN, ii) N-Hydroxysuccinimide; b) 27, Et3N, MeCN;  
c) TFA:DCM (1:1); d) various conditions tested 
 
 
a 
 
27 
 
Scheme 3.3: Synthesis of mono-protected ethylene diamine chain:  
Reagents and Conditions: a) Boc2O, DCM 
 
Chapter 3: Synthetic Routes Towards Pendant Groups 
82 
 
Following the synthesis of the rhodamine ester 24, in order to ensure mono-addition of the 
ethylenediamine chain without any unwanted side-reactions, especially when free amine groups are 
available, the ethylenediamine linker chain was mono - protected as shown in Scheme 3.3.   
Ethylenediamine was left to stir in cooled DCM whilst di - tert - butyl dicarbonate (Boc2O) was added 
to allow for mono - tert - Butyloxycarbonyl (Boc) protection at one of the amine groups.  The product 
was extracted with DCM and its identity confirmed via ESI
+
 mass spectrometry and 
1
H NMR analysis 
with values consistent with the literature.
36
 
The rhodamine B ester 24 was left to react with the mono-protected ethylenediamine in MeCN and an 
excess of triethylamine to give 25.  Following initial purification via column chromatography on 
alumina, 25 was difficult to isolate and a second attempt to purify via column chromatography gave a 
yield of 16 %.  The 
1
H NMR spectrum (Spectrum 3.1) exhibited a singlet at 1.39 ppm attributed to the 
Boc group.  The singlet at 2.79 ppm that was present in the succinimide ring disappeared, indicating 
reaction of the rhodamine B ester 24.   
 
 
Spectrum 3.1: 
1
H NMR (CDCl3) spectrum of 25: a) aromatic region; b) aliphatic region;  
c) protons of the xanthene ring. 
 
The CH2 of the ethylenediamine was allocated to peaks overlapping at 3.30 ppm, a shift from the 
starting material which previously had two identifiable triplets at 3.13 ppm and 2.71 ppm due to the 
now present rhodamine moiety being more electron withdrawing towards the ethylenediamine linker.  
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Peaks corresponding to triethylamine were also present and indicated a triethylamine molecule was 
present.     
The 
13
C NMR spectrum indicated no CO peak from the succinimide moiety and instead a signal at 
155.8 ppm was observed for the CO introduced via the Boc group.  The sp
3
 carbon attached to all 
three methyl groups was assigned at 78.7 ppm and the methyl groups of the Boc protecting group 
were also assigned at 28.4 ppm.  The ESI
+
 mass spectrum had peaks at m/z = 585 amu and 607 amu 
corresponding to [M]
+
 and [M+Na]
+
 signals respectively.   
In order to add the additional linker chain containing the carbonyl group and terminal chlorine to 
allow functionalisation for addition on to a DOTA-like platform, the Boc group had to be cleaved to 
allow the terminal amine to be relieved.  This was done via stirring 25 in a mixture of TFA and DCM.  
The deprotected product (26) was produced in a quantitative amount and analysed in CD3OD.  The 
1
H 
NMR spectrum confirmed removal of the Boc group with no singlet peak being observed around 1.40 
ppm.  The ESI
+
 mass spectrum also gave a peak at m/z = 485 amu corresponding to [M]
+
 further 
demonstrating cleavage of the Boc group. The triethylamine that was previously present in 25 was not 
found to interfere with the compound as it was no longer observed. 
The free amine on 26 could be reacted with chloroacetyl chloride to give the carbonyl group for 
eventual coordination to the lanthanide centre.  Rhodamine derivative 26 was left to stir with MeCN 
and chloroacetyl chloride with triethylamine as in the literature.
37
 The crude product indicated 
formation of the product via ESI
+
 mass spectrometry, however following purification via column 
chromatography with alumina, fractions that were isolated did not exhibit any signs of the product 
being isolated.  The 
1
H NMR spectrum showed a shift in peaks in expectant areas and it was 
postulated that an additional rhodamine derivative of compound 26 could have reacted with the 
terminal Cl of the final product 23, but neither the ESI
+
 mass spectrum or 
1
H NMR spectrum 
confirmed this.  The non-fluorescent spirolactam could also have formed but the 
1
H NMR spectrum 
did not have peaks that indicated this was the case.  The various challenges that come up when 
attempting to prepare rhodamine B derivatives are that purification procedures are often tedious and 
sometimes not feasible due to the high polarity of the tetraethyl - rhodamine B scaffold.  Additionally, 
rhodamine derivatives are either prone to lactone formation under basic conditions
38
 or rapidly cyclise 
to form a non-fluorescent spirolactam when it reacts with primary amines or hydrazines.
31
     
In light of this, it was decided that work should continue in other research fields rather than invest 
further resources towards the synthesis of these rhodamine derivatives and therefore work 
commenced with the dansyl fluorophore.   
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3.5.  Synthesis Towards Dansyl Fluorophore Derivatives 
3.5.1. Dansyl Fluorophore 
Dansyl derivatives as potential fluorophores have increasingly become of interest in particular for 
their use in molecular recognition
39
 and in the detection of metal ions.
40
 The dansyl fluorophore 
comprises a naphthalene ring with a dimethylamino group at the 5-position and a sulfonyl group at the 
1-position.  The dansyl fluorophore is an environmentally sensitive optical probe with a large Stokes 
shift.  It has also found use as an optical sensor for neutral analytes and metal ions based on an open-
chain ligand and macrocyclic chelator.
41
 These dansyl groups are usually introduced into the structure 
via a sulfonamide bond with a primary amino group of polyamines.
41
 This gives these ligands an 
ability to interact with metal ions by coordination of the amino group, followed by abstraction of the 
sulfonamide by a hydrogen atom.
42,43
 This type of interaction has the ability to cause significant 
changes in the absorption or emission spectrum of the dansyl chromophore.
40-42
 Aoki et al. invested a 
significant amount of resources in to synthesising and testing new fluorescent probes for Zn
2+
 sensing 
using dansyl derivatives in cells for fluorescent staining.
43
  Aoki appended various dansyl derivatives 
onto a cyclen moiety which itself was used to sense Zn
2+
 ions (Figure 3.14).   
 
 
Figure 3.14: Initial probes designed by Aoki et al using dansyl derivatives.
43
 
 
3.5.2. Synthesis Towards Dansyl Derivatives 
In order to introduce a dansyl moiety to the eventual target compound the commercially available 
dansyl chloride was to be covalently attached to the polyaminocarboxylic cyclic ligand to give the 
compound seen in Figure 3.15.  The reaction conditions of this will be discussed in Chapter 4.   
 
 
Figure 3.15: Dansyl fluorophore to be attached to macrocyclic ligand 
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As the dansyl fluorophore was to be attached directly to the initial starting material of the cyclic 
backbone, it was thought that the resultant sulfonamide group would unlikely be able to coordinate 
with the eventual lanthanide (Ln
3+
) metal centre due to the steric hindrance.  Typically DOTA-like 
derivatives form 8 - coordinate sites for the chelating Ln
3+
 centre and although one less coordinating 
site could lead to two H2O molecules being bound to the Ln
3+ 
centre, which would be advantageous 
for the magnetic resonance imaging component of the target multi - modal agent as it would increase 
the relaxivity value.  The loss of a coordinating site towards the Ln
3+
 centre could mean a decrease in 
stability of the metal complex, which is not ideal for molecular imaging purposes.  In order to include 
a coordinating site so that the macrocyclic ligand has 8 coordinating sites as opposed to only 7, a 
linker containing a carbonyl group with sufficient distance from the dansyl fluorophore to allow for 
coordinating to the eventual metal centre was to be included. 
   
 
 
28 
Figure 3.16: Target dansyl derivative 
 
The same linker used for the attempted synthesis of the rhodamine dye derivative was deemed a 
suitable candidate (Figure 3.16).  Previous work with dansyl fluorophores attached to polyamines,
41,42
 
provided an ideal starting point, which led to the introduction of a carbonyl group via chloroacetyl 
chloride and a terminal Cl as a handle for appending to the cyclic backbone.  In order to form 28, the 
dansyl ethylenediamine first needed to be synthesised as in Scheme 3.4.   
 
The dansyl ethylenediamine derivative 29 has previously been synthesised in the literature, with 
applications such as a fluorescent metal chelator,
41
 bisphosphonic acid derivatives,
44
 and binding of 
the dansyl fluorophore to a lipid bilayer membrane surface.
45
 Following the methodology of Doyle et 
al.,
45
 1,2-ethylenediamine was reacted in an excess of 10 equivalents with dansyl chloride to ensure 
that mono-substitution was favoured.  Despite this excess of amine, some dansyl chloride still 
remained unreacted which was separated via acidification of the reaction mixture and extraction with 
DCM.   
A 
1
H NMR spectrum showed two triplets at 2.94 ppm and 2.76 ppm indicating that the 
ethylenediamine had reacted with the dansyl chloride.  Aromatic peaks of the dansyl fluorophore were 
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consistent with the literature.  Although the yields obtained from various attempts were satisfactory, 
they were not as high as those reported in Doyle‟s results.   
 
 
a 
 
 
29 
  b 
 
  
 
28 
Scheme 3.4: Synthesis towards dansyl - derivative 28:  
Reagents and Conditions: a) NH2CH2CH2NH2; b) ClCOCH2Cl, Et3N, THF 
 
Other research groups using similar methods also reported a variation of yields from 25 to 67%.
41,46
 
Despite the relative success found with this method, it was thought that the washings and extractions 
were causing the product to be lost plus the presence of the unreacted dansyl chloride seemed 
something that could be avoided, prompting further investigation towards a more convenient and 
efficient method. 
The bisphosphonate derivatives synthesised by Chen et al.,
44
 included the desired dansyl 
ethylenediamine 29 which was achieved via an alternative method.  This method made use of 
ethylenediamine as a solvent as well as a reactant in an excess of about 70 equivalents.  Using this 
method, a solution of dansyl chloride was added dropwise to 10 ml of ethylenediamine and left to stir.  
After 4 hours, the thick yellow solution was concentrated, and the ethylenediamine removed under 
reduced pressure.  Following extraction of the product with ethyl acetate, a yield of 81 % was 
observed, which was an increase from 13 % seen using the previous reaction conditions.  The product 
was analysed via 
1
H NMR spectroscopy with two triplets at 2.93 ppm and 2.72 ppm being observed, 
indicative of to the two CH2 groups of the ethylenediamine linker.  The 
13
C NMR spectrum gave 
peaks at 45.5 ppm and 45.4 ppm indicative of the CH2 carbons of the linker chain.  Other peaks were 
consistent with literature values and found in expected regions.     
Following the synthesis of 29, introduction of a carbonyl group was next.  A similar reaction has been 
observed by Chen et al.
44
 who reacted 29 with bromoacetic acid.  The carboxylic acid group of the 
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bromoacetic acid was activated via the coupling agent DCC which allowed the reaction with the 
primary amine to yield their desired product.  In this case chloroacetyl chloride was used in place of 
bromoacetic acid, to eliminate an extra synthetic step in the reaction which would save time and loss 
of reagents.  The dansyl ethylenediamine 29 was treated with chloroacetyl chloride and triethylamine.  
Following completion of the reaction, as monitored via TLC, the primary amine attacked the carbonyl 
of the chloroacetyl chloride causing the loss of the chloride and the formation of an amide bond.  The 
product was isolated and purified via column chromatography to give an 85 % yield.  The 
regioselective sulfonylation at the less-hindered primary amine group was observed, as deduced from 
the lack of symmetry in the 
1
H NMR spectrum and from fragments in the ESI
+
 mass spectrum.   
 
 
Spectrum 3.2: 
1
H NMR (CDCl3) spectrum of 29:  
a) aromatic region; b) aliphatic region; c) whole spectrum 
 
The 
1
H NMR spectrum was similar to the starting dansyl-ethylenediamine 29 as expected and saw the 
emergence of a singlet at 3.88 ppm, a shift from the 4.50 ppm of the CH2 of the starting material in 
the acetyl chloride indicating a successful reaction.  The two triplets observed at 6.83 ppm and 
5.42 ppm correlated to the NH groups of the two different amide bonds.  The acidic nature of the 
proton of the NH adjacent to the sulfonamide gave the defined triplet at 5.42 ppm, compared with the 
broadened triplet at 6.83 ppm corresponding to the NH adjacent to the carbonyl.  The 
13
C NMR 
spectrum exhibited a new peak at 167.0 ppm befitting of the presence of the new CO bond and an 
additional peak at 45.4 ppm, showing the presence of an additional CH2 from the chloroacetyl 
chloride, which did not show a pronounced shift from the starting material as expected.  The product 
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was successfully characterised with mass spectrometry and IR spectroscopy, and its utilisation is 
detailed in the following chapters.  
Following work with derivatising fluorophores and attempts to synthesise novel ones, work 
corresponding to the Zn
2+
 sensing groups was carried out in tandem and is detailed in the next section 
of this chapter. 
 
3.6.  Attempted Synthesis of Zn2+ Sensing Groups 
3.6.1. Introduction to The Zn2+ Sensing Component 
In this section Zn
2+
 specific receptors that were designed to be used to make up the final multi-modal 
imaging agents will be discussed.  A few examples of common Zn
2+
 specific receptors (also 
mentioned in chapter 1) are di - 2 - picolylamine (DPA, 30), N,N - bis(2 – pyridyl - methyl) ethylene 
diamine (BPEN, 31), N,N,N‟ - tris(2 - picolyl)ethylenediamine (TRPEN) (Figure 3.17), quinoline and 
cyclen.
47-50
 These specific receptors have formed the basis of many Zn
2+
 sensors which are often 
attached to fluorophores for fluorescence imaging.  Fluorescence imaging has become the most 
prevalent method used towards Zn
2+
 sensing in cells as a result of the spectroscopically silent Zn
2+
, 
due to its d
10
 outer shell (as explained in chapter 1).   
 
 
 
30 
 
 
31  
DPA BPEN TRPEN 
Figure 3.17: Structures of common Zn
2+
 specific receptors 
 
Di - 2 - picolylamine (DPA, 30) is the most popular moiety when constructing Zn
2+
 chemosensors and 
provided the starting point for the synthesis of Zn
2+
 sensors for conjugation onto the final polyamine 
macrocycle of the final multi - modal imaging agent.  DPA is a derivative of N,N,N‟,N‟ - tetrakis(2 -
pyridylmethyl) - ethylenediamine (TPEN), a classical membrane-permeable Zn
2+
 chelator with high 
selectivity for Zn
2+
 over alkali and alkaline - earth metal ions, such as Ca
2+
, Mg
2+
, K
+
 and Na
+ 
that 
occur in much higher concentrations in biological samples.
48
 DPA has shown the same selectivity and 
is often used due to its ability for modification and incorporation within Zn
2+
 sensors.  The most 
common method of using the DPA moiety has been via directly connecting various fluorophores 
Chapter 3: Synthetic Routes Towards Pendant Groups 
89 
 
through the secondary amine nitrogen atom of the DPA molecule.  This nitrogen atom serves as a 
versatile reaction site which has seen the synthesis of a variety of fluorescence turn - on and 
ratiometric sensors.
47-50
  
The inclusion of a DPA derivative to a macrocyclic ligand for eventual Zn
2+
 sensing has also been 
observed by Pope
51
 and Esqueda
52
 (Figure 3.18) where both synthesised DPA derivatives before final 
addition to a polyamine macrocycle.  Pope directly derivatized the DPA molecule with 2,6-
chloromethylpyridine (Figure 3.18).
51
  This DPA derivative was then appended to a DO3A platform 
to give fluorescent Zn
2+
 sensor EuDO3A-2-methyl, 6-pyridyl-DPA (Figure 3.18a).  Esqueda made use 
of the DPA derivative BPEN (31) which has previously been used in Zn
2+
 sensors for both 
fluorescence imaging
53-55
 and MRI
52
 investigations.  In Esqueda‟s work, the BPEN was not 
synthesised directly from DPA but instead from two equivalents of 2 - picolylamine and an 
ethylenediamine to yield a BPEN moiety for further reaction (Scheme 3.5).
52
  Two BPEN molecules 
were then attached to a cyclen-based macrocycle at the 1,7 - position via activation of the free 
carboxylic acids to give GdDOTA - diBPEN (Figure 3.18b). 
 
 
 
a) EuDO3A - 2 - methyl, 6 - pyridyl - DPA 
 
 
 
b) GdDOTA-diBPEN 
Figure 3.18: Probes made by a) Pope
51
 and b) Esqueda
52
 with hypothesised binding with Zn
2+
 ions 
 
In light of this, initial attempts were made to conjugate DPA to a small linker with a functionality that 
would allow for addition to the eventual macrocyclic ligand. 
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3.7.  Design and Synthesis of Zn2+ Specific Sensors Based on DPA 
Due to the number of coordinating sites required for the eventual lanthanide centre, it was necessary 
to include a carbonyl group onto the DPA moiety with a short linker which would allow for 
attachment to the polyamine macrocycle.  Compound 32 was designed and thought to be an ideal 
candidate.  Despite its relative simplicity it has not yet, to the best of the author‟s knowledge, been 
reported in the literature.  
 
 
32 
Figure 3.19: Proposed Zn
2+
 sensor target molecule 
 
As Pope reported successful addition of DPA to 2,6 - chloromethylpyridine to yield 33 (Scheme 3.5), 
it was hoped that the same reaction would occur with chloroacetyl chloride.  It was envisaged that the 
nucleophilic nature of the secondary amine of the DPA molecule would allow for a reaction with the 
DPA derivative providing a terminal chlorine (Cl) for addition to the polyamine cyclic ligand.  DPA 
30 was prepared via a condensation reaction between 2 - (aminomethyl)pyridine and pyridine – 2 -
carboxyaldehyde (Scheme 3.5).  The nucleophilic attack of the primary amine towards the aldehyde 
group led to formation of an imine intermediate which was then reduced with sodium borohydride in 
a similar manner to the reaction of the pyrroles.  Following stirring at room temperature, the reaction 
volume was reduced and dissolved in a mixture of chloroform and water.  This mixture was acidified 
with the desired product migrating into the aqueous layer to allow for the elimination of impurities via 
the organic layer.  The acidic aqueous layer was then basified and the product extracted via 
chloroform to give DPA 30 in a 61 % yield, which was consistent with literature values.
56
 The 
1
H 
NMR spectrum exhibited a singlet at 4.51 ppm which integrated correctly in correspondence with the 
aromatic protons.  Other characterisation methods matched the values from the literature.
56
 
Having observed functionalisation at the secondary NH with various moieties such as 2,6 -
chloromethylpyridine
51
 and methyl acrylate
57
 it was predicted that the high reactivity of the acyl 
chloride present in chloroacetyl chloride would be sufficient to react with the free amine present on 
the DPA 30 molecule (Scheme 3.5) to give 32.  The reaction yielded poor results and no indication 
that the product had been formed was observed despite the various reaction conditions attempted as 
summarised in Table 3.1.   
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Conditions Result 
1: ClCH2COCl (1.2 Eq.), Pyridine (1.4 Eq.), CHCl3, rt  
 
No evidence of 32. 
2: ClCH2COCl (4 Eq.), Cs2CO3 (4 Eq.), MeCN, rt 
 
No evidence of 32. 
3: ClCH2COCl (4 Eq.), K2CO3 (4 Eq.), MeCN, rt 
 
No evidence of 32. 
Table 3.1: Summary of the reaction conditions and results for the attempted synthesis of  
DPA derivative 32 
 
Condition 1, saw the reaction monitored via TLC over a few hours with the DPA 30 spot diminishing 
alongside the emergence of another spot, and a change in colour in the reaction mixture.  The crude 
1
H NMR spectrum exhibited peaks in the expected regions but with extra aromatic peaks which were 
attributed to the excess pyridine used.  Column chromatography was used for purification, however 
the fraction containing the potential product exhibited extra aliphatic peaks in the 
1
H NMR spectrum.  
The integration was also inaccurate, with an integration of 10:1 being observed for aromatic to 
aliphatic protons.  Further spectroscopic techniques were unable to provide further information as to 
what exactly had been formed.  Polymerisation could have been a problem and possibly the reason 
why the pyridine had not been separated sufficiently.  The pyridine proved difficult to separate and 
was thought to have catalysed side reactions which were detrimental to the synthesis of the desired 
compound.   
Following work in the literature regarding the addition of a chloroacetyl chloride molecule to a 
secondary amine, these reaction conditions were altered.
58
 Cutri et al. 
58
 reacted a chloroacetyl 
chloride with a sterically hindered secondary amine to succesfully form an amide bond.  Thus, a 
comparatively weaker base than pyridine and a change in solvent prompted use of reaction conditions 
2.  Cesium carbonate was used due to its increased solubility properties.  Following the reaction 
progression via TLC, it was observed that the rate at which the DPA starting material spot diminished 
was slower than when under reaction conditions 1.  As per the literature,
58
 the desired product was 
extracted via DCM and dried to yield a golden brown crystalline solid.  The 
1
H NMR spectrum 
indicated a compound with extra peaks in both the aromatic and aliphatic regions.  The crude ESI
+
 
mass spectrum contained a peak at m/z = 276 amu which was attributed to the desired product.  A 
system of DCM/MeOH/NH4OH for TLC analysis indicated two spots that could be separated via 
column chromatography.  However, following column chromatography the fractions obtained were 
not indicative of the desired product following extensive analysis via NMR spectroscopy and mass 
spectrometry.  It was possible that purification via column chromatography caused the product to 
either degrade or to react further.  A change in the base to the less soluble potassium carbonate 
(reaction conditions 3) showed no improved results.  
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Various hypotheses to why the desired product 30 could not be isolated may have been due to the 
high reactivity of chloroacetyl chloride or the pyridyl ring of the DPA moiety acting as a base.  DPA 
30 also has the ability to undergo hydrolysis, racemization and a multitude of side reactions, which 
could also have contributed to the failure of the reaction. 
The basic nature of the pyridyl ring, whereby if 32 formed meant that the lone pair of the nitrogen on 
the pyridyl ring was able to attack the α - carbon of the carbonyl as the adjacent Cl is able to act as a 
good leaving group.  This reaction would lead to a six-membered ring alkaloid - type product, which 
is thermodynamically favourable (Figure 3.20).  This hypothesis was further supported when the 
1
H 
NMR spectrum (under reaction conditions 2) before column chromatography was analysed further.  
The extra peaks in the aliphatic region were assigned to the CH2 groups of the six - membered ring 
formed via the cyclization reaction and the extra peaks in the aromatic region due to the pyridyl rings 
no longer being equivalent. 
 
 
 
 
 
 
Figure 3.20: Possible cyclisation reaction occurring hindering formation of 32. 
 
33 
   
 
32 
 
 
 
  
 
30 
 
 
 
   
+ 
  
 
 
 
 
34    
Scheme 3.5: Synthesis and attempted synthesis of DPA (30) and DPA derivatives. 
Reagents and Conditions: a) i) MeOH, ii) NaBH4; b) 2,6-chloromethylpyridine, NaHCO3, MeCN 
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In order to investigate whether or not the reactivity of the chloroacetyl chloride was a contributing 
factor, 1,3 - dichloracetone was tested to see if any positive change in the reaction was observed and if 
the CH2 between the Cl and the carbonyl group made any difference when attempting to synthesise 34 
(Scheme 3.5).  This small increase in chain length and a potential reduction reactivity of starting 
reagents would hopefully allow for the DPA derivative 34 to be formed.  It was hoped that the amine 
alone could attack the α - CH2 unit, and so, no base was used in the reaction in order to eliminate the 
potential formation of side - products.  
Following stirring over several days, monitoring the reaction by TLC indicated that the starting DPA 
30 material was still present along with another spot.  Column chromatography was used to separate 
the two compounds detected, however only one product could be isolated and was identified as the 
DPA starting material indicating that the 1,3 - dichloroacetone was not reactive enough to cause any 
reaction with the secondary amine and that harsher reaction conditions were required.
59
  Potential 
hydrolysis could have occurred and as seen previously the desired compound 34 may have degraded 
during column chromatography. 
Due to the difficulties of trying to attach a small linker to DPA, making use of the work carried out by 
Esqueda
52
 on BPEN was seen as the next logical step.  The terminal amine of the BPEN could be 
reacted with chloroacetyl chloride to yield an amide bond and a terminal Cl for facile attachment to 
the polyamine macrocycle.  BPEN has been synthesised previously
52,54,55
 and the method used by Ling 
was followed due to the mild conditions used and high yields obtained. 
 
3.8.  Design and Synthesis of Zn2+ Specific Sensors Based on BPEN 
The synthetic route employed for the preparation of BPEN is described in Scheme 3.6.  
Ethylenediamine was mono - protected with a Boc group as previously carried out and detailed in 
work regarding the rhodamine B derivatives.  A mixture of the mono protected-ethylenediamine 27 
was heated to 50 ˚C together with 2 - picolyl amine chloride, NaOH in THF and water.  The biphasic 
reaction allowed the mono - protected ethylenediamine to remain dissolved in the organic layer and 
allowed the water soluble 2 - picolylamine chloride to remain in the aqueous solution and eventually 
pass into the organic layer once the mono-protected BPEN 35 had formed.   
The organic layer was eventually separated after 5 days and additional Boc2O was added to react with 
any residual secondary amine that had not formed 35.  The extra addition of the Boc group facilitated 
separation via flash column chromatography as otherwise both the secondary and tertiary amine 
products would have eluted together.   
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31 
Scheme 3.6: Synthesis and Attempted Synthesis of BPEN (31) and BPEN Derivatives 
Reagents and Conditions: a) 2-picolyl chloride.HCl, NaOH, THF, H2O, 50   C; b) HCl/EtOH; 
c) ClCOCH2Cl, Et3N, THF. 
 
The mono - protected BPEN 35 was observed with the appearance of a peak at 1.45 ppm in the 
1
H 
NMR spectrum displaying addition of two picolylamine molecules to 27.  Further peaks at 3.87 ppm, 
3.25 ppm and 2.71 ppm indicated all CH2 groups with relevant integrations.  The 
13
C NMR spectrum 
and the ESI
+
 mass spectrum also confirmed synthesis of 35.  The pure mono protected-BPEN 35 
moiety was then stirred with HCl/EtOH to cleave off the Boc protecting group.  The 
1
H NMR 
spectrum exhibited a loss of the peak at around 1.41 ppm confirming cleavage of the butyl groups 
from the Boc group.  The 
13
C NMR spectrum also did not exhibit any peaks corresponding to a CO 
group carbon.  The ESI
+ 
mass spectrum also displayed the product peak at m/z = 243 amu for [M+H]
+
 
further indicating cleavage of the Boc group.  Despite the high yields reported in the literature (91 %) 
for the final product,
60
 it was not possible to reproduce them and instead obtaining yields of 22 %.   
With both BPEN 31 and the starting mono-Boc protected ethylenediamine 27 having been analysed in 
CD3OD via NMR, the shift in peaks from both could be compared.  The CH2 adjacent to the Boc 
group had shifted from 3.13 ppm to 3.32 ppm once the Boc group had been cleaved.  This small 
downfield shift is due to the loss of the inductive effect created in the presence of the CO group.  The 
free NH2 that reacted with the 2-picolylamine moieties to create the BPEN 31 target compound had 
the adjacent CH2 of 27 shift from 2.71 ppm to 3.04 ppm, this downfield shift was due to the now 
present pyridyl rings causing a deshielding effect to those protons.  
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In order to incorporate a coordinating site into BPEN 31 for the eventual metal centre of the final 
target compounds, BPEN was reacted with chloroacetyl chloride to yield a novel BPEN derivative for 
attachment to the macrocyclic backbone.  BPEN was left to stir with chloroacetyl chloride and 
triethylamine in THF.  Following two days of stirring at room temperature, the crude ESI
+
 mass 
spectrum indicated the product was present.  The reaction mixture was concentrated followed by 
attempts to purify via column chromatography which were unsuccessful.  The 
1
H NMR spectrum 
confirmed the continued presence of impurities and with more time required to solve the purification 
problems, it was decided to pursue other avenues. 
 
3.8.1. Design and Synthesis Towards Alternative Zn2+ Sensors 
Due to the difficulties encountered with the synthesis of DPA and BPEN derivatives, the focus shifted 
to other possible Zn
2+
 sensors, with acetamides being a good alternative from a synthetic point of 
view.  Acetamide 37 had previously been used as a fluorescent chemosensor for Cu
2+
 binding, 
whereby it had been attached to a dansyl fluorophore.
37,61
  In a different approach it made up part of 
an N2S2 tetradentate ligand to form various metal complexes including Zn
2+
 based ones.
62
 There were 
several methods available towards the synthesis of acetamide 37 (Scheme 3.7).
37,61,63,64
  Building on 
successful reaction conditions used in the laboratory when working with identical functional groups, it 
was decided to use 2-picolyamine and chloroacetyl chloride with stirring in chloroform and pyridine.  
Unfortunately the reaction was extremely low yielding and was attributed to the pyridine being too 
reactive and difficult to eliminate.  Following this, the method employed by Yin et al.
37
 was used 
(Scheme 3.7).  
 
 
 
 
a 
 
37 
b 
 
38 
c 
 
39 
   
Scheme 3.7: Synthesis of acetamide 37 and its derivatives 
Reagents and Conditions: a) ClCOCH2Cl, Et3N, THF; b) CH3COONH4, NH4OH(aq); c) ClCOCH2Cl, Et3N, THF 
 
Chloroacetyl chloride was added dropwise to a solution of 2 - picolylamine with triethylamine and 
THF with the reaction going to completion within 5 hours following nucleophilic attack from the 
amine group.  The presence of triethylamine yielded a better result than using pyridine and a yield of 
69 % compared to the previous 11 % was obtained.  The 
1
H NMR spectrum (Spectrum 3.3) contained 
a doublet at 4.61 ppm which was due to the CH2 protons adjacent to the NH group, which had become 
more stable and allowed coupling with the neighbouring CH2.  The 
13
C NMR spectrum exhibited a 
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peak at 166.1 ppm which was attributed to the CO of acetamide 37.  The synthesis of 37 was further 
confirmed via ESI
+ 
mass spectrometry and IR spectroscopy which were consistent with literature 
values.
37
 The resulting chloroacetamide was then used to alkylate cyclen derivatives, which is 
explained in subsequent chapters. 
 
 
Spectrum 3.3: 
1
H NMR (CDCl3) spectrum of acetamide 37 
 
Following the successful synthesis of acetamide 37 it was unclear how it would interact with the Zn
2+
 
metal once alkylated onto a macrocycle due to the short length of the ligand.  An extended acetamide 
arm would potentially have a higher affinity towards Zn
2+
 when compared to the original acetamide, 
especially once appended on to the macrocycle.  The carbonyl of the acetamide 37 was also involved 
in coordinating with the Zn
2+
 ion in the N2S2 tetradentate ligand.
62
 A logical step was thus to increase 
the chain length of the acetamide to include another carbonyl group which would then be available for 
coordination to the eventual Ln
3+
 centre, leaving the one present in the acetamide group free for Zn
2+
 
binding.  In order to increase the chain length, the terminal chloride was converted to an NH2 unit 
then treated with chloroacetyl chloride as carried out previously when synthesising the first 
acetamide.   
The terminal chlorine (Cl) of the chloroacetamide was converted to an NH2 group with ammonia 
solution and ammonium acetate (Scheme 3.7b).  All reactants were left to stir for a few days and the 
product extracted with chloroform from the ammonia solution.  A shift of the CH2 adjacent to the 
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carbonyl was observed from 4.16 ppm to 3.47 ppm in the initial 
1
H NMR spectrum.  The 
13
C NMR 
spectrum showed a peak at 172.9 ppm indicative of the CO, a shift from 166.1 ppm from the starting 
chloroacetamide.  All peaks from the aromatic protons were observed at the expected resonances.  
The salt version of the amine was formed using HCl as previous work had shown that further 
reactions with just the amine led to polymeric reactions.
65
  The salt was characterised via the usual 
spectroscopic techniques.  The solubility of the compound had changed and NMR spectroscopy was 
carried out in CD3OD.  The CH2 adjacent to the NH2 was observed at 3.89 ppm in the 
1
H NMR 
spectrum.  The CO group was observed at 168.2 ppm in the 
13
C NMR spectrum.  All other aromatic 
protons were found in the expected regions.  The ESI
+ 
mass spectrum gave a peak at m/z 166 amu at 
[M+H]
+
.  Elemental analysis and the IR spectrum confirmed that the Cl had successfully been 
converted to the NH2 salt 38. 
 
 
Spectrum 3.4: 
1
H NMR spectrum of 39: a) aromatic region; b) aliphatic region. 
 
The newly formed 38 was then treated with chloroacetyl chloride in the same manner as for the 
original acetamide (Scheme 3.7c).  The amine salt was stirred in THF, triethylamine and chloroacetyl 
chloride.  The product 39 could not be extracted easily as in the synthesis of acetamide 37 and so 
column chromatography was required to isolate the product.  The yield was low at 21 % with some 
impurities still remaining.  The 
1
H NMR spectrum of 39 exhibited three singlets at 4.52 ppm, 4.06 
ppm and 4.00 ppm indicating three CH2 groups were present in the new acetamide (Spectrum 3.4).  
The peaks at 4.52 ppm and 4.00 ppm were attributed to the CH2 groups adjacent to the NH groups.  
These were singlets instead of the expected doublets due to the proton exchange occurring between 
the NH and OD in CD3OD.  The 4.06 ppm peak was assigned to the CH2 adjacent to the Cl.  The 
13
C 
NMR spectrum gave two peaks at 168.5 ppm and 156.4 ppm indicative of the two CO groups now 
present.  All aromatic peaks and carbons were found at expected resonances.  The ESI
+
 mass spectrum 
gave an m/z = 242 amu peak indicative of [M+H]
+
.  Following the successful synthesis of novel 39, 
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attempts were then made to connect the extended arm onto the polyamine macrocycle and are 
explained in subsequent chapters.  
 
3.9.  Conclusions 
The aim of this chapter was to synthesise the varying pendant groups for use in the final macrocyclic 
compound.  These pendant groups made up either the fluorescent component or the Zn
2+
 sensing 
component of the final target molecule.  The first part of the chapter details work on three types of 
fluorophores (F - BODIPY dyes, rhodamine dyes and dansyl dyes).  Each were chosen mainly due to 
their robust nature to chemical modifications and previous applications towards cellular studies. 
Work towards the F - BODIPY dyes began with synthesis of a pyrrole with a pyridyl substituent.  The 
idea of condensing two of the pyrroles to form the F - BODIPY via a „dipyrrin‟ type intermediate 
would have given a novel F - BODIPY dye, with hypothesised spectral properties that would have 
been unique and not previously synthesised.  The target was also to establish a synthetic method using 
normal laboratory conditions by avoiding the need for air sensitive techniques.  This would give to 
give the final F - BODIPY dye greater application especially with the desire to covalently bond them 
to the macrocycle of the final target molecule and use for molecular imaging. 
The synthesis and isolation of the intermediate dipyrrin would have provided an alternative chelating 
ligand with Zn
2+
 sensing potential or possibly other cations.  Unfortunately work towards the target F 
- BODIPY dyes and their respective dipyrrins was unsuccessful.  It was noted that use of the 
chloroacetyl chloride as the linker between the two pyrroles did not form a stable enough product that 
could be isolated and other linkers need to be explored, as the spectral properties of this novel F-
BODIPY dye would be of great interest and the respective dipyrrin would yield a new synthetic 
method and could be investigated as a new chelating ligand. 
Work towards the desired rhodamine derivative via a new synthetic route was partially successful.  
Synthesis towards 26 was achieved via a new route and avoided use of the carcinogenic BOP reagent.  
The use of N - hydroxysuccinmide to yield the rhodamine succinimide ester followed by the mono-
protected ethylenediamine may have given lower yields but used milder conditions.  The 
triethylamine salt that was observed in the 
1
H NMR spectrum, also did not interfere with formation of 
26 and was eliminated following deprotection of the terminal amine.  Further derivatisation of 26 has 
yet to be seen in the literature and if successful would have provided an excellent fluorophore for 
attachment to the final macrocycle encompassing all the desired traits. 
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Research with the dansyl derivatives saw the introduction of a linker chain and carbonyl group to the 
starting dansyl chloride which also contained all the traits needed for the final macrocyclic compound.  
The route towards 28 was synthesised directly from 29 with chloroacetyl chloride which differed from 
the use of bromoacetic acid and eliminated the extra synthetic step with comparable yields, whilst 
avoiding the long work - up procedure. 
The second part of the chapter focused on work towards the Zn
2+ 
sensing groups.  Despite the 
relatively simple molecules designed, some had not previously been reported in the literature.  
Although DPA is widely used as a Zn
2+
 sensor functionalisation with small linkers have not been 
observed in the literature.  Following various reaction conditions to attach a small linker chain, direct 
derivitisation of DPA was not possible probably due to the chemical reactivity of DPA.  The 
chloroacetyl chloride could also have been too reactive to give the product desired and although 1,3-
dichloroacetone was used to try and test this hypothesis, DPA was obtained again. 
Other attempts towards DPA derivatives by avoiding direct use of DPA was not successful, further 
confirming that use of chloroacetyl chloride within reactions involving pyridyl groups for formation 
of a DPA derivative could not be used.  Instead milder reaction conditions need to be investigated 
which would give a novel DPA derivative for not only use towards the final macrocyclic compound 
but also as a platform for use in other Zn
2+ 
sensing probes synthesised in the future. 
The several lessons learnt from the experiments, i.e. the set - back met with the synthesis towards 
DPA derivatives and lack of facile routes towards the newly designed novel Zn
2+ 
sensors envisaged, 
led to work commencing with acetamide 37.  Acetamide 37 was synthesised via literature methods 
and elongated with a chloroacetamide linker (39) to provide further chelating sites as it was unknown 
how 37 would bind once on the macrocycle.  A new synthetic route was established for this novel 
compound, and further optimisation of reaction conditions would give higher yields. 
All successful pendant groups synthesised, both for the fluorescent component and the Zn
2+
 sensing 
component were to be incorporated into the final multi - modal imaging target compound, which is 
detailed in the following chapters.  
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4. Design and Synthesis Towards 1,7-Bi-Substituted DOTA - Based Derivatives 
4.1. Introduction 
Despite the continued development of Zn
2+
 sensing imaging agents, only a few examples combining 
two different imaging modalities exist in the literature.
1-4
 The majority of the Zn
2+
 sensing agents are 
fluorescence-based and used for fluorescence imaging,
5
 with a minority being MRI-based.
5-7
 Within 
the literature, none of the sensors developed have yet to find success in a clinical setting, and so, the 
need to design an imaging Zn
2+
 sensor with the ability for in vivo applications is highly desirable.  The 
focus of this project is to develop a multi-modal imaging agent with Zn
2+
 sensing abilities 
incorporating both fluorescence imaging and MRI properties.  This chapter will focus on work 
regarding the target molecule Gd.40 (Figure 4.1), following on preliminary work carried out in 
chapter 3.   
 
 
 
Gd.40 
 
Figure 4.1: Target compounds of this Thesis (see chapter 1) 
 
The development of this new Gd
3+
- based multi - modal imaging agent Gd.40 is focussed on a 1,7 – 
bi - substituted DOTA-based core with surrounding pendant groups made up of a fluorophore, a Zn
2+
 
sensor and carboxylate groups.  The Gd
3+
 centre provides the ligand with MRI properties which could 
lead to tests in clinical settings if successfully synthesised.  This cyclic derivative was chosen in place 
of the linear derivative of the ligand, DTPA, as it has been seen to be a more effective chelator of 
Gd
3+
, with the capability of retaining the metal ion even in the acidic environment of endosomes.  The 
majority of the clinically approved MRI agents that are based on this polyamine macrocycle have 
shown high in vivo stability and exhibit minimal toxicity.
8
 Although the main focus is forming the 
Gd
3+
 complex, other lanthanide (Ln
3+
) metal centres will be considered, mainly europium (Eu
3+
) so 
that physical measurements, in particular NMR experiments, can be carried out.   
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4.2.  Design Towards Gd.40 
The nitrogen atoms of the starting cyclen material will serve as points of attachment for the 
appropriate pendant groups.  In this case, the fluorophore initially tested will be the dansyl 
fluorophore and the Zn
2+
 sensing group will be the acetamide synthesised in chapter 3.   
A general scheme for retrosynthetic analysis of Gd.40 is given in Scheme 4.1.  
  
 
Gd.40 
 
 
41 
 
 
 
 
42 
  
43 
+  
  
 
 
 
 
44 
+ 
 
37 
 
 
 
6 
+ 
 
 
Scheme 4.1: Retrosynthetic scheme for formation of Gd.40 
 
The Gd
3+ 
chelate (Gd.40) is formed from the metal free ligand 41, by addition of a suitably labile 
Gd
3+
 ion source.  Both carboxylic acid groups of compound 41 are prepared from appropriate 
alkylation of the secondary amines of the corresponding cyclen derivative with acetate groups (42).  
This 1,7-substituted cyclen derivative is formed via sequential addition of the dansyl fluorophore and 
acetamide to give 43.  Initial disconnection between the acetamide and macrocycle will yield the 
acetamide 37 previously synthesised, followed by a subsequent disconnection of the sulphonamine 
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bond giving the starting dansyl chloride and cyclen starting material.  Alternatively the initial 
disconnection can be at the sulphonamide bond, followed by disconnection between the acetamide 
and macrocycle.  The first method of disconnection was followed and found successful.  
 
4.2.1. Synthesis Towards Mono-Functionalisation of Cyclen 
The synthetic route to target compound 40, exhibited in Scheme 4.2, began with the introduction of 
the dansyl fluorophore to the cyclen moiety.  A solution of dansyl chloride was added dropwise to a 
solution of excess cyclen.  The use of excess cyclen provided excellent selectivity towards the mono-
functionalised cyclen derivative 44.  Previously the high cost of cyclen has been a problem, however 
with new synthetic procedures and improved methodologies,
9-12
 it is more readily available.   
 
 
 
 
6 
a 
 
 
44 
             
                    b 
 
 
42 
c 
 
 
43 
d 
 
  
 
41 
e 
 
 
40 
Scheme 4.2: Synthesis towards Gd.40 
Reagents and Conditions: a) DnsCl (0.4 equiv), CHCl3; b) 37 (0.4 equiv), K2CO3, MeCN;  
c) tert-butyl bromoacetate (2.2 equiv), Et3N, MeCN; d) HCl/dioxane; e) various conditions tested. 
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The mono - functionalised compound 44 was isolated using silica column chromatography with 20 % 
MeOH in DCM as eluent with unreacted cyclen also being retrieved.  It was important that the dansyl 
fluorophore was added dropwise to the mixture of cyclen, despite the use of it in excess, to ensure 
mono - addition as the by-product containing two dansyl groups was observed on the cyclen moiety if 
addition was too rapid.   
The formation of 44 was confirmed in the 
1
H NMR spectrum (Spectrum 4.1) whereby four triplets 
representing the different CH2 groups of the cyclen ring were observed once the dansyl fluorophore 
had been attached.  The most shifted peak of these CH2 groups at 3.50 ppm was attributed to both CH2 
groups either side of the dansyl fluorophore.  The other peaks due to the CH2 groups were found 
closer together at 2.95, 2.86 and 2.71 ppm.  This spectrum differed from the 
1
H NMR spectrum of the 
starting cyclen which had a single peak at 2.73 ppm indicative of the identical CH2 groups of the 
macrocycle (Spectrum 4.1b).  The 
13
C NMR spectrum of the mono - functionalised compound also 
exhibited four peaks in the expected CH2 region also indicative of the differing carbons of the CH2 
groups, and thus further confirming mono-functionalisation of the starting cyclen material with the 
dansyl fluorophore. The 
1
H NMR shifts for protons in the aromatic rings were found at expected 
resonances (Spectrum 4.1c).  The ESI
+
 mass spectrum also gave a dominant peak at m/z = 406 amu 
representing [M + H]
+
.  Compound 44 was obtained in yields from 85 - 91 % and was further 
characterised via elemental analysis and IR spectroscopy. 
 
 
Spectrum 4.1: 
1
H NMR Spectrum of dansyl-cyclen derivative 44  
a) aromatic region; b) aliphatic region; c) whole spectrum 
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4.2.2. Synthesis of the 1,7-Substituted Cyclen Derivative 43 
Work towards the formation of 1,7 - substituted cyclen derivatives has been intensely investigated in 
the literature, with use of protecting groups the standard methodology.  Work by Burdette and 
Lippard
13
 regarding synthesis towards a 1,7 - substituted cyclen derivative based on a hybrid 
fluorescein is an example of the strategy often taken (Figure 4.2).   
 
 
 
 
 
 
    
 
 
 
 
 
 
Figure 4.2: Work by Burdette and Lippard exhibiting the general synthetic procedure towards  
1,7-substituted cyclen derivatives involving protecting groups.
13
 
 
Burdette made use of a mono-substituted cyclen moiety and treated it with an aldehyde to yield the 
1,7 - substituted cyclen derivative with excellent selectivity.
13
 Cyclen is often protected at three of its 
nitrogens to ensure mono-functionalisation.  Once mono - functionalisation is achieved, the protecting 
groups are cleaved off followed by addition of a second substituent at 1 equivalent which is pushed 
into the trans-N position mainly due to sterics.  This was observed by Burdette
13
 where the 1,4 -
product was not observed and only a small amount of the compound exhibiting a second substituent 
was detected when the quantity of aldehyde was restricted to 1 equivalent.  These successful reactions 
formed the basis towards attempts to attach the acetamide arm to the mono - substituted dansyl-cyclen 
44.  In the case of ligand 41, it was decided to attempt to synthesise the 1,7 - substituted derivative by 
avoiding protecting groups and the need to have an extra synthetic step towards the 1,7 - substituted 
derivative 43. 
Acetamide 37 began was added dropwise to a solution of dansyl - cyclen and left together with 
sodium hydrogen carbonate and a catalytic amount of potassium iodide.  The crude ESI
+
 mass 
spectrum of 37 indicated the product had formed but in addition the product containing a second 
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acetamide arm was also observed.  Attempts to separate the 1,7 - substituted product from this 
additional product proved difficult via column chromatography as both compounds were of similar 
polarities and ran close together on the column.  Both silica and alumina media were tested, but 
neither could provide successful separation.  
Subsequent attempts limited the acetamide arm to 0.98 equivalents to the dansyl - cyclen in order to 
minimise addition of a second acetamide arm.  Potassium carbonate was used instead of sodium 
hydrogen carbonate and potassium iodide, in order to minimise the reagents used.  The reaction 
mixture was heated gently as had been seen in previous alkylation methods.  Initial TLC analysis 
exhibited the same pattern observed in previous attempts but with an additional spot with a higher Rf 
value.  Following purification via column chromatography on alumina, the extra spot was 
characterised as the compound containing three acetamide arms.  However separation of the desired 
compound and the compound containing a second acetamide group remained difficult as both 
compounds continued to elute out together.   
Following the formation of the side - product with three acetamide arms and the constant observation 
of the compound with two acetamide arms, a 1:1 ratio of dansyl - cyclen and acetamide was not 
deemed sufficient to provide excellent selectivity towards the 1,7-product.  The alkyl chain of the 
acetamide chain was not bulky enough to prevent subsequent addition of more acetamide groups.  In 
order to prevent formation of the undesired products, initially an excess of 3.5 equivalents of dansyl-
cyclen was used as a test to react with 1 equivalent of acetamide.  The acetamide was added dropwise 
to a solution of dansyl-cyclen with potassium carbonate.  Following purification via column 
chromatography, none of the side-product containing the three acetamide arms was observed.  The 
target product 43 was isolated in a yield of 42 %, although later fractions did contain the product 
containing the two acetamide arms.  These reaction conditions were repeated with 2.5 equivalents of 
dansyl - cyclen, as was done when synthesising the dansyl - cyclen 44, and yielded similar results, 
indicating that 2.5 equivalents was sufficient for the reaction and enough to yield some of 43 for use 
in subsequent steps.  Further attempts to optimise the reaction conditions included carrying out the 
reaction at room temperature in an attempt to try and prevent the addition of an extra acetamide arm.  
This did not improve results and the same observations were noted.  The acetamide was thought to be 
a lot more reactive than anticipated and it was left to react with 44 at 1:2.5 equivalents in chloroform. 
Unfortunately both addition of one acetamide arm and two acetamide arms was still observed and as 
found with previous purification attempts using column chromatography, both compounds eluted at 
similar polarities when using the commercially available silica and alumina media.  
It was decided to try to manipulate the commercially available media in an attempt to improve 
separation.  A small percentage of water was introduced to the alumina to increase its grade value 
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from I (standard commercial value) to V, by 15 % water (v:w).  Initial results were promising when 
looking towards the separation of products with one acetamide group and two acetamide groups.  Two 
bands thought to be the target compound and by - product although still running close together, were 
at their most distinct when compared to previous column chromatography attempts.  This was as a 
result of the increased amount of water molecules which filled a portion of the pores in the alumina 
and allowed for the mixture to move through at a slower rate than previously observed in alumina 
grade I, thus improving the seperation.  Although the yield was not greatly improved, with more time 
and further optimisation, grade V alumina could further improve yields and the efficacy of the 
reaction. 
 
 
Spectrum 4.2: ESI
+
 mass spectrum of 43 with side-products observed (inset). 
 
Despite the difficulty of separating the desired product from the side - product containing two 
acetamide arms, a sufficient amount of 43 was obtained with good purity for initial characterisation.  
The 
1
H NMR spectrum saw a shift in the CH2 adjacent to the Cl of the starting acetamide from 4.18 
ppm to 3.28 ppm indicating addition to the dansyl-cyclen macrocycle.  The distinct peaks from the 
1
H 
NMR spectrum of the dansyl - cyclen material indicated that the four different CH2 groups around the 
macrocycle were now overlapping giving a large multiplet, a common observation in the literature 
due to the „ring flipping‟ of the macrocycle.  „Ring flipping‟ is the rapid process of chair - chair 
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interconversion, whereby in this case the CH2 groups of the cyclen macrocycle are able to interconvert 
from the axial position to the equatorial position and vice versa.  This leads to a broad signal of 
multiplets being observed.  The ESI
+
 mass spectrum gave a peak at m/z = 554 amu indicative of 
[M+H]
+ 
(Spectrum 4.2).  Although minor impurities still remained present, the synthetic route was 
continued in an attempt to synthesise the target compound.   
Carboxylic acid groups were incorporated into the design in an attempt to make the ligand water-
soluble and provide coordinating sites for the eventual lanthanide centre (Figure 4.3).  In order to 
introduce the carboxylic acid groups into the final moiety, methodologies used by Balogh et al.
14
 
towards dimeric triazacyclonanone-based ligands bearing carboxylate functional groups was used. 
Balogh introduced carboxylic acid groups to the free NH groups of the macrocycle via initially 
reacting them with tert-butyl bromoacetate.  The 1,7 - substituted product 43 and tert-butyl 
bromoacetate were left to stir in MeCN followed by the addition of triethylamine.  After stirring for a 
few days, the reaction was worked up via extraction using a basified solution and the product 
extracted via ether as carried out in the literature.
14
   
 
 
Figure 4.3: Ligand 41 incorporating carboxylic acids to improve solubility 
 
This work - up however did not eliminate much of the triethylamine salt despite repeating and 
eventually only after purification via column chromatography was the majority of triethylamine salt 
eliminated.  However the 
1
H NMR spectrum still exhibited traces of impurities.  Subsequent 
purification attempts of this reaction lead to the crude mixture initially being purified via column 
chromatography, however the triethylamine salt was still detected at 12 % from the 
1
H NMR 
spectrum.  The fractions containing the product and traces of the triethylamine salt were then washed 
with a solution of NaOH and the product 42 extracted via diethyl ether.  This sequence of steps 
yielded the cleanest result.  The 
1
H NMR spectrum exhibited a peak at 1.42 ppm attributable to the 
now present Boc group.  The CH2 groups of the acetamide arms adjacent to the pyridyl ring and 
adjacent to the polyamine macrocyclic ring were respectively observed as a doublet at 4.57 ppm and a 
singlet at 3.16 ppm.  The singlet had shifted downfield slightly due to the addition of the tert-butyl 
acetate groups creating an increased electronegative environment with the inclusion of the carbonyl 
groups.  The four CH2 groups of the polyamine macrocycle could also be identified in distinct 
Chapter 4: Design and Synthesis Towards 1,7-Bi-Substituted DOTA-Based Derivatives 
113 
 
regions.  The peaks appeared at four shifts starting at 3.37, 2.99, 2.75 and 2.63 ppm with splitting 
patterns of a triplet, triplet, doublet of doublets and doublet of doublets respectively.  The CH2 of the 
tert-butyl bromoacetate shifted slightly upfield from 3.70 ppm to 3.14 ppm once appended to a 
nitrogen as opposed to the bromine.  The 
13
C NMR spectrum exhibited a shift in acetamide and tert-
butyl acetate groups from 166.1 ppm and 165.0 ppm to 170.6 ppm and 170.0 ppm respectively.  
Aromatic peaks from the acetamide and dansyl groups were found at expected resonances.  The ESI
+ 
mass spectrum showed the desired product 42 at m/z = 782 amu for [M]
+
.   
 
 
Spectrum 4.3: 
1
H NMR (CDCl3) spectrum of 42:  
a) aromatic region; b) aliphatic region I; c) aliphatic region II; d) whole spectrum 
 
In order to free the carboxylic acid groups from the acetate groups and produce compound 41, the tert 
- butyl groups had to be cleaved via an appropriate method.  Two common methods often used for 
Boc cleavage are either via a mixture of TFA:DCM or with HCl and dioxane.  Initial attempts to 
liberate the carboxylic acid groups began by using a mixture of TFA:DCM due to previous successes 
in the laboratory.  The reaction was followed over several hours and aliquots taken every hour as 
initial attempts saw the compound degrade after 7 hours.  After every hour, a peak in the expected 
Boc region was still observed, even after 7 hours and although the 
1
H NMR remained similar 
throughout each hour, the ESI
+
 mass spectrum no longer exhibited the peak synonymous to the 
desired product after 3 hours and instead a peak possibly representing one of the starting materials 
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was observed at m/z = 554 amu.  This gave the impression that perhaps the TFA:DCM mixture was 
starting to cleave the whole of the acetate arms, as opposed to just the tert - butyl groups.  This may 
be due to the acidity of TFA.  In order to circumvent this problem the milder HCl and dioxane 
combination was tested.  Following overnight stirring, the 
1
H NMR spectrum exhibited no peak in the 
1.40 – 1.50 ppm region indicating cleavage of the Boc groups.  The ESI+ mass spectrum also 
exhibited a peak at m/z = 670 amu indicating [M+H]
+
 with more defined peaks than had previously 
been observed when cleaving the butyl groups with TFA:DCM.  The resultant oily residue had the 
aliphatic region broadened due to the now present OH groups from the carboxylic acids.  This was 
also due to the reaction occurring in aqueous conditions leading to the sample containing a large 
amount of water.  Attempts were made to completely dry the sample under vacuum with gentle 
heating but it was not possible to completely dry the desired product.  The ligand was also found to be 
water-soluble, a highly desirable property for use in biological studies. 
 
4.2.3. Complexation Methods Towards Gd.40  
Although the aim was to complex the ligand to various lanthanide centres, in particular Eu
3+
 and Gd
3+
, 
initial efforts towards the complexation focussed on Gd
3+
.  When successful, the same methodology 
would be applied for Eu
3+
 and other Ln
3+
 centres.  With a variety of methods existing in the literature 
towards complexation of lanthanides to polyamine macrocycles, GdCl3 was chosen, as it is commonly 
used with water soluble ligands.
15
 Literature methods dissolve the ligand in MilliQ water and add 
GdCl3 which leads to the complex precipitating out of the solution allowing for easy isolation.  In this 
case, this method was not successful with ligand 41 and Gd
3+
, and both were left as a mixture with 
GdCl3, as had been observed with work on the quinoline based probe in chapter 2.  Free Gd
3+
 ions 
were also detected via the xylenol orange test (explained in chapter 2).  The initial attempt at 
complexation turned the solution purple indicating that free Gd
3+
 ions were present, although this 
could have meant not all the Gd
3+
 had reacted and that some of the desired complex had been made.  
However no precipitate was observed and the crude ESI
+
 mass spectrum gave no indication that any 
complex had formed.  Instead the starting ligand was observed and no isotopic pattern for Gd
3+
 ions 
could be seen. 
As with the quinoline - based probe detailed in Chapter 4, the method employed by Esqueda was 
followed once again.
7
 The pH of the reaction mixture was manipulated once GdCl3 had been 
completely added.  The pH of the solution initially dropped to approx pH 3, indicating the formation 
of HCl as the Gd
3+
 ions were released for complexation to the polyamine macrocycle.  Once all the 
GdCl3 had been added, the pH was returned to pH 6.8 with NaOH and the reaction mixture left to stir.  
Continuous observation using the xylenol orange test indicated that free Gd
3+
 ions were still in the 
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solution mixture despite using a 1:1 stoichiometry and stirring for two days.  The remaining reaction 
mixture was heated to 50 ˚C in an attempt to form the complex but the ESI+ mass spectrum only 
exhibited peaks of the ligand and nothing representative of the complex.  In an attempt to overcome 
the slow thermodynamic properties towards the formation of the desired metal complex, the reaction 
mixture was heated to 90 ˚C but once again the same observations were seen. 
Other Gd
3+
 ion sources were investigated as possible alternatives, those that are available 
commercially include Gd(OTf)3, Gd(NO3)3 and Gd2(CO3)3 to name but a few.  One that has been used 
with great success has been Gd(OTf)3.
16,17
 The ligand and Gd(OTf)3 are often heated in a solvent, 
sometimes including a base, to form the desired metal complex.  This protocol was followed, but 
initial attempts using MeOH were unsuccessful with the ESI
+
 mass spectrum not giving any peaks of 
significance.  Subsequent attempts made use of triethylamine, which was left to stir with the ligand 
initially, in case any salts present were hindering the complexation, followed by addition of Gd(OTf)3.  
Free Gd
3+
 ions were still detected in the xylenol test, and no peaks of significance could be seen in the 
ESI
+
 mass spectrum.  The 
1
H NMR spectrum still exhibited peaks synonymous to the ligand, as 
opposed to the expected broadened spectrum.  A number of variations were also attempted using other 
solvents such as MeCN, with a change in reaction temperatures also investigated.  However despite 
all these various attempts, the desired metal complex could not be synthesised. 
 
4.3.  Conclusions 
The synthesis of Gd.40 was expected to provide a novel route towards this new compound.  By 
incorporating  a fluorophore and Zn
2+
 sensor as well as carboxylic acids to aid solubility in aqueous 
media, this synthetic route could have been a platform towards this type of design of molecule.  By 
avoiding protecting groups, it enables milder reaction conditions to be used.  The preliminary success 
towards ligand 41, has established a synthetic route that with further optimisation of purification 
techniques will provide improved yields.  Thus far, a foundation for the synthesis towards the various 
intermediates has been established.  The mono - functionalisation of cyclen with the dansyl 
fluorophore is achieved by controlling the stoichiometry of the reaction and purified with high yields.  
Subsequent attempts to introduce the acetamide to give a 1,7 - substituted product were successful 
when using the macrocycle in excess to the acetamide.  By manipulating the commercially available 
alumina, a small improvement in purification was observed and deserves further investigation.  With 
regards to the various attempts of Gd
3+
 and ligand 41, initial attempts following the method used in 
chapter 2 by altering the pH of the reaction media were unsuccessful.  Alternative methods using 
MeOH, increasing the reaction temperature, leaving it to stir with triethylamine to remove any salts 
were also unsuccessful and further work in this direction needs to be carried out so that methods can 
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be translated towards making other lanthanide complexes for use as NMR probes for biomedical 
applications.  
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5. Design and Synthesis Towards Zn2+ Responsive Gd3+ - Based DOTA - tetraamide Derivatives 
5.1. Introduction 
One of the driving forces for the use of tri and tetrasubstituted cyclen ligands are their ability to form 
complexes with a very high degree of kinetic and thermodynamic stability.  The clinically approved 
[Gd(DOTA)
-
] has a pKd value of 28.5 and a half - life within in vivo  settings of thousands of years.
1
 
DOTA-tetraamide derivatives in particular have found use as potential PARACEST contrast agents in 
MRI
2,3
 and/or as luminescent probes
4
 through the formation of lanthanide (Ln
3+
) complexes.  DOTA -
like cyclen derivatives have been investigated in great lengths and are prevalent towards the design of 
MRI contrast agents.
5
 
The acetamide synthesised in Chapter 3 has formed one of the building blocks of the lanthanide (Ln
3+
) 
DOTA - tetraamide cyclen derivative synthesised by Woods and Sherry for use as either a pH 
responsive luminescent probe
6
 or MRI contrast agent.
7
   
 
 
 
Figure 5.1: Acetamide previously used for DOTA - tetraamide complexes 
 
It has yet to be seen, to the author‟s knowledge that the acetamide has been used as a metal sensing 
probe.  This chapter will focus on the synthesis towards the triamide - cyclen complex 45 (Figure 2.2) 
first introduced in chapter 1, followed by addition of a fluorophore for use in fluorescence imaging.  
 
 
  
Gd.45 
Figure 5.2: Target compounds (see Chapter 1). 
 
This target compound would make use of the acetamide as a Zn
2+
 sensing moiety and be evaluated on 
for its ability to sense Zn
2+
 ions in comparison to the traditionally used DPA moiety.
6-8
 As explained
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in earlier chapters, although Gd
3+ 
is used throughout the schemes, other lanthanide centres are 
considered for complexation, especially Eu
3+
. 
Complex Gd.45 was designed with three acetamide arms and fluorophore appended to the nitrogen 
atoms of the macrocycle.  Other designs of tetrasubstituted cyclen ligands with this type of design of 
three identical groups on the cyclen macrocycle and a different group on the final nitrogen has been 
observed in work by Faulkner
9
 and Ratnakar.
10
  
It is hypothesised that complex 45 would form a 7 - coordinate complex with a Ln
3+
 centre, with 
coordination sites being provided by the three carbonyls of the acetamide groups and four nitrogens 
from the macrocycle ring.  The dansyl group would not be able to provide a coordinating site due to 
the strain at the sulphonamide bond and close proximity to the ring.  This 7 - coordinate complex 
would leave the Gd
3+
 which has the ability to form 9-coordinate complexes, with two sites available 
for H2O molecules (q = 2).  If successful in synthesising this Gd.45, the reaction conditions could be 
applied to the other building blocks made in previous chapters, to form a small library of compounds 
(Figure 5.3).  
 
 
 
 
Gd.45a 
 
Gd.45b 
 
Gd.45c 
Figure 5.3: Gd.45 analogues 
 
 
Three Gd.45 analogues are proposed and differ either through a change towards the dansyl derivative 
with a linker chain (Gd.45a) or the elongated acetamide chain (Gd.45b) or both (Gd.45c).  Gd.45a 
would make use of the dansyl-derivative with an extra linker containing a carbonyl group which 
would introduce an extra coordinating site, bringing the complex to an 8 - coordinate complex leaving 
one site free for H2O (q = 1).  Although it would be ideal for two H2O molecules to be detected, free 
Gd
3+
 ions in the body are detrimental to neuron passages and patients with renal problems.  This extra 
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binding site will provide increased stability of the Gd.complex with a coordinating site dedicated to 
the Gd
3+
 centre.  Gd.45b contains the elongated acetamide group whilst keeping the short dansyl 
fluorophore as in Gd.45.  The elongated acetamide group was synthesised as it was unknown how 
acetamide 37 in the DOTA - tetraamide would bind to Zn
2+ 
ions.  It is hypothesised that with 
acetamide 44 either two groups from the same macrocycle could complex to the Zn
2+ 
or two Gd.45 
molecules would bind to a single Zn
2+
 forming a 2:1 complex of Gd.45 to Zn
2+
 ions.  The elongated 
acetamide chain would provide additional coordinating sites of the Zn
2+
 ion.  The addition of a 
carbonyl could help in Zn
2+
 binding leaving the other carbonyl completely free to coordinate to the 
Gd
3+
 ion centre.  The analogue containing both the elongated dansyl derivative and elongated 
acetamide derivative would give Gd.45c and form a substanitially bulkier complex, which would 
have a slower tumbling rate and may improve the relaxivity values as observed with various dendritic 
like compounds.  
The initial aim of this chapter is to describe the synthesis of Gd.45 and establish synthetic methods 
followed by photophysical, cellular and preliminary MRI studies.  If the synthesis of Gd.45 is 
successful attempts towards making its analogues will commence.  Other lanthanide centres would 
also be explored in order to gain further information relevant to biomedicine by means of NMR 
techniques, which can be provided by magnetic properties possessed by the different lanthanides.   
 
5.2.  Synthesis of Gd.45 
5.2.1. Retrosynthetic Analysis Towards Gd.45 
A retrosynthetic analysis of the target Gd.45 is presented in Scheme 5.1.  Firstly, the Gd complex is 
formed from the free ligand 46 by the addition of a Gd source.  Possible disconnections at the 
sulphonamide bond and the acetamide bonds yields two possible methods towards the formation of 
ligand 46.  The first route sees a disconnection at the sulfonamide bond, resulting in the dansyl 
chloride starting material and trialkylated cyclen 47.  The trialkylated cyclen 47 could be disconnected 
at the amide bonds leaving the starting chloroacetamide 37 and cyclen (46).  The second route that 
can be employed disconnects at the amide bonds resulting in 37 and dansyl cyclen 44.  Dansyl cyclen 
44 can then be further disconnected at the sulfonamide bond leaving dansyl chloride and cyclen. 
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Scheme 5.1: Retrosynthetic scheme towards target Gd.45 via two possible methods. 
 
5.2.2. Synthesis Towards Ligand 46 
The first disconnection method was investigated following work by Ratnakar et al.,
10
 who synthesised 
a variety of Eu
3+
 DOTA - tetraamide complexes.  These complexes followed a similar design to the 
target compound with three acetamide arms attached to three nitrogens of the cyclen with the 
remaining nitrogen being alkylated with p - substituted bromoacetyl aniline derivatives.  In this case a 
dansyl fluorophore will take the place of the aniline derivative.  Ratnaker started by selectively 
trialkylating cyclen with three equivalents of ethyl - N - bromoacetylglycinate using NaHCO3 and 
then subsequently alkylating the free N with various bromoacetyl aniline derivatives.  This route was 
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chosen over initially mono - functionalising the cyclen with the respective aniline derivative following 
work carried out by Gunnlaugsson
11
 who investigated both methods towards the synthesis of various 
lanthanide complexes.  The investigation found that trialkylation of the cyclen as the initial step as 
opposed to mono - funtionalisation of the cyclen followed by trialkylation gave higher yields. 
 
 
 
6 
 
a 
 
 
 
C 
 
47 
 
 
44 
b 
 
 
46 
 
D 
 
e 
 
 
 
 
Gd.45 
 
Scheme 5.2: Synthesis towards Gd.45 
Reactions and Conditions: a) 37, NaHCO3, MeCN; b) DnsCl, CHCl3; c) 44, CHCl3;  
d) 37, K2CO3, MeCN; e) Gd(OTf)3, MeCN, heat under reflux 
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Cyclen was trialkylated with 3 equivalents of chloroacetamide 37 using NaHCO3 in MeCN (Scheme 
5.2(a)).  Following overnight stirring at 65 ⁰C, the ESI+ mass spectrum of the reaction mixture showed 
the presence of a variety of multi - substituted products with the majority of the trialkylated cyclen 
derivative obtained as a mixture.  In order to avoid the side-products, the second disconnection route 
despite the low yields reported was followed.  The dansyl-cyclen 44 was synthesised as detailed in 
Chapter 4.  Following the synthesis of 44, it was reacted with a slight excess of chloroacetamide 37 to 
ensure that all free nitrogens of the macrocycle reacted in MeCN and in the presence of a base.  Both 
Et3N and K2CO3 were examined, with K2CO3 giving higher yields. 
After stirring at 65 ˚C for 65 h in the presence of K2CO3, purification by alumina column 
chromatography using 95:5 DCM/MeOH provided 46 in 65 % yield, compared when using 
triethylamine, where 10 % of the pure product was isolated.  Compound 46 was identifed via its 
1
H 
NMR spectrum (Spectrum 5.1) by the presence of two doublets at 4.45 ppm and 4.51 ppm with 
integrations of 2:4 indicative of the CH2 groups adjacent to the NH.  The CH2 groups between the CO 
and the macrocyclic ring had shifted from 4.14 ppm in the starting chloroacetamide to two 
overlapping peaks at 3.17 ppm.  The CH2 groups of the macrocycle were found as four groups at 3.29 
ppm, 3.13 ppm, 2.73 ppm and 2.68 ppm indicating that the ring had become strained and inflexible 
and thus individual groups could be detected.   
 
 
Spectrum 5.1: 
1
H NMR spectrum in CDCl3 of ligand 46. 
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The 
13
C NMR spectrum had peaks at 156.8 ppm assigned to the CO carbons shifting from 166.1 ppm 
in the starting acetamide 37.  The ESI
+
 mass spectrum gave a peak at m/z = 851 amu further 
indicating that the product had formed.  The novel ligand 46 was further characterised with IR 
spectroscopy and elemental analysis. 
 
5.2.3. Complexation of Ligand 46 
Following synthesis of 46, initial complexation methods using Eu
3+
 were investigated to find the best 
method for complexation so that further lanthanide complexes could be synthesised.  Eu
3+
 was used 
initially, as NMR analysis and characterisation would be easier in confirming whether the complex 
had been made.  Methods towards complexation were not as simple as the literature suggested and the 
methods investigated are summarised in Table 5.1. 
 
Conditions Results 
1) 46, EuCl3.6H2O, MeOH, 50 ˚C, 
24 h 
Oily residue was left and found to be unreacted 46. 
2) 46, Eu(OTf)3, MeOH, 50 ˚C, 24 h Hygroscopic yellow solid, found to be unreacted 46. 
3) 46, Eu(OTf)3, DCM, rt, 18 h Yellow solid where the 
1
H NMR spectrum exhibited wide-
shift.  FAB
+
 mass spectrum indicated that the metal complex 
had formed.  Low yields and impurities were present despite 
various recrystallisation attempts.   
4) 46, Eu(OTf)3, MeCN, 90 ˚C, 18 h Orange powder which was confirmed and characterised as 
desired complex 45. 
Table 5.1: Summary of the reaction conditions investigated towards the Eu
3+
 metal complex. 
 
Initial attempts using EuCl3.6H2O in MeOH at 50 ˚C were not successful (condition 1), as although 
the 
1
H NMR spectrum exhibited a change, the ESI
+
 mass spectrum only gave a peak attributable to 
ligand 46.  Other electrospray techniques were carried out in case ESI
+
 was too harsh to detect the 
desired complex, however softer techniques commonly successful with detecting metal complexes 
such as MALDI
+
 and FAB
+
 mass spectrometry only indicated that the ligand was present.  The nature 
of ligand 46 with the surrounding amides may have made complexation thermodynamically difficult 
and a more labile group in the starting Eu
3+
 material was researched.  Triflates are known to be labile 
groups and the literature has seen them used for lanthanide complexation with DOTA-like 
derivatives.
6,8,12
 Eu(OTf)3 was left to stir with the ligand in MeOH at 50 ˚C as Pope
12
 had reported 
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(condition 2), but again only the free ligand could be observed.  The protic nature of MeOH may have 
affected the desired reaction and a change in solvent to DCM was tested.  The ligand was left to stir in 
DCM and Eu(OTf)3 at room temperature (condition 3).  After 18 h, a yellow powder was obtained 
following recrystallisation showing a change in the 
1
H NMR spectrum.  The spectrum contained 
peaks comparatively broadened when compared to the starting ligand (see page 184 for 
1
H NMR of 
Eu.45).  The FAB
+
 MS technique gave a peak at m/z = 1150 amu assigned to [M + OTf].  Elemental 
analysis indicated that impurities were present, possibly due to the metal complex coordinating to 
solvents such as DCM or diethyl ether from recrystallisation.  Despite the successful result, due to the 
low yield and presence of impurities, MeCN was used for subsequent attempts at complexation so that 
the reaction could be heated to higher temperatures to improve yields.  The ligand and Eu(OTf)3 were 
left to heat under reflux for 18 h in MeCN (condition 4).  A dark orange powder was obtained 
following recrystallisation and the presence of free Eu
3+
 ions was also tested for with the xylenol 
orange assay (mentioned in chapter 4).  This detected the presence of free Eu
3+ 
ions.  Due to the 
necessity required for these compounds to be free of Ln
3+ 
ions, especially when using Gd
3+
, which is 
highly toxic to the body in its free form, attempts were made to eradicate this.  The reaction 
conditions were altered to eliminate the possibility of free Eu
3+
 ions, whereby the stoichiometry of 
Eu(OTf)3 to ligand was weighted in favour of the ligand at 1:0.9 and even down to 1:0.5.  The 
reaction was also heated at elevated temperatures and left for a week to ensure full complexation of 
the Eu
3+ 
but free Eu
3+
 ions were still being detected.   
A literature search revealed that a variety of resins were available for separating free Ln
3+ 
from 
complexation reactions that had not gone to completion.  Amberlite resin
13
 was initially used and 
found to bind the free Eu
3+ 
ions once the compound had been loaded and eluted with H2O.  The 
solubility of the ligand in MeOH meant that a solution of the compound could be obtained with a 
mixture of MeOH:H2O.  However following an increase in MeOH and various crystallisation attempts 
of the oil obtained, only the free ligand 46 could be observed by 
1
H NMR spectrum.  The complex 
containing free Eu
3+
 ions was treated via alumina column chromatography eluting with 5 % MeOH in 
DCM as seen by work done by Gunnlaugsson.
14
 This provided Eu.45 free of free Eu
3+ 
ions and 
following various recrystallization attempts Eu.45 was eventually yielded as a yellow powder, which 
had to be isolated by filtration cautiously, and identified via FAB
+
 mass spectrometry, with peaks at 
m/z = 1007 amu and 1305 amu assigned to [M]
+
 and [M + 2CF3SO3
-
]
+
.  The 
1
H NMR spectrum was 
comparable to the one previously seen when the reaction was carried out in DCM.   
These same reaction conditions were applied to ligand 2 to form the Gd
3+ 
metal - complex Gd.45.  
Following recrystallisation from MeCN and Et2O, an orange powder formed.  FAB
+ 
mass 
spectrometry gave peaks at m/z = 1002 amu, 1151 amu, and 1300 amu indicated [M]
+
, [M + CF3SO3
-
]
+
, [M + 2CF3SO3
-
]
2+ 
respectively.  The 
1
H NMR spectrum in CD3CN gave broadened peaks due to the 
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paramagnetic nature of the Gd
3+ 
centre and the molecular formula was established via elemental 
analysis.   
 
5.2.4. Attempted synthesis towards Gd.45 analogues 
 
 
 
 
Gd.45a 
 
Gd.45b 
Figure 5.4: Gd.45 analogues 
 
Following the successful synthesis of complex Gd.45, efforts towards Gd.45 analogues (Figure 5.4) 
were attempted.  Efforts were concentrated on Gd.45a and Gd.45b.  Complex Gd.45a was 
synthesised as in Scheme 5.3.  The dansyl-cyclen derivative 48 was synthesised with the same 
conditions as the dansyl chloride and cyclen seen in Scheme 5.2.   
 
 
28 
a 
 
48 
 
  b 
 
 
Gd.45a 
c 
 
49 
 
Scheme 5.3: Synthesis towards analogue Gd.45a 
Reactions and Conditions: a) DnsCl, CHCl3; b) 37, K2CO3, MeCN;  
c) Gd(OTf)3, MeCN, heat under reflux 
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The dansyl - derivative 44 was stirred in CHCl3 with an excess of cyclen to give 48 as a bright yellow 
powder in high yields.  The peak indicative of the CH2 group adjacent to the Cl in the 
1
H NMR 
spectrum at 3.38 ppm in the starting material was no longer visible and had shifted upfield whereby 
peaks representing the CH2 groups of the macrocycle and linker of the dansyl - derivative were 
overlapping in the region between 1.50 – 3.00 ppm.  This overlapping region was observed due to the 
extra linker chain on the dansyl fluorophore allowing the macrocyclic ring to „flip‟.  Dansyl - cyclen 
derivative 48 was left to stir with acetamide 37 using the same conditions used for the DOTA-
tetraamide 46.  The resultant 
1
H NMR spectrum did not show the distinct peaks as the original 
analogue.  Again this is due to the extra linker between the dansyl fluorophore and macrocycle not 
providing any strain or rigidity meaning the macrocycle is able to „ring - flip‟ more easily.  The 
product Gd.45a was confirmed via ESI
+
 mass spectrometry and elemental analysis.  The same method 
was applied towards the synthesis of complex Gd.45b (Scheme 5.4), which made use of an elongated 
acetamide group and the dansyl cyclen containing the sulphonamide bind directly adjacent to the 
macrocycle.   
 
a 
 
50 
 
  b 
 
  
 
Gd.45b 
Scheme 5.4: Attempted synthesis of analogue Gd.45b 
Reactions and Conditions: a) DnsCl (44), CHCl3; b) 37, K2CO3, MeCN; c) Gd(OTf)3, MeCN, heat under reflux. 
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Dansyl - cyclen (44) was left to stir with the acetamide derivative previously made in chapter 3, in 
MeCN and in the presence of K2CO3.  The crude 
1
H NMR spectrum indicated a reaction had occurred 
as the CH2 adjacent to the Cl of the starting acetamide at 2.64 ppm had diminished.  Purification via 
column chromatography indicated that only products with one elongated acetamide group and two 
acetamide groups were present (Figure 5.5).  The ESI
+
 mass spectrum gave peaks at m/z = 611 amu 
for [M + H]
+ 
for the product with one acetamide group and m/z = 816 amu [M + H]
+
 for the product 
containing two acetamide groups. 
 
A 
 
 
B 
Figure 5.5: Side-products observed when synthesising ligand 50 
a) with one acetamide arm; b) with two acetamide arms. 
 
The desired product was not observed, and may be due to the compound being sterically congested.  
A higher reaction temperature is required to alleviate this problem, but due to time constraints, other 
aspects of the project were focussed on. 
 
 
5.3.  Photophysical Properties of the Ln.DOTA - Tetraamide Derivatives 
In order to investigate the Zn
2+
 ion binding properties of Eu.45, Gd.45 and Gd.45a (Figure 5.6) 
titrations in the presence of Zn
2+
 ions were carried out and the absorption and the emission spectrum 
obtained.    Titrations against other cations (Cu
2+
, Ca
2+
, and Mg
2+
) were also carried out with Eu.45, to 
observe any difference in spectral behaviour.  In addition Gd.45 was submitted for cellular and MRI 
studies. 
 
 
Ln.45 
 
Gd.45a 
Figure 5.6: Probes used for absorption and fluorescence titrations, where Ln = Eu, Gd. 
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5.3.1. Absorption and Emission Effects of Eu.45 Induced By Zn2+ 
The absorption spectrum of Eu.45 showed a maximal absorption peak at ~255 nm, ~260 nm and a 
broad shoulder band at the longer wavelength of ~340 nm before titration of the various metal cations 
(Figure 5.7).  Experimental details for the titration experiments can be found in Chapter 7, section 7.3.  
This curve shape has been typically observed by dansyl derivatives.
15-18
 The maxima observed in 
close proximity between 250 nm and 260 nm are due to the pyridyl and the dansyl chromophore.  The 
band at 255 nm being the π - π* transitions in the pyridyl rings and the band at 260 nm being the π - 
π* transitions in the napthalene ring of the dansyl chromophore.  The band at 340 nm is caused by the 
charge-transfer character caused by the promotion of the lone-pair electron from the amino group into 
a π anti - bonding orbital of the napthalene ring.15 Upon addition of Zn2+, the absorbance at 255 nm 
increased steadily until 1 equivalent was reached, after which subsequent absorbance values remained 
the same (Figure 5.7).   
 
 
Figure 5.7: Absorption spectrum of Eu.Gd.45 (39.87 μM) upon addition of Zn2+ (0 - 2 equivalents, 
MeOH).  Inset: Absorption spectral changes between 250 – 265 nm.  
 
Three isosbestic points were observed at around 243 nm, 280 nm and 335 nm (Figure 5.8) during the 
titration of Zn
2+
.  Fitting of the absorption titration curve, using Origin 10.0 software, of Eu.45 
(Figure 5.9, details in Chapter 7, section 7.3) revealed a 1:1 stoichiometry of the Eu.45/Zn
2+ 
species 
with an association constant of 4.37 x 10
-3 
M
-1
.  The absorption spectrum expressed small 
hyperchromic behaviour at the bands in the 250 - 260 nm region, due to the Zn
2+
 interacting with the 
pyridyl rings and contributing to the π - π* transitions.  The band at 340 nm also showed a 
bathochromic behaviour and produced a red - shift of about 3 nm upon complexation with Zn
2+.  
This 
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slight change may be due to the polarity of the enviroment
16,19
 as opposed to a direct interaction 
between Zn
2+
 and the dansyl chromophore which would have otherwise caused a hypsochromic 
shift.
20,21
  
 
a) 
 
b) 
 
                                       c) 
 
Figure 5.8: Isosbestic points found at a) 243 nm; b) 280 nm; c)335 nm. 
 
 
Figure 5.9: Titration profile of Eu.45 (39.87 μM) showing the change in absorption with increasing 
amounts of Zn
2+
 (0 – 2 equivalents) at 260 nm, with calculated association constant (K). 
 
For the emission spectrum (Figure 5.10) Eu.45 gave a maximum emission centred around 535 nm in 
the absence of Zn
2+
 ions, which was characteristic of the dansyl fluorophore emission behaviour.
15
 
With the addition of Zn
2+
 ions (0 - 2.5 equivalents), the fluorescence intensities showed a 3.5 - fold 
quenching and a 10 nm blue - shift indicating a chelation enhanced quenching (CHEQ) effect.  A 
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steady decrease in intensity was observed until 1 equivalent was reached, after which the intensity 
remained approximately the same.  As Zn
2+
 is not expected to interact directly with the dansyl 
fluorophore,
16,22
 this quenching mechanism could be attributed to the „heavy atom effect‟ causing the 
increase in intersystem crossing rate constant instead of the dansyl-to-ions energy transfer which can 
also be responsible for quenching and a blue - shift effect.  The typical value observed for Zn
2+
 
fluorescent complexes at 470 nm
23
 could also explain the blue - shift towards the 470 nm region.  The 
titration profile (Figure 5.11) of the fluorescence absorption spectrum also indicated a complex 
formation of 1:1 and a calculated association constant of 4.24 x 10
-3 
M
-1
.
 
 
 
Figure 5.10: Fluorescence spectrum (λex= 330 nm, MeOH) of EuGd.45 (39.87 μM) upon titration with 
Zn
2+
 (0 - 2.5 equivalents) 
 
Figure 5.11: Titration profile with increasing amounts of Zn
2+
 at 300 nm 
with calculated association constant. 
 
The small difference in value between the absorption and emission spectrum may be due to 
experimental error as the values are both in similar regions.  
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5.3.2. Absorption and Emission Effects of Gd.45 Induced By Zn2+ 
Complex Gd.45 was also titrated against Zn
2+ 
in MeOH with both absorption and emission spectra 
recorded to confirm that a different Ln
3+
 centre would not have any significant effect on the 
absorption and emission spectra upon Zn
2+
 complexation.   
 
 
Figure 5.12: Absorption spectrum of Gd.45 (39.87 μM) following addition of Zn2+  
(0 - 2 equivalents, MeOH).  
 
 
a) 
 
b) 
 
                                      c) 
 
Figure 5.13: Isosbestic point highlighted at a) 249 nm; b) 285 nm; c) 350 nm 
The absorption spectrum (Figure 5.12) also exhibited three isosbestic points at 249 nm, 285 nm and 
350 nm, highlighted in Figure 5.13.  Again, the formation of a 1:1 complex between Gd.45 and Zn
2+
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ions was found with the titration profile (Figure 5.14) of the UV/Vis absorption giving a calculated 
association constant of 2.92 x 10
-3
 M
-1
. 
 
 
Figure 5.14: Absorption titration profile of Eu.45 upon addition of Zn
2+
 showing absorption intensities at 
337 nm and calculated association constant. 
 
The fluorescence emission spectrum of Gd.45 also exhibited a fluorescence quenching as expected, 
following the same rationale as Eu.45 which was explained previously.  The binding association 
constant was calculated at 2.44 x 10
-3 
M
-1
. 
 
 
Figure 5.15: Fluorescence spectrum exhibiting emission of Gd.45 (39.87 μM, MeOH) upon addition of 
Zn
2+
 (0 - 2 equivalents, λex= 330 nm). 
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Figure 5.16: Emission titration profile of Gd.45 upon addition of Zn
2+
 showing emission intensities at 
532 nm and calculated association constant. 
 
In order to gain a better comparison between the association constants of Eu.45 and Gd.45, which at 
present are slightly different, these titrations must be repeated a few times so that an average value 
can be drawn before any firm conclusion can be made.  However, it was seen that both complexes 
formed a 1:1 complex with Zn
2+
 and a mechanistic elucidation of the interaction between Gd.45 and 
Zn
2+ 
ions, and consequently Eu.45 and Zn
2+
, is proposed in Scheme 5.5. 
 
 
 
 
Scheme 5.5: Schematic binding mode of Gd.45 bound to Zn
2+
. 
 
5.3.3. Absorption and Emission Effects of Gd.45a Induced By Zn2+ 
Complex Gd.45a, with the extra linker chain between the macrocyclic unit and the dansyl unit, was 
titrated with Zn
2+ 
ions.  Following the addition of Zn
2+
 (0 to 1.6 equivalents), the absorption spectrum 
(Figure 5.17) produced the same bands as previously seen for the Eu.45 and Gd.45 coming from the 
pyridyl rings at 250 nm and the dansyl chromophore at 260 nm and 340 nm due to the π - π* 
transitions of each.   
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Figure 5.17: Absorption spectrum of Gd.45 following addition of Zn
2+
 (0 - 1.6 equivalents, MeOH). 
Inset: Close - up of peak between 240 – 270 nm showing a very small increase in absorption with 
increasing amounts of Zn
2+
. 
 
 
Complex Gd.45a only produced one distinct isosbestic point at 246 nm.  A smaller increase in change 
in the absorption spectrum was observed when compared to the absorption spectrum of Gd.45.  
Again, the change at the 250 nm was due to the interaction between the Zn
2+
 ions and the pyridyl 
rings of the complex.  The band at 340 nm, representative of the dansyl chromophore showed a lack 
of absorption change as expected from previous titrations.  The absence of a blue or red shift was 
probably due to the distance between the fluorophore and the Gd.DOTA - tetraamide derivative core 
meaning any solvent interactions were too weak to detect.  Fitting the UV/Vis (Figure 5.18) titration 
as explained earlier gave a calculated association constant of 1.14 x 10
-3 
M
-1
. 
 
 
 
Figure 5.18: Absorption titration profile of Gd.45a upon addition of Zn
2+
 showing absorption intensities 
at 252 nm and calculated association constant. 
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The fluorescence titration (Figure 5.19) of Gd.45a showed the fluorescence intensity did not change 
with increasing amounts of Zn
2+
 ions.  The increased distance meant that the expected quenching 
effect as previously seen and previously attributed to the „heavy atom effect‟ could not take place. 
 
 
 
Figure 5.19: Fluorescence spectrum exhibiting emission of Gd.45a (40 μM) upon addition of 
Zn
2+
 (0 - 2 equivalents) in MeOH (λex= 330 nm). 
 
 
The lack of change in fluorescence intensity was explained via the increased distance between the 
dansyl fluorophore and Gd.DOTA tetraamide core.  This behaviour demonstrated that distance 
between the fluorophore and Ln.DOTA - tetraamide core is a key factor in forming an effective 
fluorescent sensor.   
The association constant calculated from the UV/Vis titration for Gd.45a showed a higher affinity 
towards (1.41 x 10
-3
 M
-1
) Zn
2+ 
ions when compared to the Gd.45 parent complex.  This is likely to be 
as a result of the extra linker chain providing two extra lone pairs from the nitrogens which are able to 
provide additional binding sites for the Zn
2+
.  Scheme 5.6 shows this hypothesised binding mechanism 
between Zn
2+
 ions and Gd.45a.  This mechanism can also explain a decrease in change in the 
absorption spectrum as interactions between the NH groups of the linker chain can not be detected 
under UV/Vis spectroscopy. 
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Scheme 5.6: Hypothesised schematic binding mode of Gd.45a bound to Zn
2+
. 
 
In order to gain a further understanding of the behavioural pattern of Ln.45 with different metal 
cations (Cu
2+
, Ca
2+
, Mg
2+
) further UV/Vis and fluorescence titrations were carried out.  
 
5.3.4. Absorption and Emission Effects of Eu.45 Induced By Cu2+ 
The Cu
2+ 
ion is often observed as a main competitor to Zn
2+
 ion in non - biological settings and so its 
behavioural patterns with Eu.45 were observed to compare it to the behaviour of Eu.45 with Zn
2+
 
ions. 
The UV/Vis titration experiment between Eu.45 and Cu
2+
 ions gave a different shaped absorption 
spectrum (Figure 5.20) to the analgous titration experiment with Zn
2+ 
ions.  The Cu
2+
 ions induced a 
larger hyperchromic effect than the Zn
2+
 ions at the pyridyl band (255 nm), via disturbance of the π - 
π* transitions, but unlike with the Zn2+ ions, the absorption spectrum did not plateau after 1 equivalent 
and instead continued to increase at 2 equivalents after which a small plateau was observed.  Although 
no definitive plateau was observed, a 1:1 complex was predicted, and an association constant of 8.5 x 
10
-3
 M
-1 
was calculated (Figure 5.21).  The more pronounced change in the absorption spectrum at 
360 nm which was responsible for the dansyl chromophore also suggested that the binding of Cu
2+ 
ions was different to the behaviour of Zn
2+
 ions and was having an effect on the dansyl chromophore. 
The different binding mode maybe due to the valence shell electron pair repulsion (VSEPR) theory, 
which suggests that Cu
2+ 
prefers a square - planar conformation.  This conformation differs from Zn
2+ 
which prefers a tetrahedral geometry.  This allows for the Jahn - Teller effect to take place allowing 
otherwise forbidden transitions to occur leading to more efficient transitions and stronger bands being 
observed, which in this case is the band responsible for the dansyl chromophore at 360 nm, as 
opposed to the tetrahedral geometry which is unable to distort sufficiently in configuration and thus 
has no ability to detect any change in the dansyl chromophore. 
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Figure 5.20: Absorption spectrum of Gd.45 (39.87 μM) upon Cu2+ titration (0 - 2 equivalents). 
Inset: Close - up of peak between 220 – 250 nm showing an enhancement of absorption with an increasing 
amount of Zn
2+
 ions. 
 
 
Figure 5.21: Absorption titration profile of Eu.45 upon addition of Zn
2+
 showing absorption intensities at 
300 nm with calculated association constant. 
 
The emission spectrum of Eu.45 with Cu
2+ 
ions (Figure 5.22), followed the same behaviour as the 
Zn
2+ 
ions, with a quenching and 10 nm blue - shift observed upon an increase in concentration of 
Cu
2+
.  Fitting the titration curve (Figure 5.23) of fluorescence exposed a plateau again after 1 
equivalent of Cu
2+
, indicating formation of a 1:1 complex of Cu
2+
 to Eu.45 with a calculated binding 
association constant of 3.3 x 10
-3 
M
-1 
determined.  A hypothesis as to why the value between the 
association constant varied between the one calculated from the absorption spectrum data and 
emission spectrum data could be due to the quenching properties Cu
2+ 
possesses. 
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Figure 5.22: Fluorescence spectrum exhibiting emission of Gd.45 (39.87 μM) upon addition of Cu2+ (0 - 2 
equivalents) in MeOH (λex= 330 nm). 
 
 
Figure 5.23: Emission titration profile of Eu.45 showing emission intensities at 532 nm and calculated 
association constant (K). 
 
This higher calculated binding association constant suggests that Eu.45 has a higher affinity towards 
Cu
2+
 ions.  This higher binding association is not a concern as Cu
2+ 
ions do not exist in large amounts 
in biological settings.
24 
The softer nature of Cu
2+
 compared to the Zn
2+ 
ion also gives it its higher 
interaction with Eu.45.  This observation follows the pattern observed by the Irving - Williams series, 
which refers to the relative stabilities of complexes formed by a transition metal ion. 
The binding mode of Cu
2+ 
to Eu.45 is expected to mimic the one hypothesised for Zn
2+
. 
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5.3.5. Absorption and Emission Effects of Eu.45 Induced By Ca2+ 
Ca
2+
 ions are present in biological media and are also potential competitors for Zn
2+
 ions.  These were 
also titrated against Eu.45 and found to produce a different shaped absorption spectrum when 
compared to the Zn
2+
 ions.  Ca
2+
 caused a two - step effect in the absorption spectrum (Figure 5.24) 
whereby an initial addition of 0.05 equivalents saw the absorbance increase immediately and remain 
in the same region until 0.6 equivalents of Ca
2+
 had been added.  At this point another increase was 
observed, followed again by the absorption values remaining in the same region.  This behaviour 
suggested that initially 2 equivalents of Eu.45 were binding to 1 equivalent of Ca
2+
.  Then following 
an excess amount of Ca
2+
, Eu.45 begins to bind to one Ca
2+
 ion.   
 
 
Figure 5.24: Absorption spectrum of Gd.45 (39.87 μM) with increasing amounts of  
Ca
2+
 ions (0 - 2 equivalents). 
Inset: Close-up of curve between 220 – 250 nm showing a two - step behaviour with  
increasing amounts of Ca
2+
. 
 
a)  
 
 
b) 
 
Figure 5.25: Titration profile with calculated association constant for binding of the first Ca
2+ 
ion (a) and 
the second Ca
2+
 ion (b). 
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Again, the change in the absorption curve was due to the increase in number of π - π* interactions of 
the pyridyl rings.  A rationalisation for the difference in behaviour of Ca
2+
 compared with Zn
2+
 is the 
difference in ionic diameter.  Ca
2+ 
ions have a diameter of 1.98 Å compared with Zn
2+ 
ions at 1.48 Å. 
Fitting the UV/Vis titration (Figure 5.25) at each distinct step, and thus fitting the curves to a 1:1 
model, gave calculated binding association constants for the first Ca
2+ 
as 0.301 x 10
-3 
M
-1 
and 
0.258 x 10
-3 
M
-1
 for the second Ca
2+
.  These low values suggest binding towards Ca
2+
 is less 
favourable than towards Zn
2+
 ions, however could be misleading as the complex is not a true 1:1 
complex and using different mathematical model to fit the complex would perhaps give a more 
accurate value.  The behaviour of the fluorescence emission spectrum (Figure 5.26) also differed to 
that of the Zn
2+
 ions.  The introduction of Ca
2+
 ions led to a 0.7 - fold enhancement of fluorescence 
and a 10 nm blue - shift.   
 
 
Figure 5.26: Fluorescence spectrum exhibiting emission of Eu.45 (39.87 μM) upon addition of 
Ca
2+
 (0 - 5 equivalents) in MeOH (λex= 330 nm). 
 
 
Figure 5.27: Emission titration profile of Eu.45 upon addition of Ca
2+
 showing emission intensities at 
500 nm and calculated association constant (K). 
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This enhancement can be reasoned through the photo - induced electron transfer (PET) pathway. 
Unlike Zn
2+
, which provided an electron to fall into the highest occupied molecular orbital (HOMO) 
of the fluorophore once it had been excited and thus causing a quenching in fluorescence, the HOMO 
of the Ca
2+
 ions is lower in energy than than the HOMO of the fluorophore which then prefers to 
received an electron from its lowest occupied molecular orbital (LUMO) once the fluorophore is 
excited and thus an enhancement is observed. 
The fluorescence titration against intensity curve (Figure 5.27) for Eu.45 and Ca
2+
 ions suggest more 
of a 1:1 complex formation, and found a calculated binding association of 3.97 x 10
-3 
M
-1
.  The large 
difference between the binding association constant calculated from the absorption and emission 
spectra may be to the different binding model applied.  It is assumed that a 1:1 complex is being 
formed from the emission data, however the same assumption although made for the absorption data, 
may not be correct.  The two - step curve observed in the absorption spectrum may indicate a change 
in complex formation, and thus a different binding model would be required to calculate the K value. 
Taking all these considerations, Scheme 5.7 proposes a binding mechanism between Ca
2+ 
and Eu.45. 
 
 
 
 
 
 
  
 
 
Scheme 5.7: Schematic binding mode of Eu.45 bound to Ca
2+
. 
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5.3.6. Absorption and Emission Effects of Eu.45 Induced By Mg2+ 
In order to further investigate whether the ionic size of the cation was a key factor in changing the 
behaviour of the absorption and emission spectra, both UV/Vis and fluorescence titrations were 
carried out with Mg
2+ 
ions against Eu.45.  Mg
2+ 
has an ionic diameter of 1.32 Å and may also act as a 
competitor to Zn
2+
 as it is present in biological media. 
The UV/Vis spectrum (Figure 5.28) showed that absorbance initially decreased indicating a minor 
interaction with the pyridyl rings and a disturbance of the π - π* transitions.  Following an increase of 
Mg
2+
 ions, the absorbance remained in the same region, indicating no further effect on the π - π* 
transitions of the pyridyl rings or the dansyl chromophore. 
 
 
Figure 5.28: Absorption spectrum of Gd.45 (39.87 μM) upon addition of Mg2+ titration (0 - 3 equivalents). 
Inset: Close - up of peak between 240 - 270 nm showing no trend with increasing amounts of Mg
2+
 ions. 
 
The titration profile (Figure 5.29) gave no strong correlation between the absorbance and increasing 
amounts of Mg
2+ 
ions. 
 
Figure 5.29: Absorption titration profile of Mg
2+
 added to Eu.45. 
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The emission spectrum (Figure 5.30) and titration profile (Figure 5.31) also showed no strong 
correlation between fluorescence intensity and an increased amount of Mg
2+ 
ions.   
 
 
 
Figure 5.30: Fluorescence spectrum exhibiting emission of Gd.45 (39.87 μM) upon addition of 
Mg
2+
 (0 - 3 equivalents) in MeOH (λex= 330 nm). 
 
 
Figure 5.31: Emission titration profile with increasing equivalents of Mg
2+
. 
 
 
This poor correlation between fluorescence intensity and increasing concentration of Mg
2+
 was 
attributed to the poor interaction, if any, between the Mg
2+
 ion and Eu.45 due to its ionic size. The 
ionic diameter of Mg
2+
 ions are considerably smaller (1.32 Å) than Ca
2+ 
ions (1.98 Å) and also smaller 
than Zn
2+ 
ions (1.48 Å), indicating that ionic size is an important factor to consider towards efficient 
binding to Eu.45. 
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Summary of Eu.45 Binding 
 
Summarising the various binding constants calculated (Table 5.2), a general conclusion for the 
binding strengths between Eu.45 and the various cations tested can be Cu
2+ 
> Zn
2+ 
> Ca
2+ 
> Mg
2+
 
according to the absorption data and Ca
2+ 
> Cu
2+ 
> Zn
2+ 
> Mg
2+ 
according to the emission data.  At 
present it would not be possible to carry out any error analysis using statistical methods as at least two 
further sets of data are required in order to quantify any errors and measure the quality of fit with 
regards to the curve obtained.  The large difference for Ca
2+
 is due to the uncertain nature of the 
complex being formed.   
 
Ion titrated 
against Eu.45 
Zn
2+
 Cu
2+
 Ca
2+
 Mg
2+
 
K value from 
absorption data  
(x 10
-3
 M
-1
) 
4.37 8.5 0.030 N/A 
K value from 
emission data  
(x 10
-3
 M
-1
) 
4.24 3.3 3.97 N/A 
Table 5.2: Summary of K values calculated from absorption data and emission data. 
 
Another problem that may arise with Eu.45, and consequently Gd.45, in the presence of other cations 
in biological media is the possibility of transmetallation.  Although Eu - chelates are 
thermodynamically stable, they are kinetically labile enough to undergo transmetallation by 
endogenous ions such as Zn
2+
, Cu
2+
 or Ca
2+
, as seen with Gd - chelates.
25-28
 For Gd - complexes, 
transmetallation can be assessed via a simple relaxometric protocol previously developed to study the 
in vitro transmetallation processes of Gd - complexes.
29
 This method measures the evolution of the 
paramagnetic longitudinal relaxation rate of water protons at physiological conditions in a phosphate 
buffer solution containing an equal concentration of Gd - complex and ZnCl2 (or other cations).  If 
transmetallation were to occur the Gd
3+
 would precipitate out as GdPO4 and have a negligible 
influence on the longitudinal relaxation rate of water
45
 thus reducing the original value of the 
longitudinal relaxation rate of water.  This test could be directly applied to Eu.45 to measure its 
susceptibility towards transmetallation. 
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5.4.  Celullar Studies on Gd.45, Eu.45 and Free Ligand 46 
5.4.1. Evaluating the Sensitivity of the Probes 
Initial cell studies were carried out with the Gd.45, Eu.45 and free ligand 46 to test the compounds 
suitability in physiological conditions.  This study was carried out in collaboration with Dr Elisa 
Bellomo in the Faculty of Medicine, Imperial College London.  A rat insulinoma beta cell line INS-1 
(832/13) was used to assess the ability of the compounds to permeate the plasma membrane and be 
retained in the cytosol. Cells were incubated with an increased concentration (1 to 100 µM) of Gd.45, 
Eu.45 and free ligand 46 at 37° C for 30 min. before imaging.  The images produced suggested that 
all the compounds tested had the ability to permeate the plasma membrane and label the cells.  Figure 
5.32 shows INS-1(832/13) cells following incubation with Gd.45 and free ligand 46.  Eu.45 exhibited 
the same behaviour as Gd.45. From Figure 5.32 it is possible to appreciate how low concentrations of 
compounds (1 μM) give high background noise, while higher concentration (100 μM) produced a 
better signal to noise ratio. For this reason, a 100 μM concentration of these compounds were used for 
further experiments, as this was the concentration that produced better quality images. 
 
 
Figure 5.32: Images showing both Gd.45 and free ligand 46 permeates beta cell plasma membrane at 
varying concentrations, with 100 μM giving the best image due to the increased signal to noise ratio. 
 
5.4.2. Evaluating Specificity of the Probes 
In order to test the specificity of the probe, compounds Gd.45, Eu.45 and free ligand 46 were used 
with two different cell lines. The rat insulinoma cell lines were used as before and compared with a 
human embryonic kidney cell line (HEK 293). INS-1(832/13) cells, being a beta cell line, contain 
insulin granules that contain high concentrations of Zn
2+
. On the other hand, HEK 293 cells do not 
possess these granules. The hypothesis was that the probes would label INS-1 (832/13) cells more 
specifically, as they contain more zinc. In order to test the hypothesis, both cell lines were incubated 
with 100 μM of Gd.45, Eu.45 and free ligand 46.  As shown in Figure 5.33, the insulinoma cell lines 
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were clearly labelled more effectively, indicating that the compounds are likely to be specific for Zn
2+
.  
Ligand 46 was found to be more receptive towards Zn
2+
 ions, than the metal complexes, this is due to 
the macrocycle providing an additional chelating site,
30
 which is then able to bind to more Zn
2+
 ions 
and thus giving a brighter signal.  In the case of the Ln.45 complexes, this macrocyclic binding site is 
no longer available and so relatively few Zn
2+ 
ions are detected. 
 
 
Figure 5.33: Images showing both Gd.45 and free ligand at 100 μM in  
HEK 293 and INS-1(832/13). 
 
Further experiments to test specificity of the compounds towards Zn
2+
 were carried out, using primary 
pancreatic cells.  CD1 mouse pancreata were digested and dissociated into islets (containing beta 
cells) and acinar tissues. These were incubated for 30 min. at 37 ˚C with 100 µM of either Gd.45, 
Eu.45 and free ligand 46 and subsequently imaged.  The relative position of islets and pancreatic acini 
was identified by brightfield illumination (Figure 5.34, left panel) and then the fluorescent intensity of 
the probe was captured by exciting the samples at 320 nm (Figure 5.34, false color, right panel).  
These images suggest that Gd.45 and Eu.45 have the ability to label beta cells - containing islets with 
some selectivity compared to acinar tissues. 
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Figure 5.34: Staining of mouse pancreas-derived cells with Gd.complex 45. (Scale bar = 50 µm). 
 
5.4.3. Preliminary MRI Studies 
In order to establish whether Gd.45 was a viable contrast agent, preliminary MRI studies were carried 
out in collaboration with Dr. Po - Wah So, King‟s College London.  In vitro MR images of Gd.45 at 
7 T in MeOH at four different concentrations (Figure 5.35, decreasing from left to right) showed a 
gradual increase in the MRI signal intensity as the concentration increased.  The same behaviour was 
observed for the clinically approved [Gd(DOTA)]
-
 agent (Figure 5.35).  This suggested that Gd.45 
was an effective contrast agent.  As expected the Eu.45 showed no signal enhancement despite high 
concentrations being used and confirmed its ineffectiveness as a T1 MRI contrast agent.  Both r1 and r2 
values were measured for the Gd.45 complex and [Gd(DOTA)]
-
 (Figure 5.35).  The relaxivity values 
observed for Gd.45 were almost double the value of [Gd(DOTA)]
-
.  This high value could be 
attributed to the extra free ligating site on the Gd
3+
 ion as a result of the dansyl fluorophore not 
providing any metal coordination thus leaving a 7 - coordinate complex (q = 2). 
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Figure 5.35: T1 - weighted (TR/TE, 200/10ms) MR images at 7T in MeOH. 
 
Some in vivo work using Gd.45 with the leg of a mouse was carried out following results that Gd.45 
was an effective contrast agent.  Following direct injection of the probe into the skeletal muscle of the 
leg of the mouse.  The MRI experiment was able to visualise in vivo settings, 48 h after the injection.  
Figure 5.36 shows the positive signal enhancement observed in the leg that received Gd.45 compared 
to the contralateral leg that received only vehicle, which acted as a reference (Figure 5.36).  
 
 
Figure 5.36: A typical 7 T T1 - weighted MR image of the hind legs of a mouse given intramuscular 
injection of Gd.45 in one leg and the vehicle in the contralateral leg. 
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5.5.  Conclusions 
The synthesis of the novel Zn
2+ 
responsive sensor Gd.45 for use as a multi-functional imaging agent 
has been successful.  UV/Vis and fluorescence titrations indicated a response to Zn
2+
 ions when 
introduced.  Cellular studies showed Gd.45 has the ability to penetrate the cell membrane and chelate 
to Zn
2+ 
ions.  MRI studies showed its effectiveness as a contrast agent and its ability to remain active 
48 h following injection. 
A successful synthetic procedure towards the novel compounds Gd.45, Eu.45 and Gd.45a has also 
been established.  Gd.45 and Eu.45 showed similar behaviour towards Zn
2+
 ions as seen from both 
the UV/Vis and fluorescence titrations.   
Observations from the UV/Vis and fluorescence titrations with the analogue Gd.45a containing the 
linker chain in the dansyl fluorophore showed that distance from the DOTA - tetraamide core was 
important towards an efficient fluorescence sensor, despite a higher binding affinity for Zn
2+
 ions 
being calculated (1.41 x 10
-3 
M
-1
).  Further titrations of other cations with Eu.45 indicated another 
important factor when designing the next generation of probes.  Ionic size was a key factor and 
although Eu.45 indicated a higher affinity for the larger Ca
2+
, however further competitive assays 
need to be completed before a firm conclusion can be made. 
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6. General Conclusions and Future Work 
6.1.  General Conclusions 
Molecular imaging and its modalities have contributed to the further understanding of biological 
processes at the molecular level in a non-invasive manner.  In recent applications its use with 
chemical sensors has provided further information and understanding of the various mechanistic 
pathways undertaken by metals in biology and medicine.  By further understanding the behaviour of 
metals involved in biological settings, it would be beneficial towards developing novel diagnostics 
and even therapeutics. The development of „smart‟ contrast agents whereby a change is induced 
through the introduction of a substrate or a change in environment have been factors that have led to a 
greater understanding in metal behaviour in biological settings. 
Zn
2+ 
was chosen for this project due to its use in a multitude of biological and metabolic functions and 
that disturbance in its homeostasis has linked it to various diseases.  Despite the large amount of work 
already carried out with Zn
2+
, the added challenge of a d
10
 outer shell making most spectroscopic 
techniques redundant, and thus the synthesis of a Zn
2+ 
probe for use in clinical settings has yet to be 
achieved. 
A further development for molecular imaging has been the concept of multi-modal imaging, whereby 
two modalities, in particular MRI and optical imaging can be used by the same contrast agent for use 
in a single specimen to produce two different pieces of information. 
Taking all these factors in mind three main target molecules were designed and introduced in Chapter 
1 (Figure 6.1). 
 
 
 
Gd.1  
 
 
Gd.40  
 
Gd.45  
Figure 6.1: Target complexes designed in Chapter 1. (Ln = Gd
3+
, Eu
3+
). 
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The work in this Thesis deals with the design and synthesis of these target compounds, precursor to 
them and various attempts towards making novel fluorophores and Zn
2+
 sensing groups.  Chapter 2 
deals with the synthesis of a Zn
2+ 
- sensing quinoline-based probe attached to a DO3A moiety with the 
ability to respond to Zn
2+ 
via UV/Vis, fluorescence titrations and relaxivity measurements.  Various 
synthetic routes were followed in order to successfully synthesise the final complex Gd.1.
Chapter 3 describes the building blocks required for eventual synthesis of target compounds Gd.40 
and Gd.45 (Ln = Gd
3+
, Eu
3+
) and those where attempts were made to further derivatise the final 
complexes.  Both target molecules contained a dansyl fluorophore due to successful work on 
derivatising them.  Successful work on the acetamide groups meant that they were chosen when 
designing the final Zn
2+
 sensing moieties. 
In Chapter 4, attempts to synthesise a 1,7 - bi - substituted DOTA derivative, Gd.40, whilst avoiding 
protecting groups via use of mild reactions conditions and controlled stoichiometries.  A synthetic 
route towards synthesising the 1,7 - bi - substituted DOTA derivative ligand has been established, for 
use towards other moieties based on this design.  Complexation of this derivative with Gd
3+
 was 
challenging and attempts of complexation were not achieved in the time available. 
The design and synthesis towards Gd.45 (Ln = Gd
3+
, Eu
3+
) is described in Chapter 5.  A synthetic 
procedure towards the DOTA - like tetraamide derivatives has been established and initial 
complexation problems circumvented through several investigations.  The target compound was 
applied and found responsive towards Zn
2+
 ions.  The behavioural pattern was also observed with 
other cations (Cu
2+
, Ca
2+
 and Mg
2+
).  Cellular studies found it could penetrate the cell membrane and 
initial MRI studies, showed that Gd.45 of the target compound exhibited MRI character and was 
successful when applied to in vivo settings. 
 
6.2.  Future Prospects 
With regards to the target compounds, an established synthesis has been set up for Gd.1 and Gd.45  
(Ln = Gd
3+
, Eu
3+
) for future synthesis of novel compounds based on the designs set out in this Thesis.  
Further work regarding the target compounds synthesised would also provide more insight to the 
behaviour expected towards Zn
2+
 and other competing cations.  These could provide methods to 
circumvent any unwanted behaviour and provide new routes towards Zn
2+
 selective probes for multi-
modal imaging. 
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6.2.1. Future Synthetic Work 
From a synthetic point of view, having established intermediates towards the various target 
fluorophore derivatives, in particular the rhodamine dye, further work is required to establish 
purification conditions in order to isolate the desired product.  Attempts using alumina with water 
(v:w), 15 % for column chromatography should be tried.  For the F-BODIPY dye, other methods 
should be followed in an attempt to synthesise the first, to the best of the author‟s knowledge, F-
BODIPY containing a pyridyl ring attached through a CH2-N-CH2 to the pyrrole.  Methods using 
milder reagents as opposed to the chloroacetyl chloride are shown in Scheme 6.1 and Scheme 6.2. 
If the focus remained on just synthesising the F-BODIPY dyes, instead of forming a dipyrrin as an 
intermediate a one-pot reaction can be followed making use of an acid anhydride such as glutaric 
anhydride could be used to join up the two pyrroles, as seen by Li et al
1
 (Scheme 6.1).  The free 
carboxylic acid produced could also be used for attachment to the final macrocycle. 
 
 +  
 
a 
  
Scheme 6.1: New synthetic methods towards F-BODIPY synthesis: Reagents and Conditions: a) i) 
BF3.OEt2 neat, reflux, 5 h; ii) BF3.OEt2, Et3N, 25 ⁰C, 12 h.
1
 
 
 
 
+ 
 
a 
 
b 
 
c 
 
   
Scheme 6.2: New synthetic methods towards F-BODIPY synthesis: 
Reagents and Conditions: a) condensation; b) oxidizing; c) BF3.OEt2, base. 
 
An expectant UV shift in the novel F - BODIPY dye especially towards the red region will make the 
probe even more useful in cellular studies. 
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Isolation of the dipyrrin with this method would not be possible due to the introduction of BF3.OEt2 at 
the start of the reaction.  In order to isolate the dipyrrin, an aromatic aldehyde could be used instead of 
the chloroacetyl chloride to condense two pyrroles together.  
 Attempts to synthesise DPA and BPEN derivatives was found difficult due to the reactivity of the 
pyridyl rings.  If further challenges arise, work towards the BPEN derivative could introduce an acetyl 
arm in place of the pyridyl ring as seen in early work by Nagano.
2
 These changes would be a step 
forward in synthesising a new set of novel compounds to will be tested for Zn
2+ 
sensing. 
A method towards complexation of ligand 41 needs to be established to allow for subsequent testing 
using this 1,7 - bi - substituted motif.  Its water - solubility gives an added incentive to form the 
complex and test its ability to sense Zn
2+
 ions in aqueous media.  Two proposed changes to the 
complexation could be via a change of solvent, such as 2 - propanol and heating under reflux
3
 or using 
alternative Ln
3+ 
sources such as reactive perchlorates.
4
 
 
6.2.2. Future Work Regarding Gd.1 and Gd.45 
Further work regarding both Gd.1 and Gd.45 can be carried out in tandem to investigate the 
interaction with Zn
2+
 ions.  A 
1
H NMR titration with Zn
2+ 
being added to each complex would provide 
a binding association constant of the complexes in a ground state.  Further confirmation as to whether 
a 1:1 complex is forming first or a different mechanism is occurring would be provided.  Competitive 
assays for both these complexes would also provide further evidence about the selectivity of these 
complexes to Zn
2+ 
when left in a biological setting.  
Further Ln
3+ 
complexes of each such as the Eu
3+
-complex can provide further information between 
species present in the inner - and outer - cellular compartments via NMR experiments.
5 
 
6.2.3. Future Work Regarding Gd.1 
More specifically for Gd.1, both UV/Vis and fluorescence titrations against other cations would show 
any different behavioural patterns to that of Zn
2+
 ions, as was seen with Gd.45 (Ln = Gd
3+
, Eu
3+
).  
Successful growth of a Zn
2+ 
- Gd
3+
.1 crystal would provide definitive evidence of the interactions 
involved in the complex.  Complex Gd.1 can also be incubated with the different cell lines (INS-
1(832/13) and HEK293) to tests its ability to permeate the cell membrane and provide information 
regarding the probes
 
selectivity and specificity towards Zn
2+
 ions in a cellular environment.  Casting 
further afield MRI studies, producing phantom images with Zn
2+
 and in the absence of Zn
2+
 would 
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provide information on relaxivity values and provide information on the effectiveness of Gd.1 as a 
contrast agent for Zn
2+
 sensing.   
Due to the probable q = 2 hydration state of Gd
3+
 in this complex, synthetic work towards derivatising 
the linker on the quinoline moiety so that the next generation of this probe is of a q = 1 hydration 
state.  The low relaxivity values obtained from the 
1
H NMR will need to be addressed and 
investigated as to whether the complex is pH sensitive by carrying out further titrations with a varying 
pH. 
 
6.2.4. Future Work Regarding Gd.45 (Ln = Gd3+, Eu3+) 
More specifically for Gd.45, the analogue Gd.45b (Figure 6.2) would provide further information 
regarding the effect of the length of the acetamide chain to Zn
2+
 ions.  Although Gd.45c is not 
expected to be an effective fluorescence sensor, due to the increased distance of the fluorophore to the 
macrocycle, its relaxivity values would be of interest, due to the expected larger tumbling effect and 
thus higher relaxivity values being observed.  Initial efforts should be aimed towards the analogue 
Gd.45b with elongated acetamide groups and the dansyl directly bound to the macrocycle.  From 
purely a point of interest, the relaxivity values measured for analogue Gd.45c with both the elongated 
acetamide groups and linker between the dansyl should be taken. 
 
 
 
 
Gd.45a 
 
Gd.45b 
 
Gd.45c 
Figure 6.2: Analogues of Gd.45. 
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6.3. Final Remarks 
Overall, it is the opinion of the author, that following subsequent testing of the initial probes 
synthesised for Zn
2+
 testing and carrying out further synthetic procedures proposed, a library of multi-
modal Zn
2+ 
sensing imaging agents will be formed. 
A long term aim would be to develop a Zn
2+ 
specific contrast agent that may be used for detecting β-
cells in the pancreas to understand the cause and provide a treatment towards diabetes. 
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7. Experimental 
7.1.  General Conditions, Instruments and Materials 
Unless otherwise stated all reactions that needed anhydrous conditions or involved moisture sensitive 
reactants were performed under an atmosphere of dry nitrogen using oven dried (80 ˚C) glassware.  
All starting materials were obtained from commercial suppliers (Sigma-Aldrich, CheMatech, Strem, 
Macrocyclics) and used without further purification.  Reactions were monitored by TLC-analysis 
using DC - fertigfolien (Schleicher & Schuell, F1500, LS254) with detection by UV-absorption 
(254nm).  Flash column chromatography was carried out with either Merck Silicagel (0.040 – 0.063 
nm), activated Al2O3 or 15 % deactivated Brockmann Type 1 Al2O3 (neutral), with either anhydrous 
or non-anhydrous solvents.  Anhydrous solvents, when needed, were dried over appropriate drying 
agents. 
All 
1
H NMR spectra were recorded as solutions in specified deuterated solvents on a Bruker 2 channel 
DRX - 400 spectrometer at Imperial College London, Department of Chemistry, NMR Service 
Facility, using the residual protic solvent signal as internal reference. Chemical shifts are expressed in 
parts per million (ppm, δ) using TMS as internal standard and are referenced to the indicated solvent. 
Coupling constants were measured in Hz. Splitting patterns are designated as s for singlet, d for 
doublet, t for triplet, q for quartet, m for multiplet and br for broad. 
13
C NMR spectra were recorded 
on a Bruker 2 channel DRX - 400 spectrometer as solutions in specified deuterated solvents. 
Chemical shifts are reported in parts per million (ppm, δ) downfield from TMS and are referenced to 
the centre line of the specified solvent as internal standard.   
ESI mass spectra were recorded using a Micromass LCT Premier spectrometer, MALDI mass spectra 
were recorded on a Micromass MALDI Micro MX spectrometer and FAB mass spectra were recorded 
on a Micromass Autospec Premier spectrometer at Imperial College London, Department of 
Chemistry, Mass Spectrometry Service Facility.  All mass spectrometry data was recorded by Mr. 
John Barton.   
UV/Vis absorption spectra were recorded on a Perkin Elmer 650 UV/Vis spectrometer and corrected 
for air and solvent absorption.  Quartz cuvettes of 1.00 cm pathlength were used.  Emission spectra 
were recorded on a Varian Cary Eclipse fluorescent spectrometer.  FT - IR spectra were measured on 
a Perkin Elmer Spectrum One FT - IR Spetrometer.   
Elemental analyses were performed by the Elemental Analysis Service, courtesy of Mr. Stephen 
Boyer at the Department of Health and Human Sciences, London Metropolitan University. The 
figures reported are the average of two separate measurements. 
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7.2.  Synthesis of Compounds 
1,1’ - Ethylenedi-2-imidazoline1 (10) 
The resultant mixture of N, N - dimethylformamide dimethyl acetate (88 ml, 0.67 mmol, 2 
Eq.) and triethylene tetramine solution (50 ml, 0.34 mmol, 1 Eq.) was heated under reflux 
for 30 mins.  This was then concentrated in vacuo, and the resulting off-white solid recrystallized 
from THF.  Following filtration under an inert atmosphere, the product was yielded as a white powder 
(34.56 g, 208 mmol, 31 %).  
1
H NMR (CDCl3): δ = 6.77 (s, 2 H), 3.81 (td, J = 9.82 Hz, J = 1.68 Hz, 4 
H), 3.21 (m, 8 H).  IR, νmax/cm
-1
: 1640 (C = N), 1347 (C - N). 
 
2,3,4,5,6,7,8,8c - Octahydro - 1H - 4a,6a,8a - triaza - 2a - azoiacyclopent[fg]acenaphthalene 
bromide salt
1
 (11) 
 10 (12.78 g, 77 mmol, 1.3 Eq.) was added to a 1 L 3-neck round bottom flask containing 
dibromoethane (9.18 ml, 107 mmol, 1.8 Eq.), potassium carbonate (8.13 g, 59 mmol, 
1 Eq.) and acetonitrile (600 ml), and heated under reflux.  After 3 hrs, potassium carbonate was 
filtered from solution, and the filtrate concentrated under reduced pressure to afford bromide salt 2 as 
a yellow powder (10.55 g, 38.5 mmol, 71 %).  The title compound was used in situ and taken through 
to the next step without further analysis. 
 
1,4,7,10 - Tetraazacyclododecane (Cyclen)
1 
(6) 
The cyclized intermediate 11, dissolved in water (70 ml) was added dropwise to a 
refluxing solution of potassium hydroxide (20.5 g, 366 mmol, 8 Eq.) and water (80 ml).  
The mixture was heated for a further 30 mins, and then filtered under gravity whilst hot.  The filtrate 
was concentrated in vacuo and co - evaporated with toluene to yield cyclen as an off-white solid.  
1
H 
NMR (CDCl3): δ = 2.67 ppm (s).  MS(ESI
+
): m/z = 173 amu [M+H]
+
. IR, νmax/cm
-1
: 3370 (NH 
stretch). 
 
2 - (2 - Chloroethoxy)ethylamine hydrochloride
2 
(8) 
Diethylene glycoamine (6.95 ml, 69.7 mmol, 1 Eq.) was saturated with HCl gas, over 
25 mins, in 1, 2 – dichloroethane (360 ml).  The cloudy white solution was then cooled, and thionyl 
chloride (13.75 ml, 189 mmol, 2.7 Eq.) added in a dropwise fashion.  The resulting mixture was then 
warmed to room temperature, and heated at 60 ˚C for 1 h.  After cooling to room temperature, the 
addition of ether resulted in the precipitation of chloride salt as a white solid (10.59 g, 66.2 mmol, 
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95 %).  
1
H NMR (CDCl3): δ = 8.40 (br, 3 H), 3.85 (m , 4 H), 3.75 (t, J = 6 Hz, 2 H), 3.29 (t, J = 6 Hz, 
2 H). 
13
C NMR (CDCl3): δ = 71.2 (H2NCH2CH2O), 66.6 (OCH2CH2Cl), 42.9 (OCH2CH2Cl), 39.6 
(H2NCH2CH2O).  IR, νmax/cm
-1
: 3391 (NH stretch), 2881 (CH stretch), 1608 (NH bend), 1107 (C-O). 
 
2 - Chloro - N - (quinol - 8 - yl)acetamide
3 
(7) 
To a cooled solution of 8 - aminoquinoline (2 g, 13.9 mmol, 1 Eq.), pyridine (1.6 ml, 19.4 
mmol, 1.4 Eq.) and chloroform (90 ml), 2 - chloroacetyl chloride (1.3 ml, 16.6 mmol, 
1.2 Eq.) dissolved in chloroform (30 ml) was added dropwise over an hour.  After stirring 
for 2 h at room temperature, the mixture was concentrated under reduced pressure and the 
resultant red - brown solid purified by silica gel column chromatography using dichloromethane to 
give the product as an off-white solid (2.02 g, 9.15 mmol, 79 %).  
1
H NMR (CDCl3): δ = 10.94 (1 H, 
br, NH), 8.89 (1 H, dd, J = 4 Hz, J = 4 Hz, NHCCHCHCH), 8.78 (1 H, dd, J = 4 Hz, J = 4 Hz, 
NCHCHCH), 8.21 (1 H, dd, J = 8 Hz, J = 4 Hz, NHCCHCHCH), 7.59 (2 H, m, NHCCHCHCH, 
NCHCHCH), 7.51 (1 H, q, J = 4 Hz, NCHCHCH), 4.34 (2 H, s, CH2).  
13
C NMR (CDCl3): δ = 164.5 
(CO), 148.5 (NHCCHCHCH), 136.6 (NCHCHCH), 133.5 (NHCCCCH), 128.0 (NHCCHCHCH), 
127.3 (NCHCHCH), 122.6 (NHCCHCHCH), 121.8 (NCHCHCH), 117.0 (NHCCHCHCH), 43.4 
(CH2Cl).  LC/MS: m/z = 221 amu [M + H]
+
.  IR, νmax/cm
-1
: 3325 (NH stretch), 1669 (C=O), 1592 
(NH bend), 1328 (C-N), 827 (C-Cl). 
 
2, 2 - Aminoethoxy - ethanol - N - (quinol - 8 - yl)acetamide
3 
(13) 
7 (0.24 g, 1.09 mmol, 1 Eq.), 2 - (2 - aminoethoxy)ethanol (1.14 g, 10.9 mmol, 10 
Eq.), N, N - diisopropylethylamine (1.41 g, 10.9 mmol, 10 Eq.) and a catalytic 
amount of potassium iodide (0.14 mmol) were heated together under reflux in 
acetonitrile (70 mL).  Following 10 h, the mixture was cooled to room temperature, 
and concentrated under reduced pressure to give a yellow oil.  This was purified via silica gel column 
chromatography using 20 % MeOH in CHCl3 to give the title compound.  
1
H NMR (CDCl3): δ = 8.83 
(1 H, dd, J = 4.06 Hz, J = 1.62 Hz, NHCCHCHCH), 8.79 (1 H, dd, J = 7.12 Hz, J = 1.60 Hz, 
NCHCHCH), 8.12 (1 H, dd, J = 8.28 Hz, J = 1.44 Hz, NHCCHCHCH), 7.50 (2 H, m, NHCCHCHCH, 
NCHCHCH), 7.24 (1 H, m, NCHCHCH), 3.72 (4 H, m, HNCH2CH2O), 3.57 (4 H, m, OCH2CH2OH), 
2.94 (2 H, t, J = 4.94 Hz, CH2NH).  
13
C NMR (CDCl3): δ = 170.8 (CO), 148.5 (NHCCHCHCH), 
139.0 (NHCCN), 136.3 (NCHCHCH), 134.2 (NHCCCCH), 128.1 (NHCCHCHCH), 127.3 
(NCHCHCH), 121.8 (NHCCHCHCH), 121.5 (NCHCHCH), 116.7 (NHCCHCHCH), 72.3 
(COCH2NH), 70.7 (OCH2CH2OH), 61.8 (OCH2CH2OH), 53.8 (NHCH2CH2O), 49.4 (NHCH2CH2O).  
MS(ESI
+
): m/z = 290 amu [M+H]
+
.  IR, νmax/cm
-1
: 3285 (OH and NH stretch), 1660 (C=O), 1596 (NH 
bend), 1324 (C-N), 1118 (C-O), 1062 (C-O). 
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2, 2 - Aminoethoxy - chloroethane - N - (quinol - 8 - yl)acetamide (12) 
13 (0.20 g, 0.69 mmol, 1 Eq.) was stirred with 1, 2 - dichloroethane (50 mL), and 
saturated with HCl gas for 30 mins.  The resulting yellow solution was then cooled 
with an ice bath, and thionyl chloride (0.22 g, 1.87 mmol, 2.7 Eq.) added dropwise.  
The mixture was then warmed to room temperature, and heated to 60 ⁰C for 1 h.  After which, the 
reaction mixture was concentrated under reduced pressure to leave an orange - red solid, which was 
recrystallized using ethanol and ether to give the title compound (17 mg, 55 μmol, 8 %).  1H NMR 
(CDCl3): δ = 9.12 (1 H, dd, J = 4.76 Hz, J = 1.20, NHCCHCHCH), 8.90 (1 H, d, J = 8.24 Hz, 
NCHCHCH), 8.41 (1 H, d, J = 7.48, NHCCHCHCH), 8.08 (1 H, d, J = 8.24 Hz, NHCCHCHCH), 
7.95 (1 H, dd, J = 8.28 Hz, J = 4.88 Hz, NCHCHCH), 7.86 (1 H , t, J = 7.96 Hz, NCHCHCH), 4.37 (2 
H, s, CH2NH), 3.88 (4 H, m, HNCH2CH2O), 3.78 (2 H, t, J = 5.38 Hz, OCH2CH2Cl), 3.46 (2 H, t, J = 
4.98 Hz, OCH2CH2Cl).  MS(ESI
+
): m/z = 308 amu [M+H]
+
.  IR, νmax/cm
-1
: 3202 (NH stretch), 1737 
(C=O). 
13
C NMR – insufficient amount obtained to gain a good spectrum after >1000 scans. 
 
2, 2 - (Boc) - Aminoethoxy - ethanol - N - (quinol - 8 - yl)acetamide (15) 
13 (590 mg, 2.04 mmol, 1 Eq.), Boc2O (534 mg, 2.45 mmol, 1.2 Eq.), Et3N 
(0.28 ml, 2.04 mmol, 1 Eq.) were stirred in DCM (60 ml) for 12 h.  The reaction 
was monitored via TLC, and eventually concentrated under reduced pressure 
and purified via column chromatography (DCM-MeOH).  
1
H NMR (CDCl3): δ 
= 10.37 (1 H, br, NH); 8.80 (1 H, d, J = 1.96 Hz, NHCCHCHCH); 8.78 (1 H, d, 
J = 1.92 Hz, NCHCHCH); 8.17 (1 H, d, J = 8.04 Hz, NHCCHCHCH); 7.47 (3 H, m, NCHCHCH, 
NHCCHCHCH, NCHCHCH, ); 4.23 (2 H, m,); 3.77-3.46 (8 H, m, NCH2CH2O, OCH2CH2OH); 1.45 
(9 H, s, (CH3)3).  
13
C NMR (CDCl3): δ = 169.0 (CO), 155.3 (CO), 148.4 (NHCCHCHCH), 138.5 
(NHCCN), 136.3 (NCHCHCH), 134.1 (NHCCCCH), 128.0 (NHCCHCHCH), 127.4 (NCHCHCH), 
121.9 (NHCCHCHCH), 121.7 (NCHCHCH), 116.6 (NHCCHCHCH), 81.3 (OC(CH3)3), 72.5 
(COCH2NH), 70.3 (OCH2CH2OH), 61.7 (OCH2CH2OH), 54.0 (NHCH2CH2O), 48.5 (NHCH2CH2O), 
28.2 ((CH3)3).  MS(ESI
+
): m/z = 390 amu [M+H]
+
;  412 amu [M+Na]
+
.  IR, νmax/cm
-1
: 3326 (OH and 
NH stretch), 1682 (C=O), 1457 (CH3), 1392 (CH3), 1246 (C-O), 1165 (C-O), 1136 (C-O).  Elemental 
Analysis: calculated C20H27N3O5.H2O (C 58.95 %, H 7.17 %, N 10.31 %); found C 58.23 %, H 
6.54 %, N 10.31 %. 
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2, 2 - (Boc) - Aminoethoxy - ethyl - methanesulfonate - N - (quinol - 8 - yl)acetamide (16) 
15 (395 mg, 1.01 mmol, 1 Eq.) was dissolved in DCM (50 ml) and cooled to 
0 ⁰C.  Triethylamine (0.42 ml, 3.04 mmol, 3 Eq.) and methanesulfonyl 
chloride (0.20 ml, 2.53 mmol, 2.5 Eq.) were then added dropwise over 20 
mins.  Following the complete addition of the reagents, the reaction mixture 
was stirred for a further 10 mins, and then at room temperature for 1 h.  The 
reaction was monitored via TLC, and purified via column chromatography (DCM-MeOH).
 1
H NMR 
(CDCl3): δ = 10.36 (1 H, br, NH); 8.70 (2 H, br, NHCCHCHCH, NCHCHCH); 8.20 (1 H, d, J = 7.72 
Hz, NHCCHCHCH); 7.57-7.48 (3 H, m, 3 H, NCHCHCH, NHCCHCHCH, NCHCHCH); 4.15-4.27 
(4 H, m,); 3.76-3.60 (6 H, m,); 2.97 (3 H, s, SO2CH3); 1.45 (9 H, s, (CH3)3).  
13
C NMR (CDCl3): δ = 
168.5 (CO), 155.2 (CO), 148.4 (NHCCHCHCH), 136.3 (NCHCHCH), 134.1 (NHCCCCH), 128.00 
(NHCCHCHCH), 127.4 (NCHCHCH), 121.8 (NHCCHCHCH), 116.4 (NHCCHCHCH), 81.3 
(OC(CH3)3), 70.4 (OCH2CH2OH), 68.7 (OCH2CH2OH), 54.6 (NHCH2CH2O), 48.6 (NHCH2CH2O), 
37.4 (SO2CH3), 28.2 ((CH3)3).  MS(ESI
+
): m/z = 490 amu [M+H]
+
; 468 amu [M+Na]
+
.  IR, νmax/cm
-1
: 
3326 (NH stretch), 1682 (C=O), 1457 (CH3), 1392 (-SO2-), 1246 (C-O), 1165 (C-O), 1136 (C-O).  
Elemental Analysis: calculated C21H29N3O7S (C 53.29 %, H 6.25 %, N 8.99 %); found C 53.19 %, 
H 6.33 %, N 8.85 %.   
 
1,4,7 - Tris(tert - butoxycarbonylmethyl) - 1,4,7,10 - tetraazacyclododecane
4 
(4) 
Into a 2-neck round bottom flask with dry acetonitrile (50 ml), 6 (1.50 g, 
8.71 mmol, 1 Eq.), sodium hydrogen carbonate (2.41 g, 28.7 mmol, 3.3 Eq.) were 
stirred at 0 ˚C, whilst tert-butyl bromoacetate (4.24 ml, 28.7 mmol, 3.3 Eq.) was 
added dropwise over 30 mins.  The resulting pale yellow suspension was left to 
stir at room temperature for 48 h.  After this time, the inorganic salts were filtered 
off to leave an orange-brown solution, which was recrystallized from toluene.  
1
H NMR (CDCl3): δ = 
3.40 (4 H, s, CO(CH2)2); 3.31 (2H, s, CO(CH2)); 3.13 (4 H, br, 1, 11 – CH2); 2.92 (12 H, m, 2,10-
CH2, 4,8-CH2, 5,7-CH2 ); 1.14 (27 H, m, ((CH3)3)3).  
13
C (CDCl3): δ = 170.5 (CO), 169.63 (CO), 
81.84 (C((CH3)3)2), 81.68(C(CH3)3), 58.21 (CO(CH3)3), 51.34 (CO(CH3)3), 51.22 (6,8-CH2), 49.19 
(5,9-CH2), 48.77 (2,12-CH2), 47.52 (3,11-CH2), 28.2 (CH3), 27.9 (CH3)2.  MS(ESI
+
): m/z = 515 amu 
[M+H]
+
; 537 amu [M+Na]
+
 
 
 
Chapter 7: Experimental 
167 
 
Tert - butyl 2,2’,2’’ - ((2, 2 - (Boc) - Aminoethoxy - ethyl - N - (quinol - 8 - yl)acetamide)) -
1,4,7,10 - tetraazacyclododecane - 1,4,7 - triyl) (3) 
16 (71.7 mg, 0.153 mmol, 1 Eq.) was dissolved in 15 ml of dry 
acetonitrile, and added dropwise to a solution of tri-ester cyclen 
(94.7 mg, 0.184 mmol, 1.2 Eq.) and triethylamine (0.11 ml, 
0.767 mmol, 5 Eq.) in 35 ml of dry acetonitrile.  After heating 
under reflux for three days, the resulting reaction mixture was 
concentrated under reduced pressure to give a thick brown oil, 
which was purified via column chromatography using silica gel 
(CH2Cl2: CH3OH, 95:5), to yield the title compound as a viscous light brown oil (0.104 g, 
0.118 mmol, 77%).  
1
H NMR (CDCl3): δ = 10.29 (1H, , NCHCHCH), 10.06 (1H, br, HN-CO), 8.78 
(2H, m, NHCCHCHCH, ), 8.21 (1H, m, NCHCHCH), 7.56 - 7.50 (2H, m, NHCCHCHCH, 
NCHCHCH), 4.13 (2H, CH2CO), 3.65 - 3.60 (4H, m, CH2NCO), 3.45 (2H, br, CH2O), 4.36 – 3.46 (16 
H, 6,8-CH2, 5,9-CH2, 2,12-CH2, 3,11-CH2), 1.42 (9H, s, CH3), 1.46 (27H, m, CH3).  
13
C NMR (CDCl3): 
δ = 172.6 (CO), 170.5 (CO), 169.7 (CO), 168.1 (CO), 148.4 (NHCCHCHCH), 138.3 (NHCCN), 
136.5 (NCHCHCH), 128.0 (NHCCHCHCH), 127.3 (NCHCHCH), 121.9 (NHCCHCHCH), 116.3 
(NHCCHCHCH), 82.3 (OC(CH3)3), 81.8 (C((CH3)3)2), 81.6 (C(CH3)3), 76.1 (COCH2NH), 70.0 
(OCH2CH2OH), 58.2 (CO(CH3)3), 56.5 (OCH2CH2OH), 55.7 (NHCH2CH2O), 52.7 (NHCH2CH2O), 
51.3 (CO(CH3)3), 50.3 (6,8-CH2), 49.2 (5,9-CH2), 48.4 (2,12-CH2), 47.5 (3,11-CH2), 28.2 (CH3), 28.0 
(CH3)2, 27.9 ((CH3)3).  ESI-MS: m/z 887 [M+H]
+
; 909 [M+Na]
+
. 
 
2,2’,2’’ - ((2 - Aminoethoxy - ethyl - N - (quinol-8-yl)acetamide)) - 1,4,7,10 -
tetraazacyclododecane - 1,4,7 - triacetic acid) (2) 
3 (50 mg, 0.0564 mmol, 1 Eq.) was dissolved in 3 ml of dichloromethane 
and trifluoroacetic acid (3 ml) added dropwise.  After overnight stirring 
at room temperature, the volatiles were removed under a stream of N2.  
The oily residue was dissolved in water and washed with 
dichloromethane.  The aqueous layer was reduced to leave a light yellow 
oil.
 1
H NMR (CDCl3): δ = 8.95 (1 H, d, 
3
JHH = 5.96 Hz, NCHCHCH), 
8.63 (1 H, d, 
3
JHH = 7.36 Hz, NHCCHCHCH), 8.41 (1 H, d, 
3
JHH = 9.8 Hz), 7.77 (1 H, d, 
3
JHH = 7.6 Hz, 
NCHCHCH), 7.63 (2 H, m, NHCCHCHCH, NCHCHCH), 4.36 – 3.46 (32 H, CH2-CO, CH2-NCO, 
6,8-CH2, 5,9-CH2, 2,12-CH2, 3,11-CH2, HNCH2CH2O, OCH2CH2N).  MS(ESI
+
) m/z = 618 amu [M + 
H]
+
, 640 amu [M + Na]
+
. 
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Gd.2,2’,2’’ - ((2 - Aminoethoxy - ethyl - N - (quinol - 8 - yl)acetamide)) - 1,4,7,10 -
tetraazacyclododecane-1,4,7-triacetate) (Gd.1) 
2 (0.0307g, 0.0497 mmol, 1 Eq.) was dissolved in H2O (10 ml) at rt.  
Following addition of GdCl3 (0.018g, 0.0497 mmol, 1 Eq.), the pH 
solution was adjusted to 6.7 by NaOH (1 M).  Following 5 h, the pH was 
further adjusted to 10.8 and left for 40 mins.  The white precipitate was 
centrifuged and the supernatant separated and concentrated under 
reduced pressure to give a white solid (47 %).  MS (ESI
+
) m/z = 773 amu 
[M + H]
+
, 618 amu [M – Gd + H]+.  Elemental Analysis: calculated (C29H40GdN7O8.5NaCl.4Na(OH)) 
C 28.38 %, 3.86 H %, N 7.99 %; found C 28.63 %, H 3.96 %, N 7.23 %. 
 
(N - 2 - Pyridylmethyl - N - (1H - pyrrolylmethylidene)amine
5
 (18) 
A solution of 2 - (aminomethyl)pyridine (2.1 ml, 20.0 mmol, 1 Eq.) and dry 
MeOH (15 ml) was added dropwise to a stirring solution of pyrrole - 2 -
carboxaldehyde (1.9 g, 20.0 mmol, 1 Eq.) and MeOH (20 ml).  After stirring at 
room temperature for 3 h, the resultant yellow solution was heated under reflux for 30 mins.  
Following a cooling down to room temperature, a 10 ml amount of the solution was removed to 
another round bottom flask, and concentrated under reduced pressure, to give a dark orange solid 
(1.38 g, 7.4 mmol, 74 %).  
1
H NMR (CDCl3): δ = 8.58 (1H, d, 
3
JHH = 4.72 Hz, NCCHCHCHCH), 8.26 
(1H, s, NCHCNCHCHCH), 7.63 (1H, td, 
3
JHH = 7.67 Hz, 
3
JHH = 1.71 Hz, NCCHCHCHCH), 7.33 
(1H, d, 
3
JHH = 7.84 Hz, NCCHCHCHCH), 7.17 (1H, t, 
3
JHH = 6.24 Hz, NCCHCHCHCH), 6.86 (1H, 
br, NCHCHCHC), 6.56 (1H, dd, 
3
JHH = 3.54 Hz, 
3
JHH = 1.06 Hz, NCHCHCHC), 6.25 (1H, t, 
3
JHH = 
3.08 Hz, NCHCHCHC), 4.88 (2H, s, NCH2).  
13
C NMR (CDCl3): δ = 159.43 (NCCHCHCH), 154.03 
(NCHCNCHCHCH), 149.26 (NCCHCHCHCH), 136.68 (NCCHCHCHCH), 129.96 (NCCHCHCH), 
122.43 (NCCHCHCH), 122.15 (NCCHCHCH), 122.03 (NCCHCHCHCH), 115.26 
(NCCHCHCHCH), 109.78 (NCCHCHCHCH), 66.06 (NCH2).  MS(ESI
+
): m/z = 186 amu [M+H]
+
 
 
N - (2 - Pyridylmethyl) - N - (1H - 2 - pyrrolylmethyl)amine
5 
(17) 
18 was cooled to 0 ˚C and NaBH4 (3.51 g, 92.8 mmol, 4.64 Eq.) added slowly.  
After the complete addition of NaBH4, the reaction mixture was stirred for another 
30 mins at 0 ⁰C, then another 30 mins at room temperature, and finally at 50 ˚C for 2 h.  The reaction 
mixture was then left to cool, and 5 ml water added.  It was then concentrated slightly under reduced 
pressure.  Water (50 ml) was then added and the organic layer extracted with diethyl ether (3 x 40 ml).  
The organic layers were combined and dried over MgSO4, then filtered and reduced under reduced 
pressure to yield the titled compound as a light yellow oil (2.17 g, 11.6 mmol, 86 %).  
1
H NMR 
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(CDCl3): δ = 9.34 (1H, s, NH), 8.58 (1H, d, J = 4.6 Hz, NCCHCHCHCH), 7.67 (1H, td, J = 7.62 Hz, J 
= 1.77 Hz, NCCHCHCHCH), 7.27 (1H, d, J = 7.88 Hz, NCCHCHCHCH), 7.20 (1H, td, J = 6.32 Hz, 
J = 1.21 Hz, NCCHCHCHCH), 6.73 (1H, m, NCHCHCHC), 6.14 (1H, m, NCHCHCHC), 6.07 (1H, 
br, NCHCHCHC), 3.92 (2H, s, NCHCHCHCHCCH2), 3.84 (2H, s, NCHCHCHCCH2).  
13
C NMR 
(CDCl3): δ = 159.26 (NCCHCHCH), 149.24 (NCCHCHCHCH), 136.69 (NCCHCHCHCH), 130.07 
(NCCHCHCH), 122.77 (NCCHCHCH), 122.19 (NCCHCHCH), 117.66 (NCCHCHCHCH), 107.79 
(NCCHCHCHCH), 106.80 (NCCHCHCHCH), 53.85 (NCHCHCHCHCCH2), 45.76 
(NCHCHCHCCH2).  MS(ESI
+
): m/z = 200 amu [M+Na]
+
. 
 
N - Hydroxysuccinimidyl Rhodamine B Ester
6
 (24) 
Rhodamine B (1.20 g, 2.51 mmol, 1 Eq) and N - hydroxysuccinimide 
(0.288 g, 2.51 mmol, 1 Eq.) were dissolved in acetonitrile (50 ml) and 
heated to 45 ˚C.  To this stirring solution, dicyclohexylcarbodiimide 
(0.569 g, 2.76 mmol, 1.1 Eq.) in acetonitrile (20 ml) was added dropwise.  
Following a further 1 h of stirring at 45 ˚C, the reaction mixture was left to 
stir at rt for 20 h.  The resultant white precipitate was filtered off and the filtrate reduced under 
vacuum.  The residue was recrystallized from acetonitrile/diethyl ether and the product obtained as 
dark green crystals (0.987 g, 1.83 mmol, 73 %).  
1H NMR (CDCl3), δ: 8.43 (1H, d, 3JHH = 7.88 Hz, 
CC(COONCOCH2CH2CO)CHCHCHCH), 8.00 (1H, d, 
3
JHH = 7.36 Hz, CC(COONCOCH2CH2CO)C
HCHCHCH), 7.85 (1H, d, 
3
JHH = 7.58 Hz, CC(COONCOCH2CH2CO)CHCHCHCH), 7.49 (1H, d, 
3
JH
H = 7.36 Hz, CC(COONCOCH2CH2CO)CHCHCHCH), 7.09 (2H, d, 
3
JHH = 9.20 Hz, 
((CH3CH2)2NCCHCHC)2), 6.88 (2H, 
3
JHH = 10.92 Hz, ((CH3CH2)2NCCHCHC)2), 6.87 (2H, s, 
((CH3CH2)2NCCHCO)2), 3.66 (8H, q, 
3
JHH = 6.60 Hz, (CH3CH2N)2), 2.80 (4H, s, COCH2CH2CO), 
1.35 (12H, t, 
3
JHH = 6.50 Hz, (CH3CH2N)2). 
13
C NMR (CDCl3), δ: 168.7 (N(COCH2CH2CO)), 160.7 (
OCCHC(N(CH2CH3)2)CHCHCC), 158.5 (CC(COONCOCH2CH2CO)CHCH), 157.8 (CC(COONCO
CH2CH2CO)CHCH), 155.7 ((CH3CH2)2NC), 155.6 (OCCHC(N(CH2CH3)2)CHCHCC), 134.9 (CC(C
OONCOCH2CH2CO)CHCH), 134.5 (OCCHC(N(CH2CH3)2)CHCHCC) , 131.8 (CC(COONCOCH2C
H2CO)CHCH), 131.1 (CC(COONCOCH2CH2CO)CHCH), 131.0 (OCCHC(N(CH2CH3)2)CHCHCC), 
130.7 (CC(COONCOCH2CH2CO)CHCHCHCH), 125.4 (CC(COONCOCH2CH2CO)CHCHCHCH), 
114.5 (OCCHC(N(CH2CH3)2)CHCHCC), 113.4 (OCCHC(N(CH2CH3)2)CHCHCC), 46.3 
(COCH2CH2CO), 25.6 (N(CH2CH3)2), 12.7 (N(CH2CH3)2).  MS(ESI
+
): m/z = 540 amu [M + H]
+
. 
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(2 - Aminoethyl) - carbamic acid tert - butyl ester
7 
(27) 
To an ice - cooled solution of ethane - 1, 2-diamine (14 ml, 0.214 mmol, 1 Eq.) and 
DCM (300 ml), a solution of di - tertbutylcarbonate (4.37 g, 20.0 mmol, 93.5 Eq.) 
in DCM (100 ml) was added dropwise over 4 h.  The resultant solution was warmed to RT and left to 
stir overnight.  This was then concentrated under reduced pressure to a colourless oil.  The mixture 
was partitioned between Na2CO3 (20 ml, 2 M, ap) and DCM (20 ml).  The aqueous layer was 
extracted with DCM (2 x 20 ml).  These subsequent organic layers were combined and dried over 
MgSO4.  The solids were filtered and filtrate concentrated in vacuo to yield the product as a colourless 
oil (3.16 g, 19.7 mmol, 92 %).  
1
H NMR (CD3OD), δ: 3.13 (2H, t, 
3
JHH = 6.28 Hz, NHCH2CH2NH2), 
2.71 (2H, t, 
3
JHH = 6.28 Hz, NHCH2CH2NH2), 1.47 (9H, s, (CH3)3).  
13
C NMR (CD3OD), δ: 157.2 
(CO), 78.6 (C(CH3)3), 42.6 (NHCH2CH2NH2), 41.0 (NHCH2CH2NH2), 27.4 (C(CH3)3). MS(ESI
+
): 
m/z = 324 amu [2M+H]
+
. 
 
Tert - Butyl - (2 - aminoethyl) - carbamic acid Rhodamine B amide (25) 
24 (0.700 g, 1.29 mmol, 1 Eq.), 27 (0.207 g, 1.29 mmol, 1 Eq.) and Et3N 
(0.90 ml, 6.47 mmol, 5 Eq.) were stirred together in MeCN at rt.  The 
reaction was monitored via TLC (2 % MeOH in DCM).  Following 5 h, 
the solution was concentrated in vacuo and the resultant mixture purified 
via column chromatography (Al2O3, gradient elution using 1 % MeOH:DCM) to yield the product as a 
light pink powder (0.119 g, 0.203 mmol, 16 %).  
1
H NMR (CDCl3), δ: 7.91 – 7.89 (1H, m, 
NHCOCCHCH), 7.45 – 7.42 (2H, m, NHCOCCHCHCH, NHCOCCHCHCH), 7.08 – 7.06 (1H, m, 
NHCOCCCHCH), 6.45 (2H, d, 
3
JHH = 8.84 Hz, ((CH3CH2)2NCCHCHC)2), 6.37 (2H, d, 
4
JHH = 2.60 
Hz, OCCHCN(CH2CH3)2CH), 6.27 (2H, dd, 
3
JHH = 8.86 Hz,
 4
JHH = 2.54 Hz, 
((CH3CH2)2NCCHCHC)2), 5.44 (1H, br, NHCOO), 3.33 (4H, q, 
3
JHH = 7.12 Hz, (CH3CH2)2N), 3.29 
(4H, br, m, CONHCH2CH2NHCOO, CONHCH2CH2NHCOO), 2.92 (4H, q, 
3
JHH = 7.27 Hz, 
(CH3CH2)2N)), 1.39 (9H, s, COOC(CH3)3), 1.29 (6H, t, 
3
JHH = 7.30 Hz, (CH3CH2)2N), 1.17 (6H, 
3
JHH = 
7.04 Hz, (CH3CH2)2N).  
13
C NMR (CDCl3), δ: 155.8 (COO), 155.8 (OCCCCC), 153.9 (CONHCH2), 
153.9 (CCCONH), 153.2 (CN(CH2CH3)2), 153.2 (CN(CH3CH2)2), 148.9 (OCCHCN), 132.6 
(CCCONH), 130.7 (OCCHC(N(CH2CH3)2)CHCHCC), 128.5 (COCCHCHCH), 128.0 
(OCCHC(N(CH2CH3)2)CHCHCC), 123.8 (CCHCHCHCHCCO), 122.8 (CCHCHCHCHCCO), 108.2 
(OCCHC(N(CH2CH3)2)CHCHCC), 78.7 (C(CH3)3), 45.9 (N(CH2CH3)2), 40.8 (NHCH2CH2NHCOO), 
40.4 (NHCH2CH2NHCOO), 28.4 (C(CH3)3, 12.6 (N(CH2CH3)2).  MS (ESI
+
): m/z = 585 amu [M + 
H]
+
, 607 amu [M + Na]
+
  Elemental Analysis: calculated (C35H45N4O4.N(CH2CH3)3) C 68.17 %, H 
8.37 %, N 9.69 %; found C 69.53 %, H 8.29 %, N 8.62 %. 
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2 - Aminoethylamine Rhodamine B amide (26) 
25 (0.119 g) was left to stir in TFA: DCM (v:v) for 2 h at rt.  Volatiles 
were removed under a stream of N2 to give a brown residue.  The residue 
was dissolved in MeOH and DCM and concentrated to leave a light 
brown oil in quantitative amount.  
1
H NMR (CDCl3), δ: 8.00 – 7.98 (1H, 
m, NHCOCCHCH), 7.65 – 7.63 (2H, m, NHCOCCHCHCH, NHCOCCHCHCH), 7.16 – 7.14 (1H, m, 
NHCOCCCHCH), 7.08 (2H, br, OCCHCN(CH2CH3)2CH), 6.88 (2H, dd, 
3
JHH = 8.78 Hz,
 4
JHH = 2.14 
Hz, ((CH3CH2)2NCCHCHC)2), 6.79 (2H, d, 
3
JHH = 8.76 Hz, ((CH3CH2)2NCCHCHC)2), 3.57 (8H, q, 
3
JHH = 7.12 Hz, (CH3CH2)2N)2), 3.47 (2H, t, 
3
JHH = 6.32 Hz, CONHCH2CH2NHCOO), 2.70 (2H, t, 
3
JHH = 6.26 Hz, CONHCH2CH2NHCOO), 1.20 (12H, t, 
3
JHH = 7.12 Hz, (N(CH2CH3)2)2).  
13
C NMR 
(CDCl3), δ: 159.4 (OCCC), 159.4 ((CH3CH2)2NCCHCO), 153.0 (OCCHC(N(CH2CH3)2)CHCHCC), 
152.9 (CO), 133.6 (CCCONH), 131.3 (OCCHC(N(CH2CH3)2)CHCHCC), 129.5 (COCCHCHCH), 
129.2 (COCCHCHCH), 129.0 (OCCHC(N(CH2CH3)2)CHCHCC), 123.7 (CCHCHCHCHCCO), 
122.9 (CCHCHCHCHCCO), 113.8 (OCCHC(N(CH2CH3)2)CHCHCC), 112.9 
(OCCHC(N(CH2CH3)2)CHCHCC), 53.4 (N(CH2CH3)2), 46.5 (NHCH2CH2NHCOO), 45.4 
(NHCH2CH2NHCOO), 10.4 (N(CH2CH3)2).  MS(ESI
+
): m/z = 485 amu [M]
+
. 
 
(2 - Aminoethyl) - dansylamide (29) 
Method 1
8
: 
A solution of dansyl chloride (0.940 g, 3.47 mmol, 1 Eq.) and DCM (75 ml) was 
added dropwise to a cooled solution of 1, 2 - ethylenedimamine (2.32 ml, 
34.7 mmol, 10.0 Eq.).  Following complete addition, the reaction mixture was left 
to reach room temperature and stirred for 12 h.  The resultant white precipitate was filtered off and the 
filtrate concentrated to 5 ml and acidified with 0.1 M HCl.  Dichloromethane (2 x 30 ml) was added 
and impurities extracted.  The aqueous layer was then made basic (pH 9) with 10 M NaOH and the 
product extracted using dichloromethane (2 x 20 ml).  The organic layers were combined and dried 
over MgSO4.  Following removal of the solids, the filtrate was concentrated to leave a bright 
yellow/green solid as the title product (0.133 g, 0.0453 mmol, 13 %).  
1
H NMR (CDCl3), δ: 8.54 (1H, 
d, 
3
JHH = 8.52 Hz, (CH3)2NCCHCH), 8.32 (1H, d, 
3
JHH = 8.68 Hz, (CH3)2NCCHCHCHC), 8.26 (1H, d, 
3
JHH = 7.16 Hz, (CH3)2NCCCHCH), 7.59 – 7.51 (2H, m, (CH3)2NCCHCHCH, 
(CH3)2NCCCHCHCH), 7.18 (1H, d, 
3
JHH = 7.52 Hz, (CH3)2NCCCHCHCH), 2.94 (2H, t, 
3
JHH = 5.48 
Hz, NHCH2CH2NH2), 2.90 (6H, s, (CH3)2N), 2.76 (2H, t, 
3
JHH = 5.72 Hz, NHCH2CH2NH2).  MS 
(ESI
+
): m/z = 294 amu [M + H]
+
. 
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Method 2
9
: 
A solution of dansyl chloride (0.564 g, 2.09 mmol, 1 Eq) in dichloromethane (25 ml) was added 
dropwise to a degassed solution of 1, 2 - ethylenediamine (10 ml, 150 mmol, 71.6 Eq) over 1 h.  The 
reaction was monitored via TLC and after 4 h, the reaction mixture was reduced under pressure to 
give a yellow syrup.  This was dissolved in ethyl acetate (25 ml) and washed with a saturated solution 
of NaHCO3 (3 x 7 ml) and water (3 x 7 ml).  The organic layer was dried over MgSO4, filtered and the 
solvent removed under reduced pressure to give a light green fluffy powder (0.496 g, 1.69 mmol, 81 
%).  
1
H NMR (CDCl3), δ: 8.55 (1H, d, 
3
JHH = 8.56 Hz, (CH3)2NCCHCH), 8.32 (1H, d, 
3
JHH = 8.68 Hz, 
(CH3)2NCCHCHCHC), 8.27 (1H, dd, 
3
JHH = 7.28 Hz, 
4
JHH = 0.92 Hz, (CH3)2NCCCHCH), 7.60 – 7.52 
(2H, m, (CH3)2NCCHCHCH, (CH3)2NCCCHCHCH), 7.20 (1H, d, 
3
JHH = 7.48 Hz, 
(CH3)2NCCCHCHCH), 2.93 (2H, t, 
3
JHH = 5.54 Hz, NHCH2CH2NH2), 2.91 (6H, s, (CH3)2N), 2.71 
(2H, t, 
3
JHH = 5.66 Hz, NHCH2CH2NH2).  
13
C NMR (CDCl3), δ: 152.0 (SO2CCCHCH), 134.7 
((CH3)2NCCCH), 130.4 (SO2CCCHCH), 130.0 (SO2CCHCHCHCC), 129.7 (SO2CCHCHCH), 129.6 
(SO2CCCHCH), 128.4 (SO2CCHCHCH), 123.2 (SO2CCHCHCH), 118.7 (SO2CCCHCHCH), 115.2 
(SO2CCCHCHCH), 45.5 (H2NCH2CH2NH), 45.4 (H2NCH2CH2NH), 40.8 (N(CH3)2).  HR MS (ESI
+
): 
calculated for C14H20N3O2S ([M+H]
+
) 294.1276; found, 294.1272.
 
 IR, νmax/cm
-1
: 3348.69 (NH), 
3285.97 (NH), 1570.66 (NH, bending band), 1316.96 (-SO2-), 1142.21 (-SO2-). 
 
N - (2 - Aminoethyl) - 5 - (dimethylamino)naphthalene - 1 - sulfonamide (28) 
 29 (0.133 g, 0.453 mmol, 1 Eq.) and Et3N (0.07 ml, 0.476 mmol, 1.05 Eq.) 
were stirred together in THF (35 ml) and cooled to 0 ˚C in an ice-water bath.  
Chloroacetyl chloride (0.04 ml, 0.476 mmol, 1.05 Eq.) was added dropwise 
and the reaction monitored by TLC (DCM/MeOH = 9/1).  After 4 h of stirring 
at room temperature, the filtrate was concentrated under reduced pressure.  And the crude mixture 
purified via column chromatography with dichloromethane/methanol to give a light green solid (0.480 
g, 1.30 mmol, 83 %).  
1
H NMR (CDCl3), δ: 8.56 (1H, d, 
3
JHH = 8.48 Hz, (CH3)2NCCHCHCH), 8.28 
(1H, d, 
3
JHH = 8.68 Hz, (CH3)2NCCHCHCH), 8.25 (1H, dd, 
3
JHH = 7.22 Hz, 
4
JHH = 0.90 Hz, 
(CH3)2NCCCHCHCH), 7.59 – 7.52 (2H, m, (CH3)2NCCHCHCH, (CH3)2NCCCHCHCH), 7.19 (1H, 
d, 
3
JHH = 7.52 Hz, (CH3)2NCCCHCHCH), 6.95 (1H, t, 
3
JHH = 6.58 Hz, SO2NHCH2), 5.84 (1H, t, 
3
JHH 
= 6.58 Hz, NHCOCH2), 3.86 (2H, s, COCH2Cl), 3.37 (2H, q, 
3
JHH = 5.70 Hz, NHCH2CH2NHCO), 
3.11 (2H, q, 
3
JHH = 5.68 Hz, NHCH2CH2NHCO), 2.90 (6H, s, (CH3)2N).  
13
C NMR (CDCl3), δ: 167.1 
(CO), 152.1 (SO2CCCH), 134.3 ((CH3)2NCCCH), 130.7 (SO2CCCHCH), 129.9 (SO2CCHCHCHCC), 
129.7 (SO2CCHCHCH), 129.4 (SO2CCCHCH), 128.6 (SO2CCHCHCH), 123.2 (SO2CCHCHCH), 
118.6 (SO2CCCHCHCH), 115.3 (SO2CCCHCHCH), 45.4 (ClCH2CO), 42.8 (CONHCH2CH2NH), 
42.4 (CONHCH2CH2NH), 39.6 (N(CH3)2).  IR, νmax/cm
-1
: 3281.89 (NH), 1657.84 (CO), 1536.45 
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(CO), 1313.11 (-SO2-), 1142.10 (-SO2-).  HR MS (ESI
+
): calculated for C16H21ClN3O3S ([M+H]
+
) 
370.0992; found, 370.0975. 
 
Bis(2 - Pyridylmethyl)amine
10 
(30) 
Pyridine - 2 - carboxaldehyde (8.8 mL, 92.5 mmol, 1 Eq.) was dissolved in dry 
MeOH, and stirred, whilst 2-pyridylmethylamine (9.5 mL, 92.5 mmol, 1 Eq.) was 
added dropwise to the reaction mixture.  This was left to stir for an hour at room temperature.  Sodium 
borohydride (7.00 g, 184.9 mmol, 2 Eq.) was then gradually added over an hour.  After stirring the 
reaction mixture overnight, it was cooled solution acidified with concentrated HCl until pH 4 was 
attained.  Following the addition of ethanol (100 mL), the resulting white solid was filtered off, and 
the filtrate concentrated under vacuum to give the title compound as the yellow oil.  
1
H NMR 
(CDCl3): δ = 8.57 (d, J = 4.60 Hz, 2 H); 7.73 (td, J = 7.70 Hz, J = 1.69 Hz, 2 H); 7.55 (d, J = 7.80 Hz, 
2 H); 7.28 (t, J = 5.68 Hz, 2 H); 4.51 (s, 4 H).  MS(ESI
+
): m/z = 200 amu [M + H]
+
. 
 
N - (2 - (bis(2 - pyridylmethyl)amino)ethyl)carbamic acid tert - butyl ester
11
 (35) 
27 (2.44 g, 15.3 mmol, 1 Eq.), 2 - picolyl chloride hydrochloride (4.96 g, 
30.2 mmol, 2.03 Eq.) and NaOH (2.38 g, 59.5 mmol, 4 Eq.) were stirred in 
biphasic media of THF (100 ml) and distilled H2O (100 ml) at 50 ˚C for 5 
days.  The organic layer was separated and the aqueous layer extracted with 
DCM (100 ml).  Di - tert - butylcarbonate (1.00 g, 4.60 mmol) and 
triethylamine were added to the combined organic layers.  After stirring at RT overnight, the solvent 
was removed and the product purified via alumina column chromatography using 1% MeOH: DCM 
to give the product as a brown viscous oil (2.00 g, 5.84 mmol, 38 %).  
1
H NMR (CDCl3), δ: 8.55 (2H, 
dt, 
3
JHH = 4.84 Hz, 
4
JHH = 0.79 Hz, NCHCHCH), 7.63 (2H, td, 
3
JHH = 7.51 Hz, 
3
JHH = 1.57 Hz, 
NCHCHCH), 7.41 (2H, d, 
3
JHH = 7.72 Hz, NCCHCHCH), 7.15 (2H, ddd, 
3
JHH = 7.30 Hz, 
3
JHH = 4.94 
Hz, 
4
JHH = 0.76 Hz, NCCHCHCH), 5.82 (1H, br, NH), 3.87 (4H, s, NCH2C), 3.22 (2H, q, 
3
JHH = 5.48 
Hz, CONHCH2CH2N), 2.71 (2H, t, 
3
JHH = 5.74 Hz, CONHCH2CH2N), 1.45 (9H, s, (CH3)3.  
13
C NMR 
(CDCl3), δ: 159.3 (CO), 156.2 (NCCHCH), 149.1 (NCHCHCH), 136.4 (NCCHCH), 123.0 
(NCCHCH), 122.0 (NCHCHCH), 78.7 (NCH2C), 60.2 (NHCH2CH2N), 53.5 (NHCH2CH2N), 38.5 
(OC(CH3)3), 28.5 ((CH3)3).  MS (ESI
+
): m/z = 343 amu [M + H]
+
. 
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N - (2 - (bis(2 - pyridylmethyl)amino)ethylamine
11 
(31) 
35 (0.119 g) was left to stir in TFA: DCM (v:v) for 2 h at rt.  Volatiles were removed 
under a stream of N2 to give a brown residue.  The residue was dissolved in MeOH 
and DCM and concentrated to leave a light brown oil.  
1
H NMR (CD3OD), δ: 8.91 
(2H, d, 
3
JHH = 5.44 Hz, NCHCHCHCH), 8.65 (2H, t, 
3
JHH = 7.58 Hz, NCHCHCH), 
8.26 (2H, d, 
3
JHH = 7.80 Hz, NCHCHCHCH), 8.09 (2H, t, 
3
JHH = 6.52 Hz, NCHCHCHCH), 4.37 (4H, 
s, (NCH2)2), 3.32 (2H, m, CONHCH2CH2N), 3.04 (2H, t, 
3
JHH = 5.30 Hz, CONHCH2CH2N), 1.45 (9H, 
s, (CH3)3.  
13
C NMR (CD3OD), δ: 152.0 (NCHCHCHCH), 147.4 (NCHCHCHCH), 141.8 
(NCHCHCHCHC), 127.8 (NCHCHCHCH), 126.6 (NCHCHCHCH), 55.5 (N(CH2)2), 52.0 
(NHCH2CH2NH2), 45.0 (NHCH2CH2N).  MS (ESI
+
): m/z = 243 [M + H]
+
.   
 
2 - Chloro - N - (pyridin - 2 - yl - methyl) acetamide
12 
(37) 
2-(aminomethyl)pyridine (0.95 ml, 9.25 mmol, 1 Eq.) and triethylamine (1.35 ml, 
9.71 mmol, 1.05 Eq.) were stirred together in tetrahydrofuran (20 ml) and cooled to 
0 ⁰C in an ice-water bath.  Chloroacetyl chloride (0.77 ml, 9.71 mmol, 1.05 Eq.) in 
tetrahydrofuran (10 ml) was added dropwise over an hour.  The reaction was monitored by TLC 
(EtOAc/MeOH = 9/1).  After 4 h of stirring at room temperature, the solids were filtered off, and the 
filtrates concentrated under reduced pressure.  The residues were dissolved in ethyl acetate (40 ml) 
and extracted with saturated sodium hydrogen carbonate solution (3 x 20 ml).  After drying the 
collective organic layers over magnesium sulphate, the solvent was evaporated under reduced 
pressure, yielding a light brown oil (1.41 g, 7.62 mmol 82 %).  
1
H NMR (CDCl3): δ = 8.58 (1H, d, 
3
J 
= 4.76 Hz, NCHCH), 7.89 (1H, s br, CH2NHCO), 7.69 (1H, dt, 
3
J = 7.69 Hz, 
3
J = 1.76 Hz, 
NCHCHCH), 7.25 (2H, m, NCHCHCH, NCCHCH), 4.61 (2H, d, 
3
J = 5.00 Hz, CH2NH), 4.13 (2H, s, 
COCH2Cl).  
13
C NMR (CDCl3): δ = 166.1 (CO), 155.5 (NCCHCH), 149.2 (NCHCHCH), 136.9 
(NCCHCH), 122.6 (NCCHCHCH), 122.0 (NCHCHCH), 44.6 (NHCH2), 42.6 (COCH2Cl).  MS 
(ESI
+
): m/z = 185 amu [M + H]
+
.
 
 IR, νmax/cm
-1
: 3286.50 (NH), 3057.30 (NH), 1659.92 (CO), 755.95 
(CCl). 
 
2 - Amino - N - (pyridin - 2 - yl - methyl) acetamide chloride (38) 
Ammonium acetate (0.490 g, 6.36 mmol, 1 Eq.) was suspended in THF (5 ml).  
NH4OH solution (100 ml) was then added, and the resultant solution stirred at rt, 
followed by the slow addition of 37 over 30 mins.  After 3 days the product was 
extracted via addition of CHCl3 (3 x 25 ml).  The organic layers were combined and dried over 
MgSO4.  The solids were the filtered off, and the filtrate concentrated under reduced pressure to give a 
brown oil, in the form of the free amine.  The salt was formed by subsequently stirring the brown oil 
in 1 M HCl (40 ml) for 35 mins.  After this was concentrated under vacuum, the product was obtained 
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via recrystallization from MeOH and CHCl3 to give an off - white solid (0.432 g, 2.14 mmol, 34 %).  
1
H NMR (D2O), δ: 8.59 (1H, d, 
3
JHH = 5.94 Hz, NCHCH), 8.45 (1H, td, 
3
JHH = 8.00 Hz, 
4
JHH = 1.49 
Hz, NCHCHCHCH), 7.86 (2H, overlapping peaks, NCCHCH, NCHCHCH), 4.75 (2H, s, CCH2NH), 
3.87 (2H, s, COCH2NH2).  
13
C NMR (D2O), δ: 168.2 (CO), 152.1 (NCCHCH), 147.2 (NCHCHCH), 
141.0 (NCCHCH), 125.9 (NCCHCHCH), 125.6 (NCHCHCH), 40.6 (NHCH2), 40.4 (COCH2NH2).  
MS (ESI)
+
: m/z = 166 ([M + H])
+
, 188 ([M + Na])
+
.  IR, νmax/cm
-1
: 3182 (NH), 3018 (NH), 1697 
(CO), 1680 (CN), 1635 (NH), 1615 (C=C), 1563 (NH), 1468 (C=C), 1263 (CN).  Elemental Analysis: 
calculated (C8H12ClN3O.2HCl) C 40.35 %, H 5.50 %, N 17.65 %; found C 40.41 %, H 5.42 %, 
16.14 %. 
  
2 - Chloro - acetamide - 2 - Amino - N - (pyridin - 2 - yl - methyl) acetamide chloride (39) 
38 (357 mg, 1.77 mmol, 1 Eq.) was suspended in THF (50 ml) and stirred at rt.  
Chloroacetyl chloride (0.15 ml, 1.86 mmol, 1.05 Eq.) and Et3N (0.30 ml, 1.86 
mmol, 1.05 Eq.) were then added, and all was left to stir for 18 h overnight.  The resulting white 
precipitate was filtered off (64.5 mg, 0.267 mmol, 21 %).  
1
H NMR (CDCl3), δ: 8.46 (1 H, d, 
3
JHH = 
4.80 Hz, NCHCH), 7.74 (1 H, br, NHCOCH2NH), 7.67 (1 H, td, 
3
JHH = 7.70 Hz, 
4
JHH = 1.76 Hz, 
NCHCHCH), 7.30 (1 H, br, NCHCHCH), 7.19 (1 H, dd, 3JHH = 7.04 Hz, 
3
JHH = 5.08 Hz, NCCHCH), 
4.52 (2 H, d, 
3
JHH = 4.24 Hz, CH2NH), 4.06, (2 H, s, NHCOCH2Cl), 4.00 (2H, d, 
3
JHH = 3.68 Hz, 
NHCOCH2NH).  
13
C NMR (CDCl3), δ: 168.5 (NHCOCH2NH), 156.4 (NHCOCH2Cl), 148.8 
(NCHCHCH), 137.3 (NCCHCH), 122.6 (NCCHCHCH), 122.3 (NCHCHCH), 44.3 (NHCOCH2Cl), 
42.8 (NHCOCH2NH), 42.3 (CCH2NHCO).  MS(ESI
+
) m/z = 242 amu [M + H]
+
.  
 
1 - ((Dimethylamino) - 1 - naphthalenesulphonamido) - 1,4,7,10-tetraazacyclododecane (44) 
Dansyl chloride (1.88 g, 6.97 mmol, 1 Eq.) dissolved in CHCl3 (30 ml, 
passed through Al2O3) was slowly added to a solution of cyclen (3.00 g, 
17.4 mmol, 2.5 Eq.) and CHCl3 (60 ml).  The resulting clear light green 
solution was left to stir at room temperature for 48 h.  The reaction mixture 
was concentrated under vacuum and purified via column chromatography (dichloromethane: 
methanol, 85:15) to yield a bright green crystalline solid (1.90 g, 4.68 mmol, 67 % yield).  Mp: 80 – 
82 ˚C.  1H NMR (CDCl3), δ: 8.55 (1H, 
3
JHH = 8.44 Hz, SO2CCHCH), 8.49 (1H, d, 
3
JHH = 8.72 Hz, 
(CH3)2NCCHCH), 8.22 (1H, dd, 
3
JHH = 7.30 Hz, 
3
JHH = 0.86 Hz, SO2CCHCHCH), 7.59 – 7.51 (2H, 
m, SO2CCCHCHCH, SO2CCHCHCH), 7.19 (1H, d, 
3
JHH = 7.52 Hz, SO2CCCHCH), 3.41 (4H, t, 
3
JHH 
= 5.08 Hz, 2, 12 – CH2), 2.89 (6H, s, CH3), 2.80 – 2.75 (8H, m, 3, 11 – CH2, 5, 9 – CH2), 2.62 (4H, t, 
3
JHH = 5.18 Hz, 6, 8 – CH2).  
13
C NMR (CDCl3), δ: 151.8 (SO2CCH), 133.5 ((CH3)2NCCH), 130.7 
(SO2CCHCH), 130.3 (SO2CCCH), 130.2 (SO2CCHCHCHCCN(CH3)2), 129.7 (SO2CCCHCH), 128.3 
(SO2CCHCHCHC), 123.2 (SO2CCHCHCH), 119.4 ((CH3)2NCCHCH), 115.3 ((CH3)2NCCHCHCH), 
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49.6 (2, 12 – CH2), 48.6 (3, 11 – CH2), 47.7 (5, 9 – CH2), 45.7 (6, 8 – CH2), 45.4 ((CH3)2N).  
MS(ESI
+
): m/z 406 [M+H]
+
; 428 [M+Na]
+
; HR-ESI: found 406.2270 [M + H]
+
.  Elemental Analysis: 
calculated (C20H31N5O2S) C 59.23 %, H 7.70 %, N 17.27 %; found C 59.11 %, H 7.66 %, 17.16 %. 
 
1 - ((Dimethylamino)-1-naphthalenesulphonamido) - 7 - N - (pyridin - 2 - yl - methyl)acetamide - 
1,4,7,10 - tetraazacyclododecane (43) 
44 (1.70 g, 4.19 mmol, 3.56 Eq.), K2CO3 (0.488 g, 3.53 mmol, 
3.18 Eq.) and MeCN (50 ml) were stirred together, followed by the 
slow addition of actemide (0.217 g, 1.18 mmol, 1 Eq.) was then left to 
stir at 60 ˚C.  After 18 h, the reaction mixture was concentrated and 
purified via column chromatography on alumina (gradient elution from CH2Cl2 to 1 % 
MeOH/CH2Cl2).  The resulting yellow product was collected (0.271 g, 0.489 mmol, 42 %).  
1
H NMR 
(CDCl3), δ: 8.54-8.52 (2 H, m, SO2CCHCH, (CH3)2NCCCHCH), 8.36 (1 H, d, 
3
JHH = 8.26 Hz, 
(CH3)2NCCHCH), 8.23 (1 H, br, NH), 8.01 (1 H, d, 
3
JHH = 8.12 Hz, (CH3)2NCCCHCH), 7.58 – 7.18 
(4 H, m, NCHCHCH, NCCHCH, NCHCHCH, SO2CCCHCH), 3.62 – 2.89 (26 H, m, aliphatic 
protons).  MS(ESI
+
) m/z = 554 amu [M + H]
+
. 
 
(1 - (Dimethylamino) - 1 - naphthalenesulphonamido) - 4,10 - (tert-butyl ester) - 7 - N - (pyridin - 
2 - yl - methyl) acetamide - 1,4,7,10 - tetraazacyclododecane (42) 
43 (0.234 g, 0.422 mmol, 1 Eq.) was stirred with tert - butyl bromoacetate 
(0.19 ml, 1.27 mmol, 3 Eq.) in MeCN (50 ml) at rt.  After 2h, Et3N 
(0.29 ml, 2.11 mmol, 5 Eq.) was added and left to stir for 12 h.  The dark 
yellow solution was concentrated and passed through a silica column 
(gradient elution from CH2Cl2 to 5 % MeOH/CH2Cl2).  The resultant dark 
yellow solid was washed with distilled water, then basified to pH > 12 by 
adding 20 % aqueous NaOH solution followed by extraction with ether (2 x 20 ml).  The ethereal 
layers were combined and dried over MgSO4.  After the solids were filtered off, the yellow solution 
was concentrated under reduced pressure to give a dark yellow solid (0.085 mg, 0.108 mmol, 24 %).  
1
H NMR (CDCl3), δ: 8.92 (1H, t, 
3
JHH = 6.36 Hz, NH), 8.55 (1H, d, 
3
JHH = 8.64 Hz, SO2CCHCH), 
8.35 (1H, d, 
3
JHH = 8.72 Hz, (CH3)2NCCHCH), 8.27 (1H, d, 
3
JHH = 5.00 Hz, NCHCHCH), 8.05 (1H, 
d, 
3
JHH = 7.32 Hz, (CH3)2NCCCHCH), 7.56 – 7.51 (3H, m, (CH3)2NCCCHCH, NCCHCH, 
NCHCHCH), 7.28 (1H, d, 
3
JHH = 7.72 Hz, NCHCHCH), 7.20 (1H, d, 
3
JHH = 7.64 Hz, SO2CCCHCH), 
6.95 (1H, d, 
3
JHH = 7.24 Hz, NCHCHCH), 4.57 (2H, d, 
3
JHH = 5.80 Hz, CH2NH), 3.37 (4H, t, 
3
JHH = 
6.20 Hz, 2, 12 – CH2), 3.16 (2H, s, NCH2CONH), 3.14 (4H, s, NCH2COO), 2.99 (4H, t, 
3
JHH = 6.12 
Hz, 3, 11 – CH2), 2.90 (6H, s, N(CH3)2), 2.75 (4H, dd, 
3
JHH = 6.08 Hz, 
3
JHH = 3.48 Hz, 5, 9 – CH2), 
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2.63 (4H, dd, 
3
JHH = 6.20 Hz, 
3
JHH = 3.32 Hz, 6, 8 – CH2), 1.43 (18H, s, (O(CH3)3)2).  m/z (ESI
+
) 782 
([M]
+
). 
 
(1 - (2(5 - (Dimethylamino) - 1 - naphthalenesulphonamido) - 4,10 - (acetic acid) - 7 - N - 
(pyridin - 2 - yl methyl) acetamide - 1,4,7,10 - tetraazacyclododecane (41) 
42 (0.085 g, 0.108 mmol) was stirred with a mixture of HCl/1, 4 - dioxane 
and left for 18 h.  The clear solution was concentrated under vacuum to give 
a light yellow film.  
1
H NMR - maintained traces of impurities after 
purification attempts via column chromatography.  MS(ESI
+
) m/z = 
670 amu [M + H]
+
. 
 
 
(1 - (2(5 - (Dimethylamino) - 1 - naphthalenesulphonamido) - 4,7,10 - N - (pyridin - 2 - yl -
methyl) acetamide - 1,4,7,10 - tetraazacyclododecane (46) 
44 (0.806 g, 1.99 mmol, 1 Eq.) was stirred together with 37 (1.12 g, 
6.08 mmol, 3.1 Eq.) and K2CO3 (0.841 g, 6.08 mmol, 3.1 Eq.) in 
MeCN at 60 ⁰C.  After 18 h, the solids were filtered off, and the filtrate 
reduced under pressure.  The resulting brown oily residue was 
subjected to column chromatography on alumina (DCM > 1 % 
MeOH), to yield a yellow powder (0.538 g, 0.633 mmol, 32 %).  Mp: 
76 - 77 ⁰C.  1H NMR (CDCl3), δ: 8.56 (1H, d, 
3
JHH = 8.44 Hz, SO2CCHCH), 8.49 (2H, dd, 
3
JHH = 4.92 
Hz, 
4
JHH = 0.84 Hz, (NCHCHCH)2), 8.35 (1H, d, 
3
JHH = 8.72 Hz, (CH3)2NCCHCH), 8.27 (1H, t, 
3
JHH 
= 5.40 Hz, CH2NH), 8.17 (1H, d, 
3
JHH = 4.72 Hz, NCHCHCH), 8.02 (2H, t, 
3
JHH = 5.80 Hz, 
(CH2NH)2, 7.99 (1H, dt, 
3
JHH = 7.26 Hz, 
4
JHH = 1.12 Hz, (CH3)2NCCCHCH), 7.63 (2H, td, 
3
JHH = 7.67 
Hz, 
4
JHH = 1.73 Hz, (NCHCHCH)2), 7.55 – 7.49 (2H, m, (CH3)2NCCCHCH), 7.48 (1H, td, 
3
JHH = 7.69 
Hz, 
4
JHH = 1.73 Hz, NCHCHCH), 7.26 – 7.14 (6H, m, (NCCHCH)2, (NCHCHCH)2, NCCHCH, 
SO2CCCHCH), 6.89 (1H, dd, 
3
JHH = 7.18 Hz, 
3
JHH = 5.14 Hz, NCHCHCH), 4.52 (4H, d, 
3
JHH = 5.36 
Hz, (NHCH2C)2), 4.45 (2H, d, 
3
JHH = 5.12 Hz, NHCH2C), 3.29 (4H, t, 
3
JHH = 6.02 Hz, 2, 12 – CH2), 
3.19 (2H, s, NCH2CO), 3.18 (4H, s, (NCH2CO)2), 3.13 (4H, t, 
3
JHH = 5.94 Hz, 3, 11 – CH2), 2.91 (6H, 
s, N(CH3)2), 2.74 (4H, t, 
3
JHH = 2.72 Hz, 5, 9 – CH2), 2.69 (4H, t, 
3
JHH = 2.60 Hz, 6, 8 – CH2).  
13
C 
NMR (CDCl3), δ: 170.8 ((CO)2), 157.0 ((NHCH2CNCH)2), 156.8 (CO), 156.7 (NHCH2CNCH2), 
149.4 (NHCH2CCHCH), 149.2 (SO2CCH), 149.1 ((NHCH2CCHCH)2), 137.3 ((NHCH2CNCHCH)2), 
136.1 (NHCH2CNCHCH), 134.3 ((CH3)2NCCH), 130.6 (SO2CCCHCH), 130.5 
(SO2CCHCHCHCCCH), 130.4 (SO2CCHCH), 130.3 (SO2CCCHCH), 128.8 (SO2CCHCHCHCC), 
123.1 (SO2CCHCHCH), 122.8 ((NHCH2CNCHCHCH)2), 122.6 (NHCH2CCHCHCH), 121.9 
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((CH3)2NCCHCH), 121.8 (NHCH2CNCHCHCH), 121.4 (NHCH2CCHCHCH), 121.2 
(SO2CCCHCHCH), 58.5 (2, 12 – CH2), 57.5 (3, 11 – CH2), 54.4 (5, 9 – CH2), 53.2 (6, 8 – CH2), 45.0 
((NCH2CO)2), 44.6 (NCH2CO), 44.5 (NHCH2C), 44.2 ((NHCH2C)2), 43.4 ((CH3)2N).  m/z (ESI
+
) 850 
([M]
+
), 851 ([M + H]
+
), 872 ([M + Na]
+).  IR, νmax/cm
-1
: 3298 (br, NH), 3061 (NH), 2828 (C=N), 
1741 (C=N), 1654 (C=O), 1518 (N-H bend), 1475 (C=C), 1313 (S=O), 1138 (S=O).  Elemental 
analysis: calculated (C44H55N11O5S) C 62.17 %, H 6.52 %, N 18.13 %; found C 62.30 %, H 6.62 %, N 
18.09 %. 
 
 
Gd.(1 - (2(5 - (Dimethylamino) - 1 - naphthalenesulphonamido) - 4,7,10 - N - (pyridin - 2 - yl -
methyl) acetamide - 1,4,7,10 - tetraazacyclododecane (Gd.45) 
46 (0.248 g, 0.291 mmol, 1 Eq.) and Gd(OTf)3 (0.159 g, 
0.262 mmol, 0.90 Eq.) was dissolved in MeCN (30 ml).  The 
solution was heated under reflux for 16 h, and then concentrated.  
Following flash chromatography (3 % MeOH in DCM) with 
alumina, the resultant yellow solution was concentrated and 
dissolved in a minimal amount of MeCN, followed by 100 ml of 
Et2O then stirring for a week to yield an orange powder (0.320 g, 0.220 mmol, 84 %).  Mp: 169 – 
171 ˚C.  MS(FAB+): m/z = 1007 amu [M]+, 1305 amu [M + 2CF3SO3
-
]
2+
.  Elemental Analysis: 
calculated (C47H55F9GdN11O14S4) C 38.81 %, H 3.81 %, N 10.59 %; found C 38.70 %, H 3.77 %, N 
10.63 %. 
 
 
Eu.(1 - (2(5 - (Dimethylamino) – 1 - naphthalenesulphonamido) - 4,7,10 – N - (pyridin – 2 – yl -
methyl) acetamide - 1,4,7,10 - tetraazacyclododecane (Gd.45) 
The same method was employed as the the Gd.analgoue. 46 
(0.233 g, 0.274 mmol, 1 Eq.) and Eu(OTf)3 (0.148 g, 0.246 mmol, 
0.90 Eq.) were used. An orange powder was obtained (0.317 g, 
0.219 mmol, 89 %).  Mp: 154-156 ˚C.  m/z (FAB)+ 1002 ([M])+, 
1151 ([M + CF3SO3
-
])
+
, 1300 ([M + 2CF3SO3
-
])
2+
.  Elemental 
Analysis: calculated (C47H55F9EuN11O14S4) C 38.95 %, H 3.83 %, 
N 10.63 %; found C 39.09 %, H 3.95 %, N 10.56 %. 
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1 - N - (2 - Aminoethyl) - 5 - (dimethylamino)naphthalene - 1 - sulfonamide - 1,4,7,10 -
tetraazacyclododecane (48) 
The same method was followed as with the 44.  In this case the 
following amounts were used: 28 (1.70 g, 4.60 mmol, 1 Eq.), 6 (1.98 g, 
11.5 mmol, 2.5 Eq.) to yield a light yellow powder (2.16 g, 4.27 mmol, 
93 %).  
1
H NMR (CDCl3), δ: 8.53 (1 H, d, 
3
JHH = 8.52 Hz, 
(CH3)2NCCHCHCH), 8.31 (1 H, d, 
3
JHH = 8.68 Hz, 
(CH3)2NCCHCHCH), 8.21 (1 H, dd, 
3
JHH = 7.20 Hz, 
4
JHH = 1.04 Hz, (CH3)2NCCCHCHCH), 7.54-
7.50 (2 H, m, (CH3)2NCCHCHCH, (CH3)2NCCCHCHCH), 7.18 (1 H, d, 
3
JHH = 7.44 Hz, 
(CH3)2NCCCHCHCH), 3.38-2.74 (28 H, m, aliphatic protons).  
13
C NMR (CDCl3), δ:  171.2 (CO), 
151.9 (SO2CCCH), 135.4 (CCH3)2NCCCH), 130.1 (SO2CCCH), 129.7 (SO2CCHCHCHCC), 129.2 
(SO2CCHCHCH), 129.0 (SO2CCCHCH), 127.9 (SO2CCHCHCH), 123.2 (SO2CCHCHCH), 118.9 
(SO2CCCHCHCH), 115.1 (SO2CCCHCHCH), 46.8 (2, 12-CH2), 46.2 (3, 11-CH2), 46.0 (5, 9-CH2), 
45.4 (6, 8-CH2), 45.2 (CH2CO), 43.1 (NHCH2CH2NHSO2), 42.3 (NHCH2CH2NHSO2), 39.6 
(N(CH3)2).  MS(ESI
+
) m/z = 506 amu [M + H]
+
.  Elemental Analysis: calculated (C24H39N7O3S.HCl) 
C 53.17 %, H 7.04 %, N 18.09 %; found C 53.37 %, H 5.90 %, 17.20 %. 
 
1 - N - (2 - Aminoethyl) - 5 - (dimethylamino)naphthalene - 1 - sulfonamide - 4,7,10 - N - 
(pyridin - 2 - yl - methyl) acetamide - 1,4,7,10 - tetraazacyclododecane (49) 
The same method was used as 46 with quantities of 48 (1 g, 
1.98 mmol, 1 Eq.) and 37 (2.11 g, 11.4 mmol, 5.76 Eq.).  The 
1
H 
NMR spectrum contained overlapping peaks. MS (ESI
+
) m/z = 
972.5 amu [M + Na]
+
.  IR, νmax/cm
-1
: 3293 (br, NH), 3059 (NH), 
1741 (C=N), 1654 (C=O), 1573 (N-H bend), 1475 (C=C), 1138 
(S=O).   
 
 
Gd.1 - N - (2 - Aminoethyl) - 5 - (dimethylamino)naphthalene - 1 - sulfonamide - 4,7,10 - N -
(pyridin - 2 - yl - methyl) acetamide - 1,4,7,10 - tetraazacyclododecane (Gd.45a) 
The same method was employed for previous Ln
3+
complexes 
with quantities as follows tetraamide - DOTA derivative (0.0713 
g, 0.0750 mmol, 1 Eq.) and Gd(OTf)3 (0.0408 mg, 0.0675 mmol, 
0.9 Eq.).  MS(MALDI
+
) – indicated fragment patterns indicative 
of the presence of a Gd
3+
.  Elemental Analysis: calculated 
(C48H12ClN3O.2HCl) C 39.40 %, H 4.08 %, N 11.71 %; found 
C 36.66 %, H 3.58 %, 9.46 %. 
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7.3.  Measurements of Photophysical Properties 
General Procedure for Recording Spectra 
All probes were prepared as a 2 mM stock solution in either H2O for Gd.1 or MeOH for Eu.45, 
Gd.45, and Gd.45a.  The cationic solutions were prepared as stock solutions from ZnCl2, Cu(ClO4)2, 
CaCl2 and Mg(ClO4)2 in either H2O for Gd.1 or MeOH for Eu.45, Gd.45 and Gd.45a at a 
concentration of 39.87 μM.    Before spectroscopic measurements, solutions were freshly prepared by 
diluting the corresponding high-concentration stock solution to 11.96 μM for each respective titration, 
for either UV/Vis or fluorescence spectrometry, so that 1 equivalent of cation was available in 10 μL. 
For each spectrum, 3 mL of a probe solution was added to a 1 cm quartz cell, to which different stock 
solutions of cations were gradullay added using a micro-pipette.  The added volume of a cationic 
stock solution was always less than 50 μL to minimise changes in the total volume of the testing 
solution.  For the fluorescence spectra, cationic fluorescence was titrated at an excitation wavelength 
of 300 nm for Gd.1 and 350 nm for Eu.45, Gd.45 and Gd.45a.  Excitation and emission slits widths 
were modified to adjust the luminescent intensity in a suitable range between 2.5 - 10 nm. 
 
7.3.1. Determination of Apparent Binding Constants with Zn2+ (and other cations) 
The absorption and the fluorescence intensity were both plotted independently against [Zn
2+
]free, the 
concentration of free Zn
2+
.  The apparent binding association constants K with Zn
2+ 
were determined 
by fitting the data to the following equation: 
  ]G[]Gd[
]Gd[
1 2
2
  dZnIIII GdGdT
T
calc GdZn
 
Where here Icalc is the theoretical Gd
3+
 emission intensity (from the fluorescence titration) or 
absorption (from the UV/Vis titration) (to be compared with the experimentally observed Gd
3+
 
emission intensity/absorption), IGd is the intensity of the Gd
3+
 complex when no Zn
2+
 is bound  (i.e. at 
the start of the titration) and IGdZn
2+
 is the intensity of the Gd
3+
 complex when Zn
2+
 is entirely bound 
(i.e. at the end of the titration).
13 
Origin 10.0 software was used to fit above nonlinear plot to give the 
K value. 
 
7.3.2. T1 Measurements at 500 MHz 
All T1 values for Gd.1 were measured with a Bruker Advance 500 NMR spectrometer at carried out in 
collaboration with Peter Haycock, Imperial College London.  The 90˚ pulse was calibrated for each 
sample individually.  Samples were measured in a 60 μL NMR tube coaxial insert within a 5 mm 
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NMR tube containing D2O.  Four NMR tube coaxial inserts were prepared with Gd.1 at 10.2 mM.  
Each insert had either 0, 0.5, 1.0, 2.0 equivalents of Zn
2+ 
added to the Gd.1 solution and left to 
equilibrate for three hours.  The concentration was subsequently measured by magnetic susceptibility 
shifts in the NMR spectra.
14 
 
7.3.3. Cellular Studies 
All cellular studies were carried out by Dr. Ellisa Bellomo, Imperial College London.  Cells were 
incubated with an increased concentration (1 to 100 µM) of Gd.45, Eu.45 and 46 at 37° C for 30 min. 
before imaging.  Images were captured using an Olympus IX - 70 widefield microscope with a x40 oil 
immersion objective and an Imago CCD camera. 
CD1 mouse pancreata were digested and dissociated into islets and acinar tissues and incubated for 30 
min. at 37° C with 100 µM of each compounds and subsequently imaged on an Olympus IX widefield 
microscope using a x10 objective (λex = 250 nm). 
 
7.3.4. MRI Studies 
All MRI studies (both in vitro and in vivo) were carried out by Dr. Po-Wah So, King‟s College 
London.  In vitro images were obtained at 4 T.   
 
7.4.  References 
1. Athey, P. S., Kiefer, G. E. A New, Facile Synthesis of 1,4,7,10 - Tetraazacyclododecane: 
Cyclen. The Journal of Organic Chemistry 67, 4081 - 4085 (2002). 
2. Lown, J. W., Joshua, A. V., McLaughlin, L. W. Novel Antitumor Nitrosoureas And Related 
Compounds And Their Reactions With DNA. Journal of Medicinal Chemistry 23, 798 - 805 
(1980). 
3. Zhang, Y., Guo, X., Si, W., Jia, L., Qian, X. Ratiometric and Water-Soluble Fluorescent Zinc 
Sensor of Carboxamidoquinoline with an Alkoxyethylamino Chain as Receptor. Organic 
Letters 10, 473 - 476 (2008). 
4. Dadabhoy, A., Faulkner, S., Sammes. P. G. Long Wavelength Sensitizers For Europium(III) 
Luminescence Based On Acridone Derivatives. Journal of the Chemical Society, Perkin 
Transaction 2, 348 - 357 (2002). 
5. Inoue, Y.M., K. New Amine - Based Tripodal Copper Catalysts for Atom Transfer Radical 
Polymerization. Macromolecules 37, 4014 - 4021 (2004). 
6. Meng, Q., Yu, M., Zhang, H., Ren, J., Huang, D. Synthesis and Application of N -
Hydroxysuccinimidyl Rhodamine B Ester as an Amine - Reactive Fluorescent Probe. Dyes 
and Pigments 73, 254 - 260 (2007). 
7. Landi, F., Johansson, C. M., Campopiano, D. J., Hulme, A. N. Synthesis And Application Of 
A New Cleavable Linker For “Click”-Based Affinity Chromatography Organic & 
Biomolecular Chemistry 8, 56 - 59 (2010). 
8. Doyle, E. L., Hunter, C. A., Phillips, H. C., Webb, S. J., Williams, N. H. Cooperative Binding 
at Lipid Bilayer Membrane Surfaces. Journal of the American Chemical Society 125, 4593 -
4599 (2003). 
Chapter 7: Experimental 
182 
 
9. Chen, C.-P., Wickstrom, E. Self-Protecting Bactericidal Titanium Alloy Surface Formed by 
Covalent Bonding of Daptomycin Bisphosphonates. Bioconjugate Chemistry 21, 1978 - 1986 
(2010). 
10. Bhattacharya, S., Snehalatha, K., Kumar, V. P. Synthesis of New Cu(II) - Chelating Ligand 
Amphiphiles and Their Esterolytic Properties in Cationic Micelles. Journal of Organic 
Chemistry 68, 2741 - 2747 (2003). 
11. Ling, K. -Q., Sayre, L. M. A Dopaquinone Model That Mimics the Water Addition Step of 
Cofactor Biogenesis in Copper Amine Oxidases. Journal of the American Chemical Society 
127, 4777 - 4784 (2005). 
12. Yin, J., Guan, X., Wang, D., Liu, S. Metal-Chelating and Dansyl-Labeled Poly(N-
isopropylacrylamide) Microgels as Fluorescent Cu
2+
 Sensors with Thermo-Enhanced 
Detection Sensitivity. Langmuir 25, 11367 - 11374 (2009). 
13. Aime, S., Botta, M., Fasano M., Terreno, E. The Chemistry of Contrast Agents in Magnetic 
Resonance Imaging: Protein Bound Metal Chelates (Wiley, 2001). 
14. Corsi, D. M., Platas - Iglesias, C., Van Bekkum, H., Peters, J. A. Determination of 
Paramagnetic Lanthanide(III) Concentrations from Bulk Magnetic Susceptibility Shifts in 
NMR Spectra. Magnetic Resonance in Chemistry 39, 723 - 726 (2001). 
 183 
 
 
Chapter 8 
 
Miscellaneous 
 184 
 
 
-2
5
-2
0
-1
5
-1
0
-5
2
5
2
0
1
5
1
0
5
0
p
p
m
E
u
.4
5
 -
 p
ro
to
n
 N
M
R
 f
o
r 
E
u
 -
 c
o
m
p
le
x
 i
n
 d
eu
te
ra
te
d
 m
et
h
a
n
o
l
